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ABBREVIATIONS
 
 
a/bFGF Acidic/basic fibroblast growth factor 
AFM Atomic force microscopy 
ALI Air-liquid interface 
ALP Alkaline phosphatase 
ATR-FTIR 
Attenuated total reflectance-Fourier 
transform infrared 
BSA Bovine serum albumin 
CE Cholesterol esterase 
CoCl2 Cobalt chloride 
DAPI 4’,6-diamidino-2-phenylindole 
DMAc N,N’-Dimethylacetamide 
DMEM Dulbecco’s modified Eagle medium 
DMFd Deuterated dimethylformamide 
DMSO Dimethylsulfoxide 
DSC Differential scanning calorimetry 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EtO Ethylene oxide 
FBGC Foreign body giant cell 
FBS Foetal bovine serum 
FDA Food and Drug Administration 
FGF-2 Fibroblast growth factor-2 
FITC Fluorescein isothiocyanate 
GelMA Gelatin methacrylate 
GPC Gel permeation chromatography 
1H NMR 1H nuclear magnetic resonance 
H & E Haematoxylin & eosin 
H2O2 Hydrogen peroxide 
HA Hyaluronic acid 
HaCaT Immortalized human keratinocytes 
HDFa Adult human dermal fibroblast 
HDI Hexamethylene diisocyanate 
HMDI 
4,4’-
methylenebis(cyclohexylisocyanate) 
hMSC 
Human bone marrow-derived 
mesenchymal stem cells 
IGF Insulin-like growth factor 
KGF Keratinocyte growth factor 
LBL Layer-by-layer 
LMW Low molecular weight 
MDA 4,4’-methylene dianiline 
MDI 4,4’-methylenebis(phenyl isocyanate) 
MMP Matrix metalloproteinases 
Mn Number average molecular weight 
Mw Molecular weight 
NaHCO3 Sodium bicarbonate 
PBS Phosphate buffered saline 
PCLU Poly(ε-caprolactone urea)urethane 
PCU Poly(carbonate urea)urethane 
PDGF Platelet-derived growth factor 
PDMS Polydimethylsiloxane 
PEG-DA Poly ethylene glycol-diacrylate 
PFA paraformaldehyde 
PGA Polyglycolic acid 
PI Propidium iodide 
PIP Poly Implant Prosthèse 
PLA Polylactic acid 
PLGA Poly(lactic co-glycolic) acid 
POSS Polyhedral oligomeric silsesquioxane 
PU Polyurethane 
RGD Arginine-Glycine-Aspartic acid 
RhB Rhodamine blue 
SEM Scanning electron microscopy 
TCP Tissue culture plastic 
TDA 2,4-toluene diamine 
TDI 2,4-toluene diisocyanate 
Tg Glass transition temperature 
TGF-β Transforming growth factor-β 
Tm Melting temperature 
TMSPMA (Trimethoxysilyl) propyl methacrylate 
VEGF Vascular endothelial growth factor 
XRD X-ray diffraction 
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ABSTRACT 
Skin protects our bodies for a lifetime and extensive loss of this barrier renders the 
individual susceptible to infections and death. Clinically available treatment options, 
however, are limited in establishing both functional and cosmetic satisfaction. The work 
described in this thesis is therefore concerned with the development and 
characterization of a novel biodegradable nanocomposite system displaying suitable 
properties as skin tissue engineering scaffolds. A novel family of segmented 
polyurethanes (PU) with increasing hard segment content based on a poly(ε-
caprolactone urea)urethane backbone incorporating POSS nanoparticles was 
synthesized and analysed in terms of material characteristics and biocompatibility. 
Incorporation of POSS nanoparticles into the PU backbone yielded mostly amorphous 
materials as corroborated by distinct glass transitions visible on differential scanning 
calorimetry spectra. With incrementally increasing hard segment content, ultimate 
tensile strength increased from ~10 to 21 MPa accompanied by increased values for 
elastic moduli from 0.03 to 0.06 MPa. Number average molecular weights (Mn) decreased 
with increasing hard segment content due to a corresponding decrease in the proportion 
of PCL.  Sterilization studies raised fundamental concerns regarding the suitability of 
conventionally available techniques since hydrolytically and temperature labile 
polymers are susceptible to degradation. The results obtained suggest 70 % ethanol to 
be a suitable laboratory-based disinfectant which was further demonstrated to have 
favourable effects on skin cell compatibility. Degradation studies revealed hard segment-
dependent modulation of the degradation rate and the materials’ viscoelasticity. In vivo 
implantation studies of porous scaffolds demonstrated firm integration with the 
subcutaneous tissue and extensive vascularization. The results obtained in this work 
highlight (i) the ability to control scaffold degradation rates and mechanical properties 
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and (ii) cellular as well as in vivo biocompatibility, all of which fundamental in the 
development of a versatile skin tissue engineering scaffold.  
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1 INTRODUCTION TO BIODEGRADABLE 
SCAFFOLDS FOR TISSUE ENGINEERING 
APPLICATIONS 
1.1 INTRODUCTION 
Scientific research is forever inspired by the quest for knowledge and the endless 
possibilities of sculpting our ideas and actions. The term ‘tissue engineering’ first emerged 
during a congregation of the National Science Foundation in 1987 and was subsequently 
further coined by Langer and Vacanti who provided an internationally accredited 
definition of this concept summarized as “an interdisciplinary field that applies the 
principles of engineering and life sciences toward the development of biological 
substitutes that restore, maintain, or improve tissue function” (Langer and Vacanti, 1993). 
The pivotal strategies underlying tissue engineering have been identified as (i) the use of 
isolated cells or cell substitutes, (ii) the use of tissue-inducing substances and (iii) the use 
of cells placed on or within matrices (Bell et al., 1981). These fundamental mechanisms 
have, over decades, evolved into the field today known as regenerative medicine which 
combines living cellular components with sophisticated biomaterials to create tissues and 
organs of physiologically satisfactory size and function. Dramatic deficiencies in organ 
and tissue donations co-existing with the ever increasing demand for such organs are 
determining factors for the exponentially rising interest and rapid development within 
the fields of tissue engineering and regenerative medicine. The emergence of 
nanotechnology and its integration into the medical arena carries the field above and 
beyond former limitations, thereby igniting a wave of interest for the exploration of 
research into biotechnological systems at the nanometer scale. One nanometer, or a 
billionth of a meter (1 x 10−9 m) is to a football what a football is to the Earth. With regards 
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to tissue engineering, the emergence of nanotechnology (‘nano-engineering’) has 
revolutionized the approach to fabricating tissues and organs since the manufacture of 
novel biosynthetic scaffolds with enhanced material properties enables scientists to 
develop controllable and application-specific biomatrices. Novel biomaterials 
synthesized within nanometer dimensions are particularly attractive as they can closely 
mimic the molecular structure of tissues and organs, thus providing an ideal environment 
for cellular interactions and tissue regeneration. Skin is the largest organ of the body and 
its outermost covering which provides a protective interface between internal organs and 
the external environment. Being subject to continuous environmental strain, its physical 
integrity is of pivotal importance. Extensive breaches (e.g. due to large burn injuries) of 
this external layer render the affected individual prone to invading pathogens and 
subsequent, potentially lethal infections. Currently available and widely used skin 
substitutes such as harvested autologous and cadaveric skin play a major role in the 
immediate coverage of such wounds and undoubtedly have saved many lives. However, 
limitations in terms of availability, mechanical properties as well as durability within the 
wound due to immunological rejection prevent permanent graft integration into the 
wound bed. The development of various polymeric biomaterials for tissue engineering 
skin constructs has advanced the development of new skin grafts. One property 
fundamental to the idea of tissue engineering scaffolds is their controlled biodegradability 
concurring with the simultaneous regeneration of new tissues and vasculature within 
such scaffolds. Biodegradation rates should ideally be tunable to suit individual 
applications, with relatively fast degradation rates potentially being more applicable to 
scaffolds placed, for example, into cutaneous wound beds, whereas longer biostability 
may be required for tissue engineered vascular grafts or heart valves (Bettinger et al., 
2009). Several important principles underlie the concept of tunable biodegradation of 
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tissue engineered scaffolds; (i) suitable polymer materials, (ii) scaffold fabrication 
methods and (iii) incorporation of cell-signaling morphogens or drugs into the scaffold 
matrix which may, over time, stimulate cell recruitment and tissue regeneration as well 
as influence biomaterial degradation. Multiple advantages of engineered synthetic over 
natural biological scaffolds exist; (i) their known production techniques, (ii) their 
controllable chemical and physical structures, (iii) their rate-tunable biodegradation, and 
(iv) biocompatibility of the scaffold material and its degradation products (Kannan et al., 
2005b).  
Nanotechnology has provided new impetus for research into biodegradable 
scaffolds composed of biologically safe natural, synthetic or composite polymers.  Nano-
engineering of such scaffolds could enhance scaffold characteristics even further by 
exploiting the fundamental changes in material properties once transition from micro- to 
nanoscale has taken place, thereby opening up new avenues for the field of regenerative 
medicine.  
1.2 DEGRADABLE POLYURETHANES FOR BIOMEDICAL APPLICATIONS 
Segmented polyurethanes (PUs) are amongst the most favoured synthetic polymers 
used in the manufacture of biomedical devices due to their superior biomechanical 
properties and a unique combination of toughness, durability, flexibility and 
biocompatibility. Generally, PUs are synthesized by reacting a polyol, often from the 
polyester family, with a diisocyanate which is followed by chain extension with a diamine. 
Since their discovery by Otto Bayer in 1937, the PU family has become the most versatile 
of any families of plastic materials, gaining considerable popularity in the biomedical field 
as pacemaker leads, catheters, vascular grafts and prosthetic heart valves (Chawla et al., 
1988, Izci et al., 2009, Rahmani et al., 2012, Desai et al., 2012). Whilst such applications 
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tend to favour the use of non-degradable materials, regenerative strategies involving 
organs such as the skin and bone as well as cases involving paediatric patients frequently 
require resorbable scaffolds to allow for unobstructed new tissue formation. In 
biodegradable systems, the ratio of the hard segment, soft polyols and chain extender 
significantly influences the rate and mode of degradation such that scaffold breakdown 
may be fine-tuned to suit individual applications. 
1.2.1 Hard Segment Isocyanates  
Isocyanates can be divided into two broad categories comprising of the relatively 
more stable aromatic isocyanates (e.g. 2,4-Toluene diisocyanate (TDI), methylene-bis-
diphenyl diisocyanate (MDI)) and the more labile aliphatic isocyanates (e.g. 4,4’-
methylenebis(cyclohexylisocyanate)). Aromatic groups are stabilised by resonance 
involving the sharing of π-electrons by adjacent atoms. This strengthens the linkages 
between atoms and results in higher bond strengths than those found in the equivalent 
aliphatic linkages, rendering aromatic PUs less susceptible to degradation (Lamba et al., 
1998). Whilst potentially useful for applications requiring long-term resistance to 
degradation, aromatic hard segments are unsuitable isocyanates for temporary PU 
scaffolds. Additionally, ongoing controversies pertaining to the potential carcinogenicity 
of breakdown products of heat-sterilized PUs containing aromatic isocyanates further 
discouraged their usage in biomedical implantable devices (Gogolewski, 1987, Bolognesi 
et al., 2001). Cleavage of the urethane linkage of PUs containing aromatic isocyanates 
results in the formation of either 2,4-toluene diamine (TDA) (Amin et al., 1993, Szycher 
and Siciliano, 1991) or 4-4’-methylene dianiline (MDA) (Mazzu and Smith, 1984) – both 
considered carcinogenic (Lamba et al., 1998, Darby et al., 1978). Aliphatic isocyanates 
such as 4,4’-methylenebis(cyclohexylisocyanate) (also referred to as hydrogenated MDI, 
or HMDI) on the other hand, have demonstrated to render degradation products which 
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are less toxic (Tang et al., 2003). Additionally, HMDI demonstrates beneficial mechanical 
properties including stronger elastomers with low elastic modulus and high strength due 
to rendering highly amorphous segmented PUs at relatively low hard segment content 
(Solis-Correa et al., 2007). 
1.2.2 Soft Segment Polyols 
The second building block of PUs is the polyol. The immense variety within polyol 
types accounts for the ability of PUs to adapt a material versatility unparalleled by other 
plastics. In terms of biomedical uses, polyols such as polyethylene glycol (PEG) are 
incorporated to confer critical material characteristics including bio- and 
cytocompatibility, haemocompatibility, biodurability or degradability producing non-
toxic degradation products. Polyols can be classified into polyethers or polyesters which 
are manufactured by the reaction of epoxides with active hydrogen compounds or via the 
polycondensation of multifunctional carboxylic acids (-COOH) and hydroxyl (-OH) 
compounds, respectively. While polyether polyols are extensively used for industrial 
purposes, biomedical applications preferably utilize polyesters which, when in their 
degradable form, break down into non-toxic end-products. Poly(ε-caprolactone) (PCL), a 
polyester, has attracted particular attention within the biomedical arena, especially in the 
field of tissue-engineering, due to its ability to fine-tune degradation rates by varying its 
starting molecular weight. Degradation under physiological conditions (e.g. 37 °C in the 
presence of body fluids, enzymes or free radicals) via hydrolysis of its ester linkages 
results in non-toxic by-products, rendering it suitable for the development of implantable 
devices and tissue engineered scaffolds. Furthermore, additives including catalysts, 
surfactants and cross-linkers exert additional control over the reaction process and final 
characteristics of the PU.  
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1.2.3 Polyurethane Structure 
PUs may have a phase separated structure or a highly cross-linked glassy 
amorphous arrangement. Phase separation occurs at room temperature as the highly 
polar hard segments of the PU which confer material stability are incompatible with the 
less polar soft segments which confer elasticity. The hard segments crystallize into 
microphases via hydrogen bonding which, in turn, link together via the flexible soft 
segments to produce flexible foams, thermoplastic PUs or elastomers. The ratio between 
the hard segment and soft segment determines the final elasticity and toughness of the 
polymer. PU rigidity is achieved via non-reversible covalent bond formation, yielding 
highly cross-linked glassy amorphous materials. The level of cross-linking and therefore 
the degree of rigidity depends on the functionality and the molecular weight of the 
starting material. A higher level of cross-linking is achieved with more available 
functional groups and lower molecular weights. 
In terms of biomedical applications of PUs, certain materials properties such as non-
immunogenicity, adequate mechanical strength, biodegradability and non-toxicity prove 
indispensable – some more and some less depending on each individual application. 
Biocompatibility certainly is a basic prerequisite for all materials intended for use in the 
human body. Increasing the soft segment in PUs has been demonstrated to enhance 
biocompatibility by reducing protein adsorption onto the polymer, thereby reducing 
harmful interference with cellular attachment and function (Braatz et al., 1992). Steric 
hindrance secondary to PU surface modification with chains of soft segment as well as 
repulsion of incoming proteins are the grounds for a reduction in surface protein 
adsorption with adsorption being inversely proportional to the chain length (Noishiki et 
al., 1987). In terms of soft tissue-engineering, material porosity is a further determining 
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factor (Stenhamre et al., 2011, McBane et al., 2011b, McBane et al., 2011a) as is 
haemocompatibility, particularly in vascular applications. Thrombosis and intimal 
hyperplasia are major causes for early and long-term vascular graft failure. Graft material 
hydrophobicity and positive charge contribute to the activation of the clotting cascade 
and subsequent inflammatory response via factor XII (Hageman factor) activation and 
platelet adherence (Sarkar et al., 2007). Therefore, synthetic graft materials with a 
hydrophilic interface and a negatively charged surface are required to exclude platelet 
aggregation. However, fibrinogen has both hydrophobic and hydrophilic binding sites, 
necessitating an amphiphilic material. The integration of nanosized silica particles into 
polymer materials has been demonstrated to confer such favourable surface qualities 
(Miyake et al., 2009) 
1.2.3.1 Polyhedral Oligomeric Silsesquioxane Nanoparticle 
First introduced into the biomedical field as an alternative, more biocompatible 
breast implant material in the 1960s, polyhedral oligomeric silsesquioxane (POSS) has 
risen considerably in global popularity ever since (K.Pielichowski et al., 2006, M.Joshi and 
B.S.Butola, 2004). This is because of its unique 3-dimensional (3D) cage structure 
consisting of silanol (Si-OH) and silicon carbide (Si-C) bonds which can serve as 
nanosized building blocks in the manufacture of unique and precisely controlled organic-
inorganic hybrid materials (E.Markovic et al., 2011, C.Sanchez et al., 2001). Hybrid, or 
composite materials are frequently considered superior in both functionality and 
processability conferred by the organic phase as well as heat/chemical stability and 
enhanced elastic modulus provided by the inorganic phase. POSS being a member of the 
silsesquioxane family, has the basic stoichometric formula (RSiO1.5)2n where n = 4 and R 
(the vertex group) = hydrogen, alkyl, aryl or halogen amongst others. These 3D 
oligomeric structures are formed by complete hydrolytic condensation of their 
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trifunctional monomers, Si4O6. Figure 1.1 illustrates the versatility of the compound’s 
molecular architecture with ladder structures, cage and partial cage structures known so 
far.  
 
 
Figure 1.1. Different structures of silsesquioxanes: (I) ladder structure, (II) partial cage structure, 
and (III) cage structure. The stoichiometric formula of the silsesquioxane family is RnSinO1.5n 
yielding a structure consisting of an inner organic framework of Si and O atoms and external 
organic groups (R) which may either be hydrogen, alkyl, alkene, aryl, and arylene group. 
 
Nanocomposite materials incorporating silica are particularly well suited for 
biomedical applications due to their biostability and degradative resistance which is due 
to shorter bond lengths (Si-Si distance = 0.5 nm) and strong intermolecular forces leading 
to a strong framework (Voronkov and Lavrent'yev, 1982). The POSS molecule may exist 
as a pendant cage, be integrated into a polymeric backbone or be cross-linked, depending 
on the number of side groups (Kannan et al., 2005b). 
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In 1995, the octameric closed caged silsesquioxane structure (POSS) based on Si-O 
linkages with one silicon atom at each of the eight vertices (R groups) was developed (Fig. 
1.1 (III)) (Lee and Lichtenhan, 1998a). The organic R groups assemble to form a 
tetrahedral structure around the inorganic silica core and play a fundamental role in 
determining the unique physical properties encountered with the POSS molecule (Suresh 
et al., 2004). POSS is regarded the smallest possible silica particle with an inner cage 
diameter of approximately 0.5 nm (Waddon and Coughlin, 2003) and an overall diameter 
of 1.5 nm including the R groups (Ghanbari et al., 2011a). POSS has an extraordinary 
potential to succeed both in scientific, biomedical and commercial terms due to several 
synergizing factors; (1) POSS is inherently versatile, thus customizable, due to the ability 
to attach any chemical moieties to the organic vertex groups (R) and its ability to be 
incorporated into many polymer matrices (Hong et al., 1997, Lee and Lichtenhan, 1998b, 
Mantz et al., 1996, Tsuchida et al., 1997, Zhao and Schiraldi, 2005, Lichtenhan et al., 1995, 
Romo-Uribe et al., 1998, Mather et al., 1999), (2) the manufacturing process with yields 
of up to 90% is straight-forward, facilitating large scale production, (3) the raw materials 
are inexpensive, thereby making commercialization economically beneficial with a 
multitude of possible applications ranging from packaging over inert material coatings to 
biomedical system enhancements (Bakhshi et al., 2011, Kidane et al., 2009, Kannan et al., 
2005b), and (4) its rigid inorganic core renders the POSS molecule chemically and 
thermally stable (Zheng et al., 2002). On oxidation of the organic R-groups, a SiO2 layer is 
formed which acts as a protective barrier to further oxidative damage of the silica-like 
core (Deng et al., 2002). This ‘self-protection’ property of POSS is increasingly exploited 
for biomedical purposes to create an ideal and dually active biosynthetic interface 
combining both antithrombogenicity and amphiphilicity (Kidane et al., 2004, J.Armstrong 
et al., 2004). Amphiphilicity, i.e. the state of being simultaneously hydrophilic and 
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lipophilic, is postulated to be of great exploitable significance within the field of 
regenerative medicine by rendering the material highly versatile and enhancing vascular 
graft endothelialisation by providing an interface for cellular attachment (Rosler et al., 
2001, Rimmer et al., 2005). During the manufacturing process, POSS nanoparticles are 
extruded onto the polymeric surface, creating an amphiphilic, antithrombogenic blood-
polymer interface with increased material durability and mechanical strength (Ghanbari 
et al., 2011a). Antithrombogenicity is a principally important feature of cardiovascular 
graft materials as thrombo-occlusive events with subsequent early graft failure represent 
the main limiting factors for successful vascular bypass procedures.  
1.2.3.2 POSS-Containing Nanocomposite Polymers 
In principle, composite materials are a combination of two or more materials where 
each individual material retains their own distinctive properties. The resulting composite 
displays synergistic material characteristics superior to those demonstrated by each 
individual component alone. Nanocomposite polymers are materials which are physically 
reinforced with inorganic particles at the nanometer level where at least one of the 
particle dimensions is less than 100 nm. Nanoparticulates come in various different 
shapes including fibers, platelets or spheres to serve as nano-bridges between individual 
molecules within the polymer. Nanoparticles are incorporated into the polymeric 
backbone and become chemically integrated into a polymer network. This incorporation 
into a polymeric host amalgamates the processibility of thermoplastic polymers with the 
properties of the filler, resulting in superior material characteristics including increased 
conductivity, higher optical activity, high use temperature and oxidation resistance as 
well as higher mechanical strength compared to their individual components (Wu and 
Mather, 2009, Zhang et al., 2004, Merkel et al., 2002).  
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POSS integration into polymers either in the form of nanoparticulate fillers or as 
pendant structures confined to the polymer backbone is known to form nanocrystalline 
aggregates (Zheng et al., 2002). Fu et al. demonstrated this with POSS-containing PUs 
where POSS was sequestered in the hard segment and enhanced microphase separation 
between hard and soft segments (Fu et al., 2001, Fu et al., 2000). This has been 
corroborated in the present study. Despite extensive knowledge on the favourable 
materials characteristics obtained by POSS-integration into polymers, comparatively 
little focus has been placed on the development of tissue engineered biomaterials 
incorporating POSS.  
Our group has synthesized and patented a family of novel biomaterials 
incorporating POSS, yielding nanocomposites of excellent biocompatibility and vast 
clinical potential (Kannan et al., 2007b, Kidane et al., 2009, Ghanbari et al., 2010). POSS-
incorporating poly(carbonate-urea)urethane (POSS-PCU), now commercially available 
as UCL-NanoTM, has emerged as a clinically applicable non-resorbable biomaterial used 
for the fabrication of tissue engineering scaffolds with first-in-man transplantations of 
artificial tracheal replacements, vascular conduits, and lacrimal drainage systems 
(Chaloupka et al., 2011, Jungebluth et al., 2011a, Kannan et al., 2006d, Kannan et al., 2006c, 
Kannan et al., 2006a, Kannan et al., 2006b). Whilst non-resorbable scaffolds are 
adequately suited for certain applications, their lack of degradation limits their use to the 
adult population and potentially necessitates revision surgeries to replace or remove 
such scaffolds. Bioresorbable scaffolds, on the other hand, must maintain temporary 
structural integrity within relatively harsh wound environments and degrade in a 
controllable fashion surrounded by enzymes and free radicals, pH as well as temperature 
44 
 
fluctuations. Whilst POSS-PCU is regarded for its exceptional biostability, this thesis will 
discuss a novel degradable nanocomposite derivative based on PCL (POSS-PCLU).  
1.3 POLYMER DEGRADATION AND BIOCOMPATIBILITY 
While bio-durability may well be of fundamental importance in certain implantable 
medical devices, biodegradability is a defining characteristic of tissue-engineered 
materials. Use of degradable materials requires rigorous assessments of cellular 
behaviour in response to (i) products released as a results of material degradation, and 
(ii) material surface changes induced by degradation. Reports on the degradative 
behaviour of PUs frequently are of qualitative nature only, documenting visual changes 
of the degraded polymer surfaces. It is, however, of fundamental importance to 
appreciate quantitative changes induced by degradation in order to understand and 
predict the in vivo behaviour of the material. Changes in molecular weight and 
crystallinity throughout the degradation process provide more reliable information 
regarding rates and modes of material breakdown. These combined with additional tests 
relating to the analysis of breakdown products can then be correlated with in vitro 
cellular behaviour and in vivo tissue responses. 
1.3.1 Polyester-based Polyurethane Degradation 
Upon implantation into the body, devices are exposed to a range of degradative 
environments, most notably hydrolysis and enzymatic attack and to a lesser extent 
oxidation. For this work, all three mechanisms will be discussed. In subsequent work, 
samples will be exposed to representative media in vitro in order to comprehensively 
assess degradation patterns. 
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Degradation is influenced by both chemical and physical properties of a material; 
surface properties (e.g. surface area and wettability), first order structures (chemical 
structure, molecular weight and molecular weight distribution) as well as higher order 
structures (glass transition temperature, melting temperature, degree of crystallinity and 
elastic modulus) of polymers play fundamental roles in the biodegradation process 
(Tokiwa et al., 2009). It is well known that higher molecular weight PCL (Mn > 4000) is 
more slowly degraded by Rhizopus delemar lipase than PCL of lower molecular weight 
(Tokiwa and Suzuki, 1978). Similarly, polymer morphology, and by extension, their 
crystallinity affects degradation. Crystalline domains consist of tightly packed molecules 
which are more resistant than the loosely packed amorphous regions where hydrolytic 
or enzymatic attack mainly occurs. Thus, with increasing crystallinity, the rate of 
degradation decreases (Tsuji and Miyauchi, 2001, Iwata and Doi, 1998). Tokiwa et al. 
further showed in several experiments that the melting temperature (Tm) has strong 
effects on the enzymatic degradation of polymers; the higher the Tm, the lower the 
polymer degradation (Tokiwa et al., 1979, Tokiwa and Suzuki, 1978, Tokiwa and Suzuki, 
1981). Such protection towards enzymatic or hydrolytic degradation can be related to 
the hard segment’s extensive hydrogen bonding network which physically protects labile 
bonds from scission (Shibayama et al., 1986). Such structural inhibition is further 
amplified as hard and soft segments within PU materials tend to phase separate and form 
domains containing many PU hard segments imbedded in a matrix of soft segment (Lelah 
and Cooper, 1986). The combined effect of phase separation and the ability to hydrogen 
bond significantly increases the formation of highly ordered structures among the hard 
segment components (Sung and Schneider, 1978). Additionally, it has been observed by 
Ratner and colleagues that the degree of phase separation in polymers influences the 
concentration of hard segment chemistry found at the surface of PUs (Ratner, 1983). All 
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of these factors influence the rate of material degradation by enzymes adsorbing to the 
surface of a PU. 
1.3.1.1 Hydrolysis 
Hydrolytic degradation of polyester-based PUs occurs as the chemical bonds within 
the polymer backbone, most often the ester bonds, are attacked by water molecules (Fig. 
1.2).  
 
 
Figure 1.2. Schematic illustration of soft segment hydrolysis. 
 
Initially, water contacts the water-labile bonds, resulting in the electrons from the 
negatively charged hydroxyl attacking the electron-deficient carbon of the ester carbonyl 
group, thereby breaking the π-bond and creating a tetrahedral intermediate. Once the 
intermediate collapses, the carbonyl reforms after severing the bond between the 
carbonyl and oxygen from the original ester group. This results in the carbonyl group now 
attaching to the hydroxyl group from the water, re-forming a carboxylic acid group. The 
previously negatively charged oxygen gains the remaining proton and forms a new 
hydroxyl group. Progressive loss of ester bonds results in the formation of low-molecular 
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weight products which dissolve in the surrounding medium, as well as in a mass loss of 
the bulk PU. 
Degradation rates and mechanisms are primarily influenced by matrix 
dimensionality, manner of assembly and consequent water penetration efficiency. If 
water molecules penetrate the 3D architecture at a higher rate than natural hydrolysis 
takes place, e.g. potentially influenced by scaffold porosity, thickness and exposed surface 
area, degradation proceeds throughout the entire polymer matrix resulting in uniform or 
‘bulk’ degradation. On the contrary, if water permeation is slow, hydrolytic erosion will 
mainly occur on the exterior surface (Fig. 1.3).  
 
 
Figure 1.3. Schematic illustration of (I) bulk degradation and (II) surface erosion over time. 
 
The internal matrix remains largely unchanged thus allowing for temporary 
shielding of any core-integrated trophic factors. Modes of degradation, however, do not 
solely depend on external conditions or material assembly but are further influenced by 
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the type of polymer material used. Hydrolytically unstable materials including polylactic 
acid (PLA) and polyglycolic acid (PGA) are known to degrade within days to weeks 
whereas polycaprolactone (PCL) takes relatively long to fully break down.  
Several in vitro studies have investigated the effect of various enzymes on 
biodegradable polymers. Such investigations are crucial for two reasons; (i) in order to 
study the effects of different micro-environments found within the body on implanted 
polymers, and (ii) to assess potential cytotoxic effects of any degradation products 
released from the polymer.  
1.3.1.2 Enzyme-Mediated Degradation 
Enzymes are essential macromolecules which work at the interface of the body’s 
metabolic pathways and are known to accelerate breakdown of many chemical bonds 
found in natural as well as artificial biomaterials (Ratner et al., 1986, Smith et al., 1987, 
Marchant et al., 1987). Hydrolase enzymes including esterases, proteases, glycosidases 
and phosphatases can all accelerate hydrolytic breakdown as well as several other 
reactions within the body in order to facilitate absorption of nutrients and solutes 
(Azevedo and Reis, 2005). Depending on the wound site, however, other enzymes become 
more prevalent as described in the following sections. 
1.3.1.2.1 Collagenase 
Collagenase is a highly specific enzyme that breaks the peptide bonds in collagen. It 
is produced and released during wound healing by macrophages and other immune cells 
surrounding any implantable device. 
1.3.1.2.2 Lipase 
Lipase is an enzyme that is able to catalyse the hydrolysis of ester bonds in 
polyesters when in the presence of an aqueous media (Liu et al., 2000). It was found that 
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certain lipases enhance the degradation of PCL when compared with incubation in 
phosphate buffered solution only (Gan et al., 1997). The enzymatic hydrolysis of PCL 
occurs mainly at the polymer surface since it is difficult for a hydrophilic enzyme to 
diffuse into a hydrophobic polymer like PCL (Lakhani et al., 2013). 
1.3.1.2.3 Cholesterol Esterase 
Earlier studies have shown that esterolytic activity is the most degradative 
enzymatic activity to a variety of PUs (Labow et al., 1999, Labow et al., 1994). Polyester-
PUs (Santerre et al., 1994) were much more degradable by CE than polyether PUs 
(Santerre and Labow, 1997) as would be expected, since the soft segment of the polyester 
PU was readily hydrolysed (Wang et al., 1997). It has further been shown that the degree 
of biodegradation of PUs, in the presence of cholesterol esterase enzyme, is about 10 
times higher than in the presence of buffer alone (Santerre et al., 1994). Our observations 
match those obtained by Santerre with a difference in degradation of up to 36 % by 
weight when PU films were exposed to esterase compared to phosphate buffered saline 
(PBS) alone (see chapter 6).  
1.3.1.3 Oxidative Degradation 
Oxidation-induced surface cracking has been proposed to be a major reason for 
premature failure of implantable devices based on PUs (Stachelek et al., 2006). This is 
thought to be due to the interaction between the body’s inflammatory cells and the PU 
implant (Schubert et al., 1995) which primarily targets the ester bonds of the PU soft 
segments (Lee and Chu, 2000). Modifications of both soft and hard segments (Takahara 
et al., 1991a, Takahara et al., 1991b, Wiggins et al., 2004) – whilst successful in preventing 
stress cracking – also resulted in inferior mechanical properties of the PU (Jorge-Herrero 
et al., 1999, Pinchuk, 1994). 
50 
 
1.3.2 Biological Response to Implants 
Prior to introduction into the human body, degradable implants require vigorous 
evaluation for their biocompatibility. However, it should be noted that cytotoxicity may 
be induced by numerous factors besides the pure biomaterial and its degradation 
products; various parameters ranging from material processing, sterilization and 
additives may influence host-material interactions. Whilst in vitro compatibility studies 
are a recognized means of screening material toxicities (Chiellini et al., 2006), the 
extrapolation of such results into an in vivo animal or even clinical setting remains 
problematic (Yildirimer et al., 2011). Such discrepancies will be discussed in chapter 3.  
Sterilization of polymeric implantable devices is an essential step in order to 
prevent host infection and implant rejection. Several disinfectant or sterilization methods 
are conventionally available including autoclaving (high temperature steam sterilization), 
gamma-irradiation, exposure to toxic ethylene oxide (EtO) vapour, soaking in hydrogen 
peroxide, ethanol or antibiotic solutions. Due to the labile nature of degradable polymers, 
autoclaving is frequently not possible. Common choices are thus EtO exposure and 
gamma-irradiation. However, both have significant disadvantages; gamma rays can 
potentially induce polymer cross-linking which influences mechanical and degradation 
profiles while exposure to EtO vapour requires prolonged degassing to prevent residual 
EtO toxicity. 
After sterilization, implantation of the polymeric device creates a host immune 
response regardless of the material’s biocompatibility due to host tissue injuries created 
by the surgical intervention. Once within the body, the biomaterial is exposed to a 
plethora of conditions created by tissue-specific and resident immune cells which 
immediately populate the material upon tissue contact. Thus, in order to predict the 
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material’s degradation behaviour as much as possible prior to implantation studies, in 
vitro experiments should attempt to closely mimic the conditions found in vivo which 
include a range of enzymatic, oxidative and purely hydrolytic environments.  
The inevitable foreign body response may be divided into several stages which 
culminate in a timely resolution of inflammation in the case of biocompatible materials. 
Initially, chemotactic factors released by cells within the wound bed attract neutrophils 
which enter the wound via the damaged vasculature. These are succeeded by the 
monocyte-macrophages which can reside within the implantation site for months and are 
commonly referred to as the hallmark cells in an acute inflammatory response. These 
cells along with resident tissue cells release enzymes and free radicals which break down 
the foreign material and engulf or phagocytose smaller particles. These particles are then 
further degraded within the cell by subjecting them to a battery of toxic chemicals 
contained within phagolysosomes. However, if a phagocyte fails to completely engulf a 
particle some toxic chemicals may be released into the extracellular space, potentially 
damaging both host cells and the implanted material. Chronic inflammation is 
characterised by the persistence of macrophages, monocytes and lymphocytes along with 
the formation of new vasculatures. Several material-adherent macrophages may fuse 
together to form foreign-body giant cells (FBGCs) which further act to degrade the 
material. Whilst even chronic inflammation should resolve within several weeks, FBGCs 
usually remain adherent to the implanted device and continue degradation. As part of the 
foreign-body response, a tough fibrous capsule consisting of Type III collagen produced 
by fibroblasts forms around the material, shielding it from its surrounding tissues in an 
attempt to prevent further interaction between the host’s immune cells and the foreign 
material. Despite that, cells continue to pass through the capsule to degrade the material. 
52 
 
Whilst the quest for developing an immune-tolerant biomaterial continues to keep 
the scientific community on their toes, it is evident that in the meantime, the analysis of 
biomaterial degradation and the interaction of material and breakdown products in cells 
and tissues is of principal importance in the evaluation of material biocompatibility.  
1.4 ORGANIZATION OF THESIS 
The following work describes the synthesis and characterization of a novel 
biodegradable nanocomposite material based on a poly(ε-caprolactone urea)urethane 
backbone with integrated POSS nanoparticles (POSS-PCLU) for the development of tissue 
engineering scaffolds. The integration of POSS nanoparticles is hypothesized to not only 
enhance cell adherence to the inherently hydrophobic synthetic PU but also confer a 
degree of immune tolerance to the material. The effects of varying the hard segment 
content of POSS-PCLU polymers on their in vitro and in vivo degradation profiles and 
subsequent material properties are analysed.  
Chapter 2 provides a comprehensive introduction into biodegradable materials 
used within the realms of tissue engineering and regenerative medicine. The potential of 
exploiting biodegradable systems as drug and cell delivery vehicles will be discussed and 
emphasis will be placed on the importance of scaffold designs to enable tunable 
degradation rates which enhances versatility in terms of scaffold application. 
Chapter 3 introduces the ideas of skin tissue engineering, critically appraising the 
current state-of-the-art skin substitutes and subsequently focussing on the 
determination of what might constitute the ideal ‘smart’ tissue engineering strategy to 
regenerate lost skin. 
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Chapter 4 discusses the synthesis of POSS-PCLU polymer of increasing hard 
segment content and polymer processing into cast or porous scaffolds. Different methods 
of scaffold surface modifications to prevent skin formation and increase overall porosity 
are presented. For initial material characterization, structural, surface and mechanical 
properties of POSS-PCLU scaffolds are discussed. 
Chapter 5 continues to discuss the problem of effectively sterilizing biodegradable 
polymer systems. Sterilization-induced changes in polymer chemistry, scaffold 
architecture and mechanical properties will be discussed, followed by the effects of 
changes in surface micro- and nanotopographies on cell adherence, proliferation and 
morphology. 
Chapter 6 begins the discussion on the degradable nature of POSS-PCLU and the 
effects of hard segment chemistries on the degradation and crystallization rates. Polymer 
films are subjected to both in vitro and in vivo degradation. Different conditions artificially 
created in vitro attempt to mimic bodily environments, as suggested above. Changes in 
material properties post-degradation in vitro and the extent of in vivo vascularization and 
tissue integration are subsequently analysed and discussed. 
Chapter 7 introduces a different tissue engineering concept, namely the use of 
naturally-derived polymers such as collagen and gelatin fashioned into a hydrogel as 
opposed to a synthetic polymer system prepared using a salt-leaching process. In a 
collaboration with the Khademhosseini laboratories at Harvard-MIT in Boston, photo-
polymerized gelatin methacrylate (GelMA) hydrogels were synthesized and their 
mechanical and degradation profiles were fine-tuned by varying parameters including 
the GelMA and PEG content. The ability of GelMA hydrogels to support keratinocyte 
growth in order to form a reconstructed neo-epidermis is discussed. 
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Chapter 8 briefly outlines the advantages and disadvantages of using either 
synthetic or natural polymers as base materials for tissue engineering platforms. It is 
suggested that the elucidation of the optimal combination of both natural and synthetic 
materials in order to create composite scaffolds may lead to the development of a ‘super-
platform’ with optimal mechanical properties and natural biocompatibility. 
Appendix. Due to the relatively recent scandal involving the French breast implant 
manufacturers Poly Implant Prosthèse (PIP), we investigated the mechanical and surface 
characteristics of explanted PIP silicone implants and compared the results to control, 
medical-grade ones. The strength and degrees of chemical degradation of both sets of 
implant shells and gels are discussed. 
1.5 HYPOTHESIS 
Poly(ε-caprolactone urea)urethane incorporating polyhedral oligomeric 
silsesquioxane (POSS-PCLU) is a novel biodegradable polymer suitable for skin tissue 
engineering purposes due to their optimal mechanical properties, biocompatibility and 
the ability to fine-tune the degradation rate. 
1.6 AIMS OF THESIS 
The primary aim of this thesis was to introduce a novel bioresorbable 
nanocomposite polymer for skin tissue engineering purposes. To this end, several 
different polymer formulations were studied in order to analyse the rate and mode of 
degradation. The selected nanocomposite polymers should be cyto- and biocompatible 
and display excellent elasticity.  
The secondary aim was to establish a method for efficient sterilization of this novel 
degradable nanocomposite. The optimal technique should reliably remove all 
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microorganisms, endotoxins and endospores whilst having no or minimal effects on the 
material’s chemical composition, surface topography and 3D structure. 
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2 3-DIMENSIONAL BIOMATERIAL 
DEGRADATION – QUITE LITERALLY 
TAKING A LEAF OUT OF NATURE’S BOOK1 
2.1 SYNOPSIS 
The apparent difficulty to precisely control fine-tuning of biomaterial degradation 
has initiated the recent paradigm shift from conventional top-down fabrication methods 
to more nature-inspired bottom-up assemblies. Sophistication of material fabrication 
techniques allows today’s scientists to reach beyond conventional natural materials in 
order to synthesize tomorrow’s ‘designer material’. Material degradation into smaller 
components and subsequent release of encapsulated cells or cell-signalling agents have 
opened medically exploitable avenues, transforming the area of regenerative medicine 
into a dynamic and self-propagating branch of modern medicine. The race to create 
complex and ever more refined scaffolding structures seems to have assumed a life of its 
own and represents an ever growing niche in the materials sciences. Recently, we have 
developed and conducted the world’s first in-human tracheal transplantation using a 
non-degradable completely synthetic biomaterial. Fuelled by such clinical potential, we 
are currently developing a biodegradable version suitable for skin tissue engineering and 
paediatric applications. However, despite enormous efforts, current, as yet 
insurmountable challenges include precise biomaterial degradation within pre-
determined spatial and temporal confines in an effort to release bio-signalling agents in 
such orchestrated fashion as to fully regenerate functioning tissues. In this chapter, the 
readers, almost anticlimactically, are asked to step out of the artificially over-constructed 
                                                             
1 A modified version of the following chapter has been accepted for publication in Biotechnology Advances. 
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spiral of ever more convoluted scaffold fabrication techniques and consider nature’s tried 
and tested approach to material degradation – the leaf. It will further be investigated how 
scaffold designs and fabrication methods may influence degradation and subsequent 
release of incorporated elements. A focus will be placed on the delivery of growth factors, 
stem cells and therapeutic agents alone or in parallel. The difficulties of designing a 
delivery vehicle capable of delivering multiple factors whilst maintaining distinct release 
kinetics will be highlighted. Finally, this chapter will be rounded off with an insight into 
current literature addressing the recurring issues of degradation product toxicities and 
suggest means of overcoming those.  
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2.2 INTRODUCTION  
Biodegradable materials have undergone extensive research and represent a popular 
platform for tissue engineering bone (Cui et al., 2012), skin (Yildirimer et al., 2012), 
cardiovascular tissues (Salacinski et al., 2003, Ghanbari et al., 2009, de Mel et al., 2008, 
Ahmed et al., 2011a) and nerves (Sedaghati et al., 2011, Pabari et al., 2011, Kannan et al., 
2005a, Tan et al., 2012) amongst many other organs and tissues. Conceptually, 
degradation is defined as a molecular change due to chemical chain scission within a 
polymer matrix. The subsequent breakdown into smaller material components and 
potential release of encapsulated cells or cell-signalling agents have opened medically 
exploitable avenues, transforming the area of regenerative medicine into a dynamic and 
self-propagating branch of modern medicine. The race to create complex and ever more 
refined scaffolding structures in order to dazzle even the most complacent tissue 
engineers seems to have assumed a life of its own and appears to represent an ever 
growing niche in the materials sciences. Despite enormous efforts, current, as yet 
insurmountable challenges include precise biomaterial degradation within pre-
determined spatial and temporal confines in an effort to release bio-signalling agents in 
such orchestrated fashion as to fully regenerate functioning tissues. It thus appears 
almost anti-climactic to be asked to step out of the artificially over-constructed spiral of 
ever more convoluted scaffold fabrication techniques and consider nature’s tried and 
tested approach to material degradation.  
2.3 TISSUE ENGINEERING SCAFFOLDS AS CARBON COPIES OF NATURE 
Taking a tree’s leaf as an example, one soon discovers the relatively simplistic 
mechanism leading to repeated blossoming over several decades if not centuries. The soft 
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matter of leaves is composed of an array of straight, chain-like cellulose molecules which 
tend to degrade first leaving behind a scaffold made of lignin (Fig. 2.1).  
 
 
Figure 2.1. (A) Lignin being a more complex folded structure than cellulose, it is more difficult to 
break down. (B) The soft matter of a leaf is made of cellulose which degrades first, leaving behind a 
3D scaffold made of lignin. Leaf degradation is the breakdown of leaf starch into simple sugars 
which are utilised in the growth and development of the plant. Images taken from (University of 
Waikato, 2014) (A), (Ridge, 2009, Decelles, 2006) (B). 
 
Lignin, being a more complex folded structure, delays enzymatic breakdown due to 
stearic hindrance thereby sustaining structural integrity for longer. A second growth-
enhancing corollary of leaf degradation is the breakdown of leaf starch into simple sugars 
which are utilised in the growth and development of the plant (Wang et al., 2013c).  
This simple and elegant combination of staggered material breakdown resulting in 
the controlled release of regenerative cues such as growth factors, cells or genes has 
found particular resonance in the field of regenerative medicine and controlled particle 
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delivery where breakdown of the delivery vehicle permits particle release and action 
whilst maintaining a structurally intact 3D scaffold for tissue ingrowth (Fig. 2.2) (Shmueli 
et al., 2013, Seras-Franzoso et al., 2013, Chen et al., 2011c, Biosciences, 2013).  
 
 
Figure 2.2. Scaffold porosity, particle dimensionality and bulk to fluid ratio play critical roles in 
regulating the degradation process. Staggered material breakdown results in the controlled 
release of incorporated factors (A, B). Images taken from (Chen et al., 2011b). (C) A structurally 
intact scaffold is maintained while incorporated cells break down the surrounding biomaterial 
matrix to make space for cell migration, proliferation and own matrix deposition. Images taken 
from (Biosciences, 2013). 
 
During unassisted wound healing, cells and cell components release a myriad of 
trophic factors including growth factors (GF), cytokines and other molecules to minimize 
wound dimensions and induce spontaneous healing (Yildirimer et al., 2012). However, 
natural healing is frequently accompanied by scar formation, functional and cosmetic 
compromise. Accelerated in situ tissue regeneration using scaffold structures 
supplemented with tissue-specific trophic factors is hoped to be able to induce complete 
scar-free tissue regeneration with preservation or restoration of function. The major 
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determinants in elucidating the complicated molecular cascade required for true 
regeneration are (a) finding the correct cocktail of GFs capable of stimulating suitable 
cellular differentiation and (b) unlocking the correct sequence of GF release. To date, the 
delivery of multiple bioactive factors with distinct kinetics to mirror physiological 
processes remains a challenge (Weissman, 2000, Chapanian and Amsden, 2010, Cheng 
and Sefton, 2009, Yan et al., 2009, Richardson et al., 2001). Initial studies demonstrated 
the use of a multi-protein delivery system for accelerated vascularisation and tissue 
formation in an effort to mimic the synergistic action of cell-signalling molecules 
(Richardson et al., 2001). Poly(lactide-co-glycolic acid) (PLGA) microspheres 
encapsulating both vascular endothelial growth factor (VEGF) and platelet derived 
growth factor (PDGF) were processed into porous scaffolds which were implanted into a 
murine hindlimb ischaemia model. Dual delivery of GFs resulted in both a high blood 
vessel density and the formation of thicker and more mature vessels exhibiting typically 
multilayered structures when compared to vessels exposed to single GFs. Further, the 
ability to modulate release kinetics for sustained or successive release of bioactive 
molecules has been found to be of fundamental importance for functional tissue 
formation (Chen et al., 2011b). It is generally accepted that in order for regenerative cues 
to function precisely, their release and activity are subject to a critical window. If release 
kinetics are timed correctly, natural regeneration of tissues ensues; if released outside 
this window, previously incorporated biological agents may potentially have antagonistic 
actions rendering localised factor delivery futile or even harmful. 
Richardson’s study exemplifies the two main modes of release kinetics of biological 
molecules incorporated into delivery vehicles (Fig. 2.3) (Richardson et al., 2001).  
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Figure 2.3. (A) A schematic illustration of the two main scaffold fabrication techniques to 
modulate release kinetics of incorporated molecules. Mixing of bioactive agents with the polymer 
solution prior to processing into a scaffold results in their molecular adhesion mainly to scaffold 
surfaces and subsequent burst release. Pre-encapsulation of molecular agents into microspheres 
and subsequent mixing and casting into a scaffold results in a more even distribution of molecules. 
(B) Microscopic image of a porous polymer surface incorporating bioactive molecules. (C, D) 
Different manufacturing processes yield different release kinetics enabling distinctly multiphasal 
release profiles. Images taken from (Richardson et al., 2001). 
 
Mixing of molecular agents with the material before processing into a 3D scaffold 
results in the factors being largely associated with the material surface and are thus 
subject to rapid release. In contrast, pre-encapsulation of molecular agents into 
polymeric microspheres and subsequent mixing and casting into a scaffold are thought 
to yield a more even distribution of agents throughout the scaffold with release regulated 
by material degradation kinetics. A combination of both methods can predictably result 
in a distinctly multiphasal release profile of more than one factor. 
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2.4 DETERMINANTS OF SCAFFOLD DEGRADATION KINETICS 
Release kinetics may further be influenced by external conditions including 
temperature (Esteban et al., 1990), presence of a degradative environment (e.g. 
hydrolytic or oxidative), pH of fluid environment and fluid dynamics surrounding the 
delivery vehicle (Agrawal et al., 2000). It has further been demonstrated that scaffold 
degradation kinetics and potential release of adsorbed bioactive molecules can be 
affected by scaffold-intrinsic features such as porosity, pore size and shape and overall 
design. It was further suggested that scaffold hydrophilicity may actively influence the 
extent to which water can diffuse through the scaffold, thereby directly affecting the 
release kinetic of any molecules adsorbed to the scaffolds (Xu et al., 2013). Precise 
molecular bottom-up assemblies warrant further and more varied modes of degradation 
ranging from bulk degradation or surface erosion to more specific and complex designer 
scaffolds capable of degrading within precise temporo-spatial confines. Degradation 
rates and mechanisms are primarily influenced by matrix dimensionality, manner of 
assembly and consequent water penetration efficiency. If water molecules penetrate the 
3D architecture at a higher rate than natural hydrolysis takes place, e.g. potentially 
influenced by scaffold porosity, thickness and exposed surface area, degradation 
proceeds throughout the entire material matrix resulting in uniform or ‘bulk’ degradation. 
On the contrary, if water permeation is slow, hydrolytic erosion will mainly occur on the 
exterior surface. The internal matrix remains largely unchanged thus allowing for 
temporary shielding of any core-integrated trophic factors. The conceptual integration of 
rapidly and slowly degrading entities within the same scaffold assembly, again, draws 
from the idea of creating longer lasting structural support structures whilst accelerating 
tissue regeneration using rapid, though constant, growth-stimulating factor release. 
Modes of degradation, however, do not solely depend on external conditions or material 
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assembly but are further influenced by the type of material used. Hydrolytically unstable 
materials including polylactide (PLA) and polyglycolide (PGA) are known to degrade 
within weeks whereas PCL may take up to two years to fully break down (Raghunath et 
al., 2009). Several in vitro studies have investigated the effect of various enzymes on 
biodegradable materials in an effort to synthesize scaffolds responsive to specific 
enzymes found at the wound site. This would then result in accelerated material 
breakdown and release of incorporated factors as well as enhanced cell migration and 
spreading (Kim et al., 2008, Galler et al., 2010, He and Jabbari, 2007). Enzymes, essential 
macromolecules working at the interface of the body’s metabolic pathways, are known to 
accelerate breakdown of many chemical bonds found in natural as well as artificial 
biomaterials. A recent study investigating bone regeneration in a rat bone defect model 
utilized a  hydrogel scaffold incorporating peptide crosslinkers which are cleaved by 
naturally occurring matrix metalloproteinases (MMPs) to release entrapped bone 
morphogenic protein (BMP) (Mariner et al., 2013). Precise cleavage and degradation of 
the delivery vehicle allowed for the incorporation of significantly reduced BMP levels for 
equally therapeutic effects. Whilst targeting susceptible bonds with naturally occurring 
enzymes is one step closer to precisely controlled scaffold breakdown, the amount of 
natural enzymes within a specific wound site is often unpredictable. Consequently, a 
synthetic hydrogel containing hydrophobic diepoxyoctane crosslinks which could only 
be broken down by endosialidases not found in the human body was developed (Berski 
et al., 2008).  
The synergistic union of enzymes and degradable biomaterials to release 
regenerative cues is comparable to the symbiosis between ants and leaves in nature – the 
breakdown of plant materials to sustain the growth of the ant population simultaneously 
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releases basic sugars required for plant development. Enzymatic degradation, however, 
is not solely responsible for scaffold breakdown and subsequent release of biomolecules; 
hydrolytically labile materials initiate degradation as soon as contact with water 
molecules is established. This has recently been exploited in a study demonstrating that 
targeted incorporation of hydrolytically labile structures within a scaffold network 
enables the precise engineering of appropriate degradation profiles (Parlato et al., 2013). 
Whilst scaffold degradation and subsequent release of an entrapped biomolecular agent 
is highly desirable, such scaffolds simultaneously lose their mechanical integrity which 
may have detrimental consequences in terms of tissue dimensionality. It has therefore 
been suggested that drug release mechanisms needed to be decoupled from the intrinsic 
scaffold degradation kinetics (Mouriño et al., 2013). Several studies thereupon 
investigated the potential of biomolecular adsorption on the scaffold surface in an effort 
to separate the two entities. However, the pattern of molecule release was found to 
frequently involve an initial burst release followed by a very slow release rate which may 
be clinically unsuitable (Fig. 2.3). Such drawbacks may be advanced upon by 
biomolecular entrapment through multilayered polymer coatings onto a slowly 
degrading scaffold surface or by loaded nano- or microspheres which are incorporated 
into the scaffold matrix (Kim et al., 2005). An excellent review has recently highlighted 
the possibility of entrapping multiple biomolecular agents within different layers of a 
nano- or microsphere that have different degradation profiles in order to release active 
agents in sequential manners (Mouriño et al., 2013). Such mixed-mode degradation 
profiles, again reminiscent of the degradation pattern of leaves, may serve as an attractive 
option for emerging tissue engineering, drug delivery and gene delivery applications. 
The following sections will aim to investigate how scaffold designs and fabrication 
methods may influence degradation and subsequent release of incorporated elements. A 
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focus will be placed on the delivery of GFs, stem cells and therapeutic agents alone or in 
parallel. The difficulties of designing a delivery vehicle capable of delivering multiple 
factors whilst maintaining distinct release kinetics will be highlighted. Finally, this 
chapter will conclude with an insight into current literature addressing the recurring 
problems of unwanted side effects including degradation product toxicity and suggested 
solutions of overcoming those.  
2.5 SCAFFOLD DESIGN INFLUENCES BIOMATERIAL DEGRADATION AND TISSUE 
REGENERATION 
Just as nature designed leaves of different shapes and patterns to face different 
challenges, biomaterial scaffolds may also be built to serve a specific purpose. Depending 
on their functional requirements, scaffolds may be designed into various morphologies 
(Fig. 2.4) using a range of biodegradable materials allowing for a precise problem-solving 
approach (Meinel et al., 2012).  
 
 
Figure 2.4. Schematic illustration of a variety of scaffold shapes. Different scaffold morphologies 
influence degradation behaviour. Images inspired by (Meinel et al., 2012). 
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Flat sheets may serve as dermal/epidermal regeneration platforms (van der Veen 
et al., 2011), whereas cell seeding on sheets and subsequent stacking or folding prior to 
implantation may improve cell distribution and accelerate wound healing by providing 
not a naked scaffold but a preconditioned cell-laden environment (Ng et al., 2005, 
Agarwal et al., 2012). Scaffolds wound into a spiral have demonstrated significant efficacy 
in bone regeneration due to macrochannels formed by spiral-wound matrices that 
enhance cell migration from the periphery to the centre (Pişkin et al., 2009). Spiral-
wound channels have further been shown to better support nerve regeneration 
compared to tubular or hydrogel-based cylindrical scaffolds (Valmikinathan et al., 2008). 
Superior results were demonstrated to be due to enhanced surface areas combined with 
good mechanical properties and porosities of spiral scaffolds to support higher cell 
attachments and proliferation. Additionally, macrochannels formed by spiral-wound 
scaffolds impart an open architecture that permeates the scaffold evenly thereby leaving 
sufficient volume for media influx and deeper cell penetration into the scaffold. A 
different approach towards achieving tissue engineered scaffolds with high cell- or drug-
loading capacity is to electrospin threaded fibres made of suspensions containing cells or 
bioactive molecules. This enables the fabrication of ‘living’ or biologically active threads 
which may be used to fabricate medical agent-loaded fibrous threads for tissue suturing 
and regenerative applications (He et al., 2009). 
 Such differences in scaffold conformations often go hand in hand with different 
surface areas exposed to potentially degradative conditions and subsequently different 
degradation modes and rates. Flat porous sheets, ideally suited for dermal regeneration 
(Wang et al., 2013a), degrade relatively fast which is likely to be related to the fact that 
thin porous films have a large surface area to volume ratio and thus a greater water 
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uptake (Lu et al., 1999b). This area-dependence was confirmed in a more recent study 
demonstrating accelerated scaffold degradation by modulating porogen size and shapes 
(Liebschner and Wettergreen, 2012). Further investigations of the impact of scaffold 
geometry on its rate of degradation and bioactive molecule release profile linked 
differences in scaffold geometries to their surface area exposed to water which directly 
impacted on the degradation (Lee et al., 2012). In this study, the descending order of the 
relative surface area was found to be honeycomb > grid > ring > circle which indicated 
that scaffolds with complex structures and inner holes (or pores) had large surface areas 
and were therefore more easily degradable. Furthermore, nanoscaled architectures on 
material surfaces predictably increase surface area and allow for significantly more rapid 
biodegradation (Sun and Downes, 2009).  
Tissue engineered scaffolds should ideally have a degradation rate synchronized 
with their replacement by regenerating tissues (Fig. 2.5) (Raghunath et al., 2007). 
 
Figure 2.5. Optimum model of mechanical properties of a scaffold as new tissue develops. Image 
taken from (Raghunath et al., 2007). 
 
It thus is of utmost importance to ensure that degradation properties and 
breakdown products of scaffolds do not interfere with cell attachment and tissue 
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regeneration. It has previously been shown that the degradation rate of scaffolds may 
affect cellular interactions including cell proliferation, tissue synthesis and host response 
(Lewandrowski et al., 2000, Mikos et al., 1998). Cell viability was found to be inversely 
related to degradation rate with slowly degrading PCL better able to support cell growth 
compared to PLGA (Sung et al., 2004). PLGA being more hydrophilic and of lower 
molecular weight compared to PCL predictably experienced accelerated material 
degradation both in vitro and in vivo conditions, thus providing progressively less surface 
area for cell integration and proliferation (Giunchedi et al., 1998). Several studies 
highlighted the importance of high surface area for sufficient cell attachment as well as a 
requirement for a 3D scaffolding structure for cell guidance and subsequent extracellular 
matrix (ECM) deposition. Yu et al. demonstrated the successful combination of large 
surface area with sufficient structural support and guidance in an in vivo nerve 
regeneration model (Yu et al., 2011). Electrospun PCL conduits were functionalized with 
a collagen layer for superior biocompatibility whilst exploiting the load-bearing abilities 
and good flexibility of PCL electrospun fibres (Wang et al., 2008). Structural support was 
provided until cells deposited sufficient ECM for scaffold-independent sustenance. It has 
been shown that certain cell types are unable to produce and correctly assemble 
sufficient ECM and form cell-cell junctions when grown without the guidance and 
signalling provided by a scaffold (Nichol and Khademhosseini, 2009). Cellular functions 
including their biosynthetic activities may be affected by cell-material interactions as well 
as scaffold degradation rate (Guaccio et al., 2008). Clearly, a balance needs to be struck 
between de novo synthesis of ECM, its deposition and maturation and the scaffold’s 
mechanical integrity (Shreiber et al., 2003). Thus, scaffold degradation kinetics play a 
crucial role in the process of tissue regeneration by influencing the final ECM composition 
and assembly (Imparato et al., 2013).  
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Degradation of synthetic materials such as the aliphatic polyesters PCL and PLGA 
proceeds via the hydrolysis of ester bonds (Schmitt et al., 1994, Grizzi et al., 1995, Li, 1999, 
Li and McCarthy, 1999). Breakage of these bonds by water molecules results in smaller 
and smaller chains (chain scission) eventually leading to the formation of short fragments 
of chains with exposed water soluble carboxyl (-COOH) end groups. As the hydrogen ions 
(H+) dissociate from the carboxyl (-COOH) groups the local pH value decreases. The acidic 
pH catalyses the hydrolysis of yet other ester bonds thus speeding up degradation. This 
mechanism is called autocatalysis (Lu et al., 1999b, Grizzi et al., 1995, Li and McCarthy, 
1999, Li, 1999). Several studies have demonstrated the detrimental effect of acidic 
environments on cellular viability (Wu et al., Razaq et al., 2003, Oh et al., 2006). However, 
the static in vitro setting is a poor representation of the more dynamic in vivo 
environment where localised acidity is more likely to become effluxed via the vasculature 
and lymphatic system (Göpferich, 1996, Yellowley et al., 1997).  
Degradation of biological scaffolding materials such as collagen or hydroxyapatite 
usually proceeds significantly faster than synthetic materials with degradation products 
considered safe. Rapid and more unpredictable degradation kinetics, however, render 
biological scaffolds unsuitable for long-term structural support and sustained particle 
delivery. Such materials may be structurally reinforced by carefully choosing suitable 
fabrication methods or creating bio-synthetic composite materials. It has been shown 
that changing of crosslinking densities using increasing concentrations of glutaraldehyde 
increases stability of gelatine microscaffolds, thereby enabling sufficient cell guidance 
and subsequent collagen deposition and assembly within the extracellular space 
provided by the scaffold (Imparato et al., 2013). Degradation was thus found to match 
collagen maturation and tissue regeneration. The use of crosslinking agents such as 
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glyceraldehydes or glutaraldehyde represents a convenient alternative to maintain 
collagen matrix stability by bridging amine groups between two adjacent polypeptide 
chains (Khor, 1997). However, high degrees of crosslinking have been shown to have 
cytotoxic effects in vitro as well as in vivo (Sisson et al., 2009, Maranto and Schoen, 1988, 
Dahm et al., 1990). Other, more biocompatible alternative crosslinking agents such as 1-
ethyl-3-(3- dimethyl aminopropyl)carbodiimide (EDC), polyepoxidic and  polyglycidyl 
have been developed and are currently under investigation (Khor, 1997, Sung et al., 1996, 
Courtman et al., 2001). Tables 2.1 and 2.2 summarise the degradation kinetics of a 
selection of synthetic, natural and composite materials and discusses methods of fine-
tuning rates of material degradation.  
 
Table 2.1. In vitro degradation outcomes of a selection of natural, synthetic and composite 
polymers. 
Scaffold material Scaffold fabrication 
method 
Degradation 
Condition 
In vitro degradation outcome Reference 
Natural Collagen Double-emulsion 
technique 
Collagenase 
 
Rate of collagen degradation was strictly a function of 
percentage glyceraldehyde crosslinking with higher 
crosslinking corresponding to stiffer substrates.  
(Imparat
o et al. , 
2013) 
Gelatin Air sprayed 
microbeads 
Collagenase/
dispase 
Rate of gelatin microbead degradation was inversely 
proportional to degree of carbodiimide crosslinking. 
(Serban 
et al. , 
2013) 
Chitosan
/gelatin 
Freeze dried and 
cross-linked with 
WSC. 
Ratio of chitosan to 
gelatin was:  
5:0 (C); 4:1 (C4G1); 
3:2 (C3G2); 1:1 
(C1G1); 2:3 (C2G3); 
1:4 (C1G4); 0:5 (G)  
pH 7.4 PBS, 
37°C 
Non-crosslinked gelatin degraded quickly in PBS in 
absence of enzymes. Chitosan degradation proceeded 
significantly more slowly due to strong hydrogen 
bonds and crystallinity. The chitosan in chitosan 
/gelatin composites promoted stabilization of the 
scaffold likely due to static electric forces created 
between chitosan and gelatin.  
(Whu et 
al. , 2013) 
Chitosan Phase separation pH 7.4 PBS, 
37°C, 
lysozyme 
Porous chitosan scaffolds degraded significantly faster 
than non-porous scaffolds. Further, degradation rate 
was accelerated in scaffolds with bigger pores or 
higher porosities. These results are due to higher 
surface areas provided in porous sponges which 
enable lysozymes to cleave chitosan molecules more 
efficiently.  
(Wan et 
al. , 2005) 
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Synthetic PCL Electrospun fibres of 
different thicknesses 
pH 7.4 Ringer 
solution, 
37°C 
Rate of PCL degradation was dependent on 
electrospun fibre diameter. Thinner fibres degraded 
faster than thicker fibres which is likely due to a 
greater surface area to volume ratio. Electrospun 
matrices exhibited slower degradation rate compared 
to scaffolds obtained via solvent casting method. 
(Bölgen 
et al. , 
2005) 
PLGA Solvent casting/ 
particulate leaching 
Ratio of PGA to PLA 
was: 
70:30 (A); 75:25 (B); 
80:20 (C)  
SBF 1-5 
formulations 
Degradation rate was fastest with sample C, possibly 
due to a relatively higher PGA content which is 
hydrophilic. However, degradation rate was not even 
which makes this combination unsuitable for clinical 
applications. Sample B had optimum and stable 
degradation rates and A had low degradation rates. 
These results indicate that increasing PLA content 
resulted in increasingly hydrophobic scaffolds which, 
in turn, results in slower degradation.  
(Mekala 
et al. , 
2013) 
PLA/PCL Electrospinning 
PLA to PCL ratios 
were: 
3:1; 2:1; 1:1  
pH 7.4 PBS, 
37°C 
Rate of scaffold degradation was a function of PLA 
concentration. Higher PLA contents corresponded to 
faster degradation rates which was consistent with 
previous findings that PLA was highly degradable. 
 
(Chen et 
al. , 2013) 
PGSU 
PGSU-S 
PGSU-SF 
Solvent casting 
Spincoating 
CO2 foaming (porous 
scaffolds) 
PGSU to HDI ratio 
was: 
1:1; 1:0.5; 1:0.3 
CE Rate of scaffold degradation was a function of degree 
of crosslinking. The ester groups in the polymer 
backbone are highly sensitive to enzymatic 
degradation; however, a higher HDI content resulted 
in free hydroxyl groups being replaced by urethane 
groups. With  increased  urethane content  the  
accessibility  to  ester  bonds  is  hindered  resulting in 
slower  degradation  rates. 
 
(Pereira 
et al. , 
2013) 
Bio-
synthetic 
composite 
PCL/ 
collagen/ 
elastin 
Electrospun vascular 
grafts 
Crosslinked with 
EDC or GEN 
PCL to elastin to 
collagen ratio was: 
45:45:10; 55:35:10; 
65:25:10  
DMEM/F12 + 
10% FBS + 
1% P/S  
Biodegradation rate of EDC crosslinked vascular grafts 
progressed more slowly than GEN crosslinked grafts. 
Additionally, degradation rate depended on the elastin 
content within the composite grafts with higher elastin 
corresponding to a faster degradation rate.  
 
 
(McClure 
et al. , 
2012) 
Chitosan
/PLGA 
Sintering to obtain 
micro-spheres 
pH 7.4 PBS, 
37°C, 
lysozyme 
The chitosan/PLGA scaffold demonstrated slower 
degradation compared to PLGA alone after 12 weeks. 
This may be due to chitosan/PLGA microspheres 
exhibiting a porous microstructure whilst PLGA 
microspheres are solid. This enables acidic 
degradation products of PLGA (which lead to 
accelerated autocatalysis) to escape more easily from 
the chitosan/PLGA scaffold. 
(Jiang et 
al. , 2010) 
mβ-TCP 
nβ-TCP 
 
Wet grinding 
method  
PLA to mβ-TCP to 
nβ-TCP ratio was: 
100:0:0 (PLA); 
90:0:10 (PLA/10 nβ-
TCP); 70:30:0 (PLA/ 
pH 7.4 PBS, 
37°C 
Porosity and average pore size decreased in the order 
of PLA/50 nβ-TCP, PLA/30 nβ-TCP, and PLA/10 nβ-
TCP. However, the size of β-TCP did not seem to affect 
scaffold porosity. The porosity of PLA/50 nβ-TCP 
scaffolds increased faster than PLA/10 nβ-TCP, 
PLA/30 nβ-TCP, or PLA/50 nβ-TCP scaffolds beyond 7 
weeks. But no significant differences in porosity were 
observed between PLA/30 nβ-TCP and PLA/30 mβ-
(Cao et al. 
, 2012) 
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30 mβ-TCP);70:0:30 
(PLA/30 nβ-TCP); 
50:0:50 (PLA/50 nβ-
TCP) 
TCP scaffolds. Weight loss of PLA/30 nβ-TCP scaffolds 
was significantly faster than PLA/30mβ-TCP scaffolds 
and weight loss of PLA/50 nβ-TCP scaffolds was 
significantly faster than PLA/10 nβ-TCP or PLA/30 nβ-
TCP scaffolds. 
β-TCP has been employed as a filler in order to offset 
acid degradation products of PLA scaffolds. It was 
demonstrated that the buffering effect of nβ-TCP was 
not only stronger than that of mβ-TCP but was also 
concentration dependent with higher nβ-TCP content 
inducing a higher buffering effect.  
PLA 
 
PLA 
blends 
Melt blending 
technique 
Blends of PLA were 
prepared as 1:1 
ratios: 
PLA+PHB; PLA+TPS; 
PLA+GA; PLA+MC; 
PLA+PEG  
Non-
carbonated 
basal mineral 
medium  
Biodegradation was in order of PLA-GA > PLA-TPS > 
PLA > PLA-MC > PLA-PEG > PLA-PHB.  
PLA-GA and PLA-TPS started disintegrating after the 
first 24 h while all other blends and virgin PLA 
retained original nature of scaffold for 48 h.  
The results demonstrated that PLA degradation could 
be tuned by the addition of gradually more 
hydrolytically resistant factors.  
(Nair et 
al. , 2012) 
Key: DMEM, Dulbecco’s modified Eagle medium; EDC, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide; FBS, fetal 
bovine serum;  GA, gum arabic; GEN, genipin; HDI, hexamethylene diisocyanate; mβ-TCP, micro-sized β-tricalcium 
phosphate; MC, microcrystalline cellulose; Mw, molecular weight; nβ-TCP, nano-sized β-tricalcium phosphate; PBS, 
phosphate buffered saline; PCL, polycaprolactone; PDI, polydispersity index; PEG, polyethylene glycol; PGA, 
polyglycolic acid; PGSU, poly(glycerol sebacate urethane); PGSU-S, solvent-based synthesis of PGSU; PGSU-SF, solvent-
free synthesis of PGSU; PHB, polyhydroxybutyrate; PLA, polylactic acid; PLGA, poly(lactic-co-glycolic acid); P/S, 
penicillin/streptomycin; SBF, simulated body fluids; TPS, thermoplastic starch; WSC, water-soluble carbodiimide. 
 
Table 2.2. In vivo degradation outcomes of a selection of natural and synthetic polymers. 
Scaffold material Scaffold 
fabrication 
method 
Animal 
model 
In vivo degradation  outcome Reference 
Natural Gelatin Air sprayed 
microbeads 
Lewis 
rats 
Cell-laden microbeads were injected into the renal 
parenchyma of rats. Degradation patterns 
observed in vivo correlated well with in vitro data.. 
(Serban et 
al. , 2013) 
Collagen BioGide (NCL) 
BioMend 
Extend (GCL) 
Ossix (RCL) 
Wistar 
rats 
3 calvarial defects of 5 mm ø each were created and 
subsequently covered with one of each membrane. 
Results demonstrate tunable degradation 
characteristics of collagen membranes using 
different crosslinking agents. These differences in 
degradation pattern may have clinical implications 
and membranes should be chosen according to the 
clinical demand. Glutaraldehyde is generally 
considered a poor agent due to low 
biocompatibility (Matsumoto et al. 1993, Speer et 
al., 1980, Wiebe et al. , 1988). 
(Moses et 
al. , 2008) 
Chitosan Phase 
separation 
Wistar 
rats 
Subcutaneously implantation revealed slower in 
vivo degradation compared to in vitro which may be 
ascribed to the fact that concentrations of lysozyme 
in rats may be lower than that used for in vitro 
enzymatic degradation, resulting in a lesser 
(Wan et al. , 
2005) 
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amount of weight loss in in vivo implanted 
scaffolds.  
Synthetic PCL Electrospun 
fibres of 
different 
thicknesses 
Wistar–
Albino 
rats 
Subcutaneously implanted scaffolds demonstrated 
faster in vivo degradation rates compared to in 
vitro. This may be due to factors including foreign 
body response which results in inflammatory cell 
accumulation around the implant. The combination 
of free radicals, acidic products and enzymes has 
been suggested to accelerate degradation (Tracy et 
al. , 1999). In particular, various lipases have been 
implicated in the degradation of PCL (Li et al. , 
2003). 
(Bölgen et 
al. , 2005) 
PLGA Electrospinning 
into random or 
aligned fibres 
Wistar 
rats 
Subcutaneously implanted scaffolds of randomly 
aligned fibres demonstrated faster degradation 
rates compared to parallel fibres. This may be due 
to a larger exposed total surface area for hydrolytic 
degradation in random fibres compared with 
parallel ones. 
(Subramani
an et al. , 
2013) 
PGA/ β-
TCP 
 
Solvent 
casting/ 
particulate 
leaching 
Ratio of PGA to 
β-TCP was: 
1:1; 1:3 
Sprague
-Dawley 
rats 
 
Critical bone defects of 3 mm ø each were created 
in femoral medial epicondyles and subsequently 
covered with PGA/ β-TCP scaffolds (1:1 and 1:3), 
100% HAP, or left blank (control). 
After 90 days, PGA/β-TCP (1:1) scaffolds exhibited 
fastest degradation rates (99.0 ± 1.0 %) compared 
to PGA/β-TCP (1:3) (96.2 ± 3.3 %) or HAP (35.1 ± 
5.5 %) scaffolds. The biodegradation rates of 
PGA/β-TCP further matched the osteogenesis rate, 
whereas the slowly degrading HAP prevented 
ingrowth of bone cells. The results indicate that the 
rate of biodegradation of PGA/β-TCP scaffolds 
allowed a more rapid replacement and 
osteogenesis than HAP. 
(Cao and 
Kuboyama, 
2010) 
Key: GCL, glutaraldehyde crosslinked; HAP, hydroxylapatite; Mw, molecular weight; NCL, not crosslinked; PCL, 
polycaprolactone; PGA/β-TCP, polyglycolic acid/β-tricalcium phosphate; PLGA, poly(lactic-co-glycolic acid); RCL, 
ribose crosslinked. 
 
One soon realizes that such multiplicity of options and parameters in the design and 
fabrication of biodegradable regeneration platforms offers incredible possibilities in 
terms of synthesizing materials for individualised scaffolds.  
2.6 BIODEGRADABLE MATERIALS AS SELF-PROPAGATING DELIVERY VEHICLES – AN 
INTERACTIVE PLATFORM 
Biodegradable materials have undergone intensive evaluation as particle delivery 
systems (Song et al., 2012, Ben-David et al., 2013, Son et al., 2011, Wang et al., 2013b, 
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Ueng et al., 2011). A prerequisite for controlled particle release after the incorporation 
into a matrix involves diffusion into and contact of water molecules with the material 
(Wischke et al., 2010). This may suggest an inherently passive nature of particle release 
which is true for many commercialised drug delivery platforms (Thakral et al., 2013, 
Rujivipat and Bodmeier, 2010). Despite decades of research, the ideal material for use as 
a delivery vehicle has not, as yet, been realized into clinical practice. A model delivery 
vehicle would allow for tailored clinical efficacy which entails potentially longer-lasting 
therapeutic effects and delivery of multiple factors in sequential fashion. Such materials 
require tunable degradation rates to subsequently enable controlled delivery of 
incorporated elements. In order for the biomaterial to achieve such independent 
‘activeness’ which according to the perspective of Materials Science is obtained by 
‘changes of its physical properties in response to external stimuli’, factors including water 
penetration efficiency, types of material and their degradation kinetics as well as 
temperature sensitivity are of fundamental importance.  
 
2.7 SINGLE AND DUAL GROWTH FACTOR DELIVERY 
In recent years, biodegradable delivery systems for localised transportation of GFs 
have received considerable attention. For example, delivery of active keratinocyte growth 
factor (KGF) was shown to be most successful using a ternary formulation based on PLA, 
PGA and sodium bis(ethylhexyl)sulfosuccinate (Aerosol-OT, AOT) (Cho et al., 2003). It 
was demonstrated the KGF release kinetics were tunable by adjusting the molecular 
weight, and by extension the degradation rate of PLA. Several studies highlighted the 
association between increasing molecular weights, reduced water penetration efficiency 
and decreased degradation rates, enabling fine-tuning of release kinetics of any 
entrapped molecular agents or cells (Fu and Kao, 2009, Gu et al., 2007). In order to 
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demonstrate the relationship between exposed surface area and biomaterial degradation 
rate, the sustained release kinetics of BMP-2 from micro- and nanosphere carrier gels 
was investigated (Wang et al., 2012). As expected, nanospheres with larger surface area 
to volume ratio were found to have significantly accelerated release kinetics compared 
to larger carrier spheres. A different approach to molecular delivery involves layer-by-
layer (LBL) assembly where sequential deposition of positively and negatively charged 
polyelectrolytes onto material surfaces can be utilized to construct drug delivery depots 
by incorporating drugs of interest into self-assembled nanoscale thin ﬁlms (Mao et al., 
2005, Saurer et al., 2011, Ma et al., 2007, Macdonald et al., 2008, Macdonald et al., 2011). 
LBL technique benefits from mild fabrication conditions which given the fragile nature of 
incorporated elements including biomolecules or cells, render more aggressive 
incorporation techniques (e.g. ones using organic solvents) obsolete. LBL incorporating 
proteins or GFs have experienced successful applications in experimental bone growth 
models amongst several others (Liebschner and Wettergreen, 2012, Go et al., 2011, Park 
et al., 2012a, Shah et al., 2011). However, clinical translatability of this technique remains 
difficult due to uncontrollable degradation kinetics and subsequent burst release rates of 
incorporated agents. Recently, an LBL technique with tunable release kinetics was 
successfully developed by varying material chemistry (Keeney et al., 2013). Increasing 
hydrophobicity has been shown to prolong the degradation profile of the resultant LBL 
films, enabling gradual release of GFs over a period of 14 days as opposed to 50 h (Zhang 
et al., 2006). 
Biodegradable delivery platforms including LBL method have sparked intensive 
interest in multiple factor delivery as well as distinct release kinetics of each incorporated 
element. For example, one study demonstrated the dual release of BMP-2 and VEGF from 
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the surfaces of PCL-based scaffolds (Shah et al., 2011). VEGF was released over the first 8 
days whereas BMP-2 was continually released for over 2 weeks. Such a multiphase 
release profile enables blood vessel formation with subsequent bone formation which 
mimics natural bone development. Further, in vivo implantation of this dual delivery 
system showed greater bone formation compared to groups receiving single GFs. Such 
staggered material breakdown, again reminiscent of a degrading plant leaf, aims to 
maintain a 3D structural framework throughout a pre-defined period of time whilst 
providing gradually enlarging gaps for ingrowing tissues. Other formulations capable of 
dual/multiple drug release include composite scaffolds as shown by Numata et al. 
(Numata et al., 2012). Rhodamine Blue (RhB) was added to the molecular network of silk 
hydrogels, whilst fluorescent isothiocyanate (FITC) was incorporated into silk 
nanoparticles within the hydrogels. Degradation of hydrogels by proteases resulted in an 
initial burst release of RhB within the first hour. Nanoparticle-incorporated FITC, 
however, exhibited a slower and more constant release over 5 days demonstrating the 
feasibility of dual drug release using composite matrices. Fine-tuning of degradation rates 
has been suggested to be regulated by physical properties including material crystallinity 
and size (Numata and Kaplan, 2010, Numata et al., 2011). 
2.8 STEM CELL DELIVERY 
Biodegradable delivery platforms have not only garnered significant interest in GF 
and drug delivery but have also been applied to the delivery of stem cells (SCs). Tentative 
early attempts of injecting SC precursors directly into an injury have yielded limited 
success (Harting et al., 2009). Poor cell engraftment is thought to stem from a 
combination of harsh, non-permissive conditions created by the injury site which lacks 
nutrients, survival factors and a supportive matrix. It thus is plausible to incorporate cells 
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into a scaffold which effectively provides structural support, shields fragile cells and 
simultaneously supplies environmental cues for cellular adhesion and proliferation (Yap 
et al., 2013, Peng et al., 2013, Di Felice et al., 2013, Tate et al., 2009). Thus, a multispherical 
chitosan-heparin complex capable of dual incorporation and targeted delivery of FGF-2 
and viable neural precursors was developed for brain tissue regeneration (Skop et al., 
2013). Degradation and subsequent release of factors were successfully controlled by the 
degree of crosslinking demonstrating both tunable degradation kinetics and controllable 
microsphere swelling. The crucial importance of supportive scaffolds in the delivery of 
regeneration cues has further been corroborated in an experimental traumatic brain 
injury (TBI) model (Guan et al., 2013). Rats with experimental TBI were transplanted 
with human bone marrow-derived mesenchymal stem cells (hMSCs) in conjunction with 
or without a supportive collagen matrix. Cells delivered inside the collagen scaffolds 
exhibited significantly higher hMSC retention at the lesion site and localised distribution 
at the transplanted region indicating a supportive and shielding effect of the scaffold. 
Additionally, cells showed better neurite outgrowth resulting in superior neuronal 
functional recovery. Collagen, being a relatively quickly degrading biomaterial, provided 
early retention of hMSCs within the lesion site without spacially hindering ingrowing 
neuronal tissue. Depending on the clinical scenario, delivery vehicles may only need to 
provide structural support for limited periods of time. In fact, slowly degrading scaffolds 
may either obstruct regenerating tissue or fail to release factors or cells in time to 
replicate the natural healing cascade. Bone regeneration by distraction osteogenesis is 
one such example where the prime concern lies in accelerating bone formation through 
providing regenerative cues rather than offering structural support. In a recent study, 
Gelfoam®, a gelatine-based soft scaffold, was loaded with bone marrow-derived MSCs 
with or without FGF-2 and transplanted into a porcine mandibular distraction site (Sun 
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et al., 2013). MSCs successfully engrafted while the scaffold completely degraded within 
a relatively fast time frame without causing local inflammation. Furthermore, scaffold-
incorporated FGF-2 induced MSC osteogenic differentiation as evidenced by dose-
dependent increases in alkaline phosphatase (ALP) expression. Such mutually beneficial, 
even synergistic interactions between scaffold matrix and incorporated factors are prime 
examples of self-sufficient, self-propagating scaffolds. Independence from surrounding 
tissues is obtained when a delivery platform transports all necessary components 
required for functional tissue regeneration whilst protecting said components from 
harsh environmental conditions generated by injuries. Composite scaffold designs are 
then able to mimic the ingenious reciprocity observed in natural plant leaf metabolism – 
the degradation of individual leaf components liberate growth-stimulating breakdown 
products which may then be used for newly growing leaves. 
Unlike natural leaf degradation, breakdown of synthetically generated scaffolds 
requires careful evaluation of potentially harmful, even toxic, by-products which may 
negatively affect tissues in immediate vicinity as well as downstream target organs. 
2.9 THE DESIGN CHALLENGE – LEAFING THROUGH THE PAST TO UNCOVER THE 
NEXT GENERATION DELIVERY VEHICLE 
Functional tissue regeneration continues to be a major, as yet unresolved challenge 
for biomedical scientists, materials engineers, and the medico-surgical community, not to 
mention the affected individuals in need for tissue replacements (Chen and Jin, 2010, 
Williams, 2006, Khan et al., 2008). Decades have passed with significant developments in 
material selection, scaffold design and successively more intricate composite structures. 
In spite of this, optimal tissue regeneration using tissue engineered scaffolds remains 
elusive, rendering clinically accepted restorative therapies reliant on organ/tissue 
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transplantations, GF therapies and synthetic devices (Chen and Jin, 2010, Williams, 2006, 
Khan et al., 2008, Varkey et al., 2004). Pivotal challenges hindering progression of tissue 
engineered scaffolds into the clinical arena include (1) the elucidation of the complex 
biomolecular cascade of cells, cell-signalling factors and structural components required 
for complete tissue restoration, and (2) identifying the ideal 3D scaffold design capable 
of providing an integrated platform which consistently mimics the natural 
microenvironment and regulates cell fates. In recent years, it has become widely accepted 
that the body’s self-healing capacities can be supported by accelerating migration, 
proliferation and differentiation of implanted cells via the integration of appropriate GFs 
and other trophic molecules (Vasita and Katti, 2006, Andreadis and Geer, 2006, Kobsa 
and Saltzman, 2008). Advanced understanding of the pathways involved in the 
development of tissues theoretically enables a more sophisticated approach to the 
development of delivery vehicles to facilitate spatio-temporal release of required factors 
(Uebersax et al., 2009). However, in order to be effective, cell-signalling agents have to 
reach their target site without degrading and remain in place for long enough to exert the 
desired actions (Chen et al., 2009b). Delivery of GFs dissolved in solution has been 
deemed ineffective due to non-specific diffusion away from the target and enzymatic 
degradation resulting in low availability or toxicity due to excess concentrations (Chen et 
al., 2009b, Tayalia and Mooney, 2009, Guldberg, 2009). It has therefore been deemed 
necessary to develop targeted release technologies capable of providing spatio-temporal 
delivery of cell-signalling factors whilst avoiding local or systemic side effects. While 
single GF delivery has been studied relatively extensively, strategies involving the 
delivery of two or more factors require further optimization. Developments in the field 
of biodegradable materials technology are being harnessed to generate the next 
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generation medical devices to stimulate endogenous repair mechanisms by means of an 
integrated and self-sufficient platform technology. 
 Table 2.3 schematically illustrates a selection of available strategies for factor 
delivery and their respective release profiles.  
 
Table 2.3. Schematic representation of selected delivery strategies and their representative 
release profiles. Adapted from (Chen et al., 2010). 
Strategies 
 
Images Release profiles Delivery models 
(Examples) 
Incorporation (bolus injection or 
growth factors directly adsorbed 
in vehicles) 
 
 
Burst release 
(frequently 
investigated, porous 
scaffolds, hydrogels 
etc.) 
Non-covalent immobilisation 
(growth factors encapsulated 
into low cross-linked 
microspheres) 
  
Sustained release  
(frequently 
investigated, 
microspheres, 
nanoparticles, etc.) 
Non-covalent immobilisation 
(growth factors encapsulated 
into high cross-linked 
microspheres) 
 
 
Delayed release  
(well-designed 
microspheres, core-
shell vehicles, etc.) 
Non-covalent immobilisation 
(growth factors delivered by 
both scaffolds and 
microspheres) 
  
Pulse-like release  
(well-designed 
composites, 
multifunctional 
vehicles, etc.) 
Covalent immobilisation 
(growth factors chemically 
cross-linked via di-functional 
linkers) 
  
Continuous release  
(fibrillar collagen, 
alginate gel, etc.) 
Covalent immobilisation or 
chemical modification 
(Environment-sensitive 
materials) 
 
 
Pulsatile release  
(Intelligent 
hydrogels, on-off 
delivery systems, 
etc.) 
 
   
 With the fact in mind that the ideal delivery system provides a large degree of 
control over the type(s) of molecule(s) delivered, the rate at which delivery takes place 
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in addition to providing protection for a bioactive agent to achieve prolonged availability, 
two delivery methods appear optimal; continuous delivery and pulsatile delivery. Both 
designs, alone or in conjunction with each other, are hoped to advance the development 
of delivery systems capable of sequential and spatio-temporally controlled delivery of 
multiple GFs (Tayalia and Mooney, 2009, Biondi et al., 2008). 
Several studies using combinatorial approaches have already demonstrated results 
using biodegradable materials which simultaneously provide physical scaffolding, a 
reservoir for sustained and/or multiple factor delivery and which act as cell 
encapsulating devices (Macaya and Spector, 2012, Syková et al., 2006). Using this 
integrative approach, Kanczler et al. developed an independent hybrid platform for bone 
repair and regeneration (Kanczler et al., 2010). Supercritical CO2 and alginate 
entrapment technique was applied to synthesize scaffolds consisting of alginate and 
poly(D,L-lactic acid) (PLA) to allow for different biodegradation and subsequent release 
rates of incorporated factors (Ginty et al., 2008). Human bone marrow stromal cells were 
seeded onto a VEGF/ BMP-2 releasing composite scaffold and implanted into a murine 
critical sized femur defect. Different degradation kinetics of alginate and PLA resulted in 
distinct release profiles of GFs which resulted in significant new bone formation. 
Similarly, Chen et al. successfully incorporated BMP-2 loaded basic gelatin and IGF-1 
loaded acidic gelatin microparticles into a glycidyl methacrylated dextran (Dex-GMA) 
hydrogel scaffold (Chen et al., 2009a). Chemical crosslinking agents such as Dex-GMA 
have previously been shown to reduce rapid solubilisation of gelatin to avoid burst 
release of GFs and are therefore preferably used for gelatin-based delivery vehicles (Chen 
et al., 2009b, Young et al., 2005, Chen et al., 2006, Chen et al., 2007a et al. 2007). In 
addition, Dex-GMA/gelatine hybrid hydrogel cannot be hydrolytically degraded but 
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requires the presence of enzymes (Chen et al., 2009b, Chen et al., 2007a et al. 2007, Chen 
et al., 2007b et al. 2007) such as dextranase which enables selective delivery of their 
cargo to sites where such enzymes are present. Alternatively, dextranase may be directly 
incorporated into the hybrid hydrogel structure, making the composite truly self-
sufficient.  
Functional tissue regeneration involves the precise regulation of GF concentrations 
and spatio-temporal gradients as these key parameters are thought to significantly 
influence the final outcome of regenerative therapies (Guldberg, 2009). It thus is of 
considerable importance to develop sophisticated delivery systems with multiple 
functionalities and tunable delivery patterns. The first step in the identification of an 
appropriate biomaterial or combination of biomaterials for delivery involves an 
assessment of the required properties, followed by a scan of available materials which 
eventually results in the selection of the best possible material or a combination of 
materials which are predicted to perform reliably (Vasita and Katti, 2006). Past efforts 
have taught that it will likely be a combination of several materials which may offer the 
best compromise for positive clinical outcomes. Composite materials may draw from 
each individual benefit as well as act synergistically to eventually create the next 
generation of ‘super-materials’.  
2.10 BIOMATERIAL DEGRADATION PRODUCTS AND TOXICITY 
Biodegradable materials intended to be used as implantable drug-eluting scaffolds 
must fulfil several requirements in order to be considered for clinical integration. They 
must not elicit abnormal responses in local tissues and should neither produce local nor 
systemic toxic or carcinogenic side-effects. First and foremost, biodegradable platforms 
should serve their intended scaffolding and cell-signalling functions whilst degrading into 
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non-toxic metabolites (Athanasiou et al., 1996, Lotz et al., 2009). As opposed to natural 
leaf degradation, breakdown of artificially manufactured scaffolds requires rigorous 
toxicological evaluation of each constituent component. Particularly when ambitious 
strategies involving the use of composite materials with integrated trophic factors is 
concerned, the importance of material biocompatibility evaluation rises significantly. The 
desired notion of effecting synergistic actions of GF and other incorporated component 
requires careful consideration of factor concentrations and release mechanisms in order 
to avoid potentially harmful overdosing. It therefore remains a priority to conduct 
systematic and rigorous toxicological studies – both in vitro and in vivo – to (1) eliminate 
grossly ineffective or toxic delivery platforms in order to (2) narrow down on potentially 
suitable candidate technologies as well as (3) ascertain any dose or time-dependencies 
which may influence the materials’ biocompatibilities. Biocompatibility refers to the 
ability of a material to perform with an appropriate host response in a specific situation. 
This means that depending on the area within the body, the implantable materials require 
different properties to obtain biocompatibility.   
Currently, there is discord between those postulating the use of naturally derived 
materials, synthetic materials or a combination of both – not least due to a lack of 
consistent proof of one’s superiority above the other. Naturally derived biomaterials such 
as collagen or hyaluronic acid are frequently selected for their benefits including 
similarity to native ECM, thus favouring natural cell-cell and cell-matrix interactions. 
Numerous studies have demonstrated both the in vitro and in vivo beneficial potential of 
natural scaffolds in wound healing (Lee and Chu, 2000, Chlapanidas et al., 2013, Park et 
al., 2012b). Using a genetically diabetic mouse model, the biocompatibility and wound 
healing properties of a fibrin-based scaffold incorporating both VEGF and bFGF was 
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demonstrated (Losi et al., 2013). Degradation of the fibrin scaffold over a 7 day period 
ensured timely release of GFs and accelerated wound healing compared to wounds not 
exposed to GFs. As previously mentioned, degradation rates of biological scaffolds may 
be fine-tuned using crosslinking agents (Zeugolis et al., 2009), but several crosslinking 
agents such as glutaraldehyde have demonstrated cytotoxicities (Duan and Sheardown, 
2006). Substitution with other, more biocompatible crosslinking agents is beginning to 
show tentative success and has to be researched further in terms of their long-term 
stability and biocompatibility (Park et al., 2002). High purification costs, relative 
unavailability and unsuitability for large scale processing as well as batch to batch 
variations and an immunogenic potential of naturally derived materials, however, have 
encouraged scientists to search for realistically applicable synthetic alternatives. 
Synthetic materials are thought to overcome the aforementioned disadvantages of 
natural materials and provide additional key benefits including the ability to tailor 
mechanical properties and degradation kinetics to suit individual applications. As seen in 
previous sections of this chapter, synthetic materials may be fabricated into various 
shapes with desired pore morphological features conducive and individually tailorable 
for tissue ingrowth.  
The majority of synthetic biodegradable materials studied for tissue engineering 
applications belong to the polyester family which include polyglycolides, polylactides and 
their various co-polymers (Fig. 2.6) (Gunatillake and Adhikari, 2003). They have long 
been used in a number of clinical applications ranging from biodegradable sutures 
(Cutright et al., 1971) to orthopaedic plates and fixture devices (Mayer and Hollinger, 
1995) and are also intensively studied as scaffold materials for cell transplantation and 
tissue regeneration (Thomson et al., 1995). 
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Figure 2.6. Chemical structures of the major biodegradable polyesters used in tissue engineering 
applications including polyglycolides, polylactides and their various co-polymers. Image taken 
from (Gunatillake and Adhikari, 2003). 
 
Polyesters mainly degrade in two stages; at first the amorphous region degrades via 
hydrolytic chain scission of ester bonds. The second stage involves mainly the 
degradation of the crystalline areas of the material. Degradation of polyesters releases 
lactic acid and glycolic acid which are resorbable even at high concentrations. However, 
concerns regarding their toxicity have been raised; several studies have highlighted the 
formation of local aseptic sinuses and osteolytic changes in conjunction with intermittent 
joint swellings in animals and patients treated with rods, screws and other fixation 
devices made of degradable PGA or PLA implants (Bergsma et al., 1993, Böstman, 1991, 
Böstman et al., 1989). Since infections were excluded, it was deemed likely that the 
observed adverse effects were related to the biodegradation of the PLA-PGA implants. 
Solazzo et al. studied the effects of PLA/PGA composite plates on osteoblastic 
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differentiation and proliferation of mesenchymal stem cells (MSCs) (Sollazzo et al., 2011). 
Initial results demonstrated strong influences on MSCs by enhancing proliferation, 
differentiation and matrix deposition but long-term effects of degradation products were 
not studied. Previous studies, on the other hand, already demonstrated long-term 
dramatic reductions of biocompatibility, likely due to degradation products causing bone 
resorption in and around the implant site (Spivak et al., 1990). Many in vitro studies 
previously determined that both PLA and PGA produced cytotoxic degradation products 
but did not consider the buffering effects of physiological solutions present in vivo. On the 
other hand, systemic distribution may result in potentially harmful degradation products  
becoming trapped in end-organs such as liver, kidney and spleen where they pose an 
inflammatory risk (Yildirimer et al., 2011, Tang et al., 2003). Implantation of larger PLA-
PGA materials as well as placement in anatomical region without access to sufficient 
quantities of body fluids may overwhelm the body’s capacity to provide adequate 
buffering. These issues were successfully addressed by incorporating basic salts within 
PLA-PGA implants which offset the pH decrease observed in the vicinity of degrading 
implants (Agrawal and Athanasiou, 1997).  
Other synthetic materials frequently used in tissue engineering applications include 
polycarbonates which possess 3 hydrolysable bonds: (1) amide, (2) carbonate, and (3) 
ester. The hydrolysis of carbonate groups yields two alcohols and CO2 thus eliminating 
the problem of the acid burst seen in polyesters. Varying the structure of the pendant R 
groups allows for tuning of mechanical properties, degradation rates and subsequent 
cellular responses to the material.  
PUs are a major class of synthetic elastomers which are usually used in the 
manufacture of non-degradable medical implants such as cardiac pacemakers and 
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vascular grafts (Ahmed et al., 2011b, Kannan et al., 2006a et al. 2006, Xie et al., 2010, 
Kannan et al., 2006c et al. 2006). Biodegradable versions of PU, obtained by incorporating 
degradable chemical linkages into the backbone, are of increasing interest due to 
excellent mechanical properties, biocompatibility and versatile degradation kinetics. 
However, a major problem has been the toxicity of degradation products, especially those 
from diisocyanate components such as 4,4’-methylenediphenyl diisocyanae (MDI) and 
toluene diisocyanate (TDI)  (McGill and Motto, 1974). Due to the advantages of precise 
control over material characteristics, it is possible to design non-toxic degradable PUs 
using diisocyanates such as lysine diisocyanate (LDI) (2,6-diisocyanatohexanoate) and 
other aliphatic diisocyanates like hexamethylene diisocyanate (HDI). 
Despite excellent and controllable physical properties of synthetic biomaterials, the 
apparent lack of innate cell recognition entities has led to the fabrication of composite 
bio-artificial scaffolds which aim to harness the distinct benefits of both material classes 
whilst simultaneously compensating for each other’s weaknesses. A good idea in theory, 
biosynthetic composite scaffolds however retain their individual drawbacks which, in the 
case of synthetic materials, are more predictable and therefore more easily rectifiable. 
For instance, natural biomaterials pose an innate risk of eliciting an immunological graft 
rejection which could be detrimental in cases of vital placements of grafts, e.g. vascular 
interpositional implants (Fig. 2.7) (Spark et al., 2008).  
With ever advancing material processing techniques, however, synthetic scaffold 
designs incorporating artificial cell-recognition entities may replace immunogenic cell 
surface epitopes with synthetic mimics which enhances biocompatibility of synthetic 
materials (Chen et al., 2011a). Additionally, synthetic materials may be designed with 
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chemical functional groups which can enhance cell attachment, proliferation and induce 
tissue ingrowth. 
 
 
Figure 2.7. Photograph of the left shoulder of a 25-year-old man with aneurysmal dilatation of a 
bovine ureteric axillary–innominate arteriovenous graft 2 months after operation. Image taken 
from (Spark et al., 2008). 
 
2.11 CONCLUSION AND FUTURE PERSPECTIVE 
Biomaterials scientists currently pursue 3 main avenues for the optimization of 
tissue engineering scaffold materials – (1) purely natural scaffolds, (2) synthetic 
alternatives, and (3) biosynthetic composites. The authors believe that rather than 
attempting an overcomplicated top down approach by aiming to modify natural materials 
with inherent material properties which may or may not be suitable, scientists would be 
better advised to adhere to the bottom-up fabrication of synthetic materials which may 
be strictly controlled throughout the fabrication process. Whilst we suggest developing 
nature-inspired materials by copying natural material structures, we postulate using 
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man-made materials for greater control and flexibility during the manufacturing process. 
This would ideally enable utilization of the best concepts of both worlds. 
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3 INTRODUCTION TO SKIN TISSUE 
ENGINEERING2 
3.1 SYNOPSIS 
Skin wounds are a major social and financial burden. However, current treatments 
are suboptimal. The gradual comprehension of the finely orchestrated nature of inter-
cellular communication has stimulated scientists to investigate growth factor (GF) or 
stem cell (SC) incorporation into suitable scaffolds for local delivery into wound beds in 
an attempt to accelerate healing. This chapter provides a critical evaluation of the status 
quo of current research into GF and SC therapy and subsequent future prospects, 
including benefits and possible long-term dangers associated with their use. Additionally, 
the importance of a bottom-up approach in scaffold fabrication is highlighted to enable 
controlled factor incorporation as well as production of complex scaffold micro- and 
nanostructures resembling that of natural ECM. 
 
 
 
 
 
 
 
 
 
 
 
                                                             
2 The following chapter has been adapted from Yildirimer et al. Trends Biotechnol. 2012;30(12):638-648. 
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3.2 INTRODUCTION – A MULTIMODAL COCKTAIL FOR SKIN REGENERATION 
Skin serves the onerous function of protecting our internal organs and tissues from 
external, potentially dangerous insults for a lifetime. Such temporal demands require not 
only impeccable integrity, but also mechanical strength and durability. Loss of large parts 
of this barrier, be it related to illness or injury, renders the individual susceptible to 
disability or death. The World Health Organisation (WHO) estimates that, annually, over 
300 000 deaths are attributable to fire-related burn injuries with millions more suffering 
from the partly devastating physical and emotional consequences thereof. A further 6.5 
million individuals suffer from chronic skin ulcers caused by prolonged pressure, venous 
stasis, or diabetes mellitus (Jones et al., 2002). The holistic goals of modern cutaneous 
wound care consist of rapid wound excision and closure with a functionally intact and 
aesthetically pleasing outcome. Currently available treatment options are lacking in 
establishing both functional and cosmetic satisfaction. Thus, combined with the burden 
of pain and the currently suboptimal therapy methods, the overall onus of cutaneous 
wounds appears vast. It seems of particular importance to dissociate oneself from the 
concept of aiming to replace lost skin tissue, and rather focus on promoting the 
regeneration of wounded tissues by stimulating the innate ability of the skin for self-
renewal. Wound contracture and scarring, properties that can misleadingly be thought 
accountable for faster wound healing, should be avoided in terms of wound regeneration. 
The gradual understanding of the biological processes involved in wound healing has 
opened the gates for developing smart bio-constructs that actively promote tissue 
regeneration via appropriately engineered regeneration platforms, or scaffolds, as well 
as the incorporation of cell-signalling elements such as GFs and SCs. In this chapter, a 
review and critical appraisal of current research efforts concerned with dermal 
regeneration scaffolds incorporating bioactive elements to promote neovascularisation 
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and tissue regeneration is provided. The most recent advances in the field of nanoscaled 
tissue engineering will also be touched upon because cellular behaviour is significantly 
influenced by the surface nanotopography of scaffolds that promotes cellular adherence, 
differentiation, and proliferation, mimicking natural ECM (Egaña et al., 2009). 
3.2.1 The Structure of Normal Skin 
Skin is the outermost covering of human beings and the largest organ of the body, 
encompassing the entire body surface. It has a complex three-layered structure (Fig. 3.1) 
which, under physiological circumstances, is intrinsically self-renewable, so that a new 
layer of skin develops every 2-3 weeks while continuously shedding the older top layers. 
 
 
Figure 3.1. An illustration of human skin showing the three constituting layers and skin adnexae. 
 
The three layers, from outermost to innermost are: (i) the epidermis which consists 
of multiple, ever renewing layers of keratinocytes; (ii) the dermis which is separated from 
the epidermis at the dermal-epidermal junction (basement membrane); and (iii) the 
hypodermis which is mainly made up of adipose tissue and collagen. 
Skin appendages such as hair follicles, sebaceous glands and sweat glands are 
numerously intermingled along blood vessels, nerve endings, and pressure and touch 
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receptors. Regional variations exist regarding skin thickness, distribution of skin 
appendages, and melanocyte density. Skin mainly functions as a protecting interface, 
physically shielding internal organs and tissues from external insults. Once the external 
barrier is breached, innate surveillance mechanisms set off a cell-signalling cascade to 
limit pain, control infection, and accelerate wound healing naturally, ultimately creating 
a scar. However, extensive wounds such as those associated with full thickness burns 
rarely, if ever, heal spontaneously and thus require an external means of protection, be it 
temporary or permanent, to stimulate not only wound healing, but scarless self-
regeneration. Current conventions hold that tissue-engineered skin constructs should 
resemble native skin both anatomically and functionally. 
3.2.2 Normal Wound Healing  
Wounds are defined as breaks in the continuity of the structure of the skin, usually 
resulting from physical trauma and leading to either temporary or terminal loss of 
function. Healing is a complex dynamic process that results in the restoration of anatomic 
continuity and function (Fig. 3.2). It consists of 4 distinct but overlapping entities that 
depend on complex and finely orchestrated cell-signalling events. Firstly, haemostasis is 
triggered post-injury by platelets within the wound bed. These interact with the ECM to 
initiate the clotting cascade which results in a blood clot forming. This, in turn, provides 
a platform for cell migration. The second stage, inflammation, is triggered by PDGF and 
TGF-β released by platelets. Neutrophils and monocytes are recruited to phagocytose 
foreign material and pathogens. Macrophages expressing CSF-1, TNF-β and PDGF act as 
chemoattractants for fibroblasts. This leads on to the proliferative phase where PDGF, 
TGF-β and ECM molecules induce fibroblast proliferation, new ECM deposition and 
integrin receptor expression to promote cell recognition and adherence. 
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Figure 3.2. A schematic representation of the normal wound healing process incorporating 
various cell-signalling molecules (Schäfer and Werner, 2008). 
 
The 4th remodelling stage involves the crosslinking of new collagen matrix. 
Fibroblast-derived enzymes including collagenases, plasminogen activators and 
gelatinases create pathways through tightly woven ECM for cellular movement. Over time, 
granulation tissue is replaced with an acellular, avascular scar. 
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3.2.3 Foetal Wound Healing 
 Foetal wound healing differs distinctly from adult healing, resulting in intrinsic and 
complete self-regeneration of a wound without scar formation. This is attributable to 
different healing mechanisms including a significantly reduced inflammatory response 
with fewer differentiated inflammatory cells in early gestational foetal wounds. Higher 
numbers of phagocytic cells and morphogenic factors result in collagen deposition akin 
to that of normal skin (i.e., large bundles of ECM in a normal reticular orientation as 
opposed to an adult-pattern abnormal deposition of parallel bundles of mainly collagen 
types I and III). Additionally, higher levels of hyaluronic acid (HA) and altered ratios of 
signalling molecules and genes are thought to play a vital role in scarless wound healing. 
However, scarless healing is only possible during the first two trimesters, attributable to 
a finely orchestrated interplay between several factors. During the third trimester, a 
transition occurs and the skin loses its ability to regenerate, resulting in the formation of 
fibrous scar tissues. 
Previous assumptions that the sterile, GF-enriched intrauterine environment is 
the determining factor for scarless healing have been refuted by several seminal studies; 
a marsupial model for cutaneous healing demonstrated that the developing opossum 
retained its ability for scarless regeneration despite growing in a pouch devoid of 
amniotic fluid (Werner et al., 1994). Transplantation studies on sheep models have 
shown that wounded adult or late foetal skin transplanted onto early- gestation foetal 
lambs healed with scar formation (Staiano-Coico et al., 1993), whereas wounded early 
foetal human skin transplanted into nude mice regenerated with no scar formation (Peng 
et al., 2011). This demonstrates independence from environmental factors and an 
intrinsic ability for early- gestational foetal skin to regenerate without scar formation. 
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The complete elucidation of the intrinsic foetal wound healing mechanisms would 
allow for the meticulous re-establishment of signalling events within an ex-foetal 
environment, resulting in scarless dermal regeneration in adult wounds. 
3.2.4 Management of Thermal Wounds 
Thermal wounds have been divided into three zones of histopathological injury; (1) 
the zone of coagulation, or eschar, is the central area of a burn wound which undergoes 
complete and irreversible necrosis and denaturation of proteins. (2) The zone of stasis 
and oedema with partially denatured proteins and slow blood flow, and (3) the zone of 
hyperaemia which is characterised by gradually increasing blood flow. 
In case of wound infection or poor perfusion, a seemingly superficial burn may in 
time develop into a more severe and deeper wound with necrotic areas extending into 
the zone of stasis. Current treatment standards of burn wounds comprise of (i) early and 
complete excision of eschar to prevent wound infection, (ii) in cases of full-thickness 
burns, wound coverage with an autologous split thickness skin graft harvested from 
intact areas of the patient's skin is used. 
If larger parts of the total body surface area have been damaged, autologous skin 
grafts may still be taken and then meshed in order to enlarge the size of the graft. The 
disadvantages of such practices are morbidity, significant pain at the donor site, and the 
characteristic corrugated scar as the recipient site heals. In cases of total or near total full-
thickness skin injuries, donor sites may be unavailable, necessitating the use of cadaveric 
skin to fulfil vital barrier functions. Cadaveric skin grafts are lyophilised, thus removing 
the cellular component to prevent graft immune rejection. They may either be obtained 
from non-profit skin banks or purchased as, for example, Karoskin. Such allografts 
represent temporary 'bridging' measures for immediate wound coverage in the acute 
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stages post-injury. Disadvantages of utilising human cadaveric skin are manifold and 
include donor organ shortage and limited skin bank availability, moral objections from 
the patient's or surgeon's perspective, and the potential risk of viral transmission from 
cadaveric tissues to the recipient. It is evident that there is an urgent need for fully 
synthetic, yet biocompatible and so-called 'smart' skin bio-constructs for the 
regeneration of scarfree skin. 
3.3 CURRENT STATE OF TISSUE ENGINEERED SKIN SUBSTITUTES 
The pressing need for more suitable wound dressings has spurred on the search for 
alternative skin substitutes that actively promote wound regeneration. The era of dermal 
tissue engineering was heralded three decades ago with a bi-layered and biocompatible 
dermal scaffold based on a bovine collagen matrix, which successfully induced the 
synthesis of a neodermis (Burke et al., 1981). This novel bio-construct revolutionised 
current burns practice and even today, Integra® dermal regeneration scaffold is often 
used as the gold standard in severe full-thickness burns that are not amenable to 
autograft harvest, due to immediate availability, skin infiltration rates similar to that of 
skin allografts (85% versus 95%) and adequate cosmetic results (Jones et al., 2002). 
Clinically available and novel skin substitutes can be broadly divided into epidermal, 
dermal, and dermo-epidermal (composite) tissue-engineered constructs (Shevchenko et 
al., 2010b). A multitude of choices and potential alternatives for tissue- engineering skin 
constructs exist and, in fact, numerous substitutes are being investigated for human 
usage; some of them already commercialised (Table 3.1). 
The current lack of more sophisticated and superior skin alternatives requires a 
focus on regeneration rather than replacement. Current research is increasingly 
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integrating the concept of engineering dermal scaffolds that actively promote 
regeneration by incorporating SCs and external GFs to recreate a favourable cellular 
microenvironment. SCs have been central to the field of regenerative medicine for over 
three decades due to an ability to induce their differentiation into any cell type with 
subsequent cell- specific GF and cytokine release to enhance angiogenesis (Egaña et al., 
2009). This approach is motivated by the understanding that numerous cell-cell and cell-
ECM cues are required to achieve physiological functioning of the surrounding cells and 
tissues (Bianchi et al., 2007). Furthermore, naturally occurring ECM components, as well 
as physiological molecules involved in wound healing, have dimensions in the nanometre 
range (1-100 nm), thus suggesting a significant and exploitable potential for ‘nano-
engineered’ particle delivery vehicles. For example, nanoparticles could be used to create 
advantageous surface nanostructures or nanotopography resembling natural structures, 
and further seeded with SCs or functionalised with GFs (Choi et al., 2008), cytokines, and 
peptides (Kim et al., 2009). 
3.4 BIOENGINEERING ‘SMART’ SCAFFOLDS FOR SKIN REGENERATION: A BOTTOM-
UP APPROACH 
The ultimate purpose of tissue-engineered skin grafts is to enable complete and 
natural, albeit accelerated, wound regeneration. A 3D supporting framework should 
serve as a template for tissue regeneration while simultaneously preventing wound bed 
contraction throughout the first stages of healing (Chevallay and Herbage, 2000). The 
framework, or scaffold, should further serve as a platform for cellular localisation, adhe-
sion, and differentiation, as well as guide the development of new functional tissues (Kim 
and Mooney, 1998). A focus on the multitude of different scaffold materials and 
fabrication techniques is beyond the scope of this chapter but has been extensively 
120 
 
reviewed elsewhere (Edalat et al., 2012). Scaffold materials may be of natural, synthetic, 
or composite origin and engineered using a multitude of approaches including porogen 
leaching, electrospinning, molecular self-assembly, and phase separation. The mixing of 
materials of different classes to obtain composite scaffolds seems particularly promising 
because individual limitations of single material scaffolds (e.g. poor mechanical 
properties) are often overcome by the composite nature (Kannan et al., 2007a). The ideal 
skin regeneration scaffold should actively direct tissue formation and prevent scarring. 
Thus, much focus has been channelled into creating suitable biomimetic surface micro- 
and nanostructures that can act as delivery vehicles for SCs or GFs. The synergistic tissue 
regenerating effects of a smart scaffold cocktail comprising (i) favourable scaffold surface 
patterns, (ii) GFs, and (iii) SCs have the realistic potential of overcoming current barriers 
and enabling fast and complete skin regeneration. 
During natural wound healing, dynamic and reciprocal interactions between 
components of the ECM and surrounding cell-signalling molecules are responsible for the 
expression of GFs and cytokines. These interactions elicit cellular responses that 
ultimately lead to new tissue formation. Overwhelming activation of the inflammatory 
system and prolific recruitment of contractile cells is thought to stem from prehistoric 
adaptations of human skin to close irregular and often contaminated wounds as rapidly 
as possible, to prevent microorganism invasion and potentially lethal infections 
(Sedaghati et al., 2014). Unfortunately, this response typically leads to scar formation, 
often resulting in disfigurement and functional disability. Nowadays, some wounds are 
closed aseptically using sutures that obviate the need for a vigorous contractile response, 
creating more time for complete tissue regeneration. Here, external modulation of cell-
signalling events via a finely tuned delivery of GFs or SCs is thought to alter the wound 
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environment, enabling orderly regeneration. Modifying the micro- and nano-
environment and surface architecture of the scaffold, termed nanotopography, actively 
influences cell migration, proliferation, and differentiation. 
In the following sections, we focus on discussing incorporation of various GFs 
involved in wound healing into scaffolds and the possibilities of exploiting the latest SC 
technologies to accelerate skin regeneration. Potential advantages of cutting-edge nano-
engineered scaffolds over macrosized skin substitutes as 3D stimulatory platforms for 
cellular growth and skin regeneration are highlighted. Overall, we support the argument 
that a bottom-up approach (i) enables tight control over important micro- and 
nanostructures within scaffold architecture; and (ii) facilitates incorporation of 
appropriate concentrations of bioactive factors as well as SCs. 
3.5 GROWTH FACTOR FUNCTIONALIZED SKIN REGENERATION SCAFFOLDS 
3.5.1 Epidermal Growth Factor (EGF) 
EGF is implicated in keratinocyte migration, fibroblast proliferation and 
differentiation, and granulation tissue formation. EGF significantly enhances wound 
healing (Alemdaroğlu et al., 2008) as well as the tensile strength of the resultant ECM 
(Throm et al., 2010). Prolonged exposure to EGF yielded a 200% increase in tensile 
strength when liposome-encapsulated EGF was delivered into murine dorsal cutaneous 
wounds (Brown et al., 1988). Similarly, EGF contained within a gelatine sheet applied to 
dorsa of hairless dogs accelerated wound closure and healing of superficial and partial-
thickness wounds (Tanaka et al., 2005). Current challenges regarding the delivery of EGF 
at physiologically relevant concentrations and durations still prevail due to its rapid 
breakdown within the wound environment, encouraging research into effective 
immobilisation and delivery techniques. For example, biodegradable microspheres that 
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contain EGF provide sustained EGF delivery and hence more effective wound healing in 
a rabbit dorsal skin wound model (Ulubayram et al., 2001). Despite such encouraging 
results, supplemental EGF has a mitogenic effect upon cells and has been implicated in 
the spread of epithelial malignancies (Hardwicke et al., 2008). However, the beneficial 
effects of EGF in the wound healing process should not be denied, thus requiring further 
research. 
3.5.2 Basic Fibroblast Growth Factor (bFGF) 
FGF comprises a large family of mitogens that are actively involved in the 
processes of wound healing, embryonic development, angiogenesis, and tumour 
progression (Thisse and Thisse, 2005, Dailey et al., 2005, Beenken and Mohammadi, 
2009). Both acidic fibroblast growth factor (aFGF) and bFGF are found within the wound 
fluid at the earliest stages of healing (Nissen et al., 2003). aFGF, like bFGF, is a potent 
mitogen and chemo-attractant for vascular endothelial cells, dermal fibroblasts, and 
epidermal keratinocytes. In the initial phases of wound healing, bFGF participates by 
activating local macrophages and can still be identified within the healing tissue during 
the remodelling phase that occurs several weeks after injury (Kibe et al., 2000). bFGF 
accelerates neovascularisation as shown in a rabbit ear wound healing model, in which 
wounds supplemented with exogenous bFGF healed significantly faster compared to 
untreated controls (Komori et al., 2005). Radiation-induced cutaneous wounds created 
in miniature pig models treated with exogenous bFGF showed increased dermo-
epidermal proliferation, new blood vessel formation, higher overall mechanical skin 
stability, and adnexae integrity (Kinoshita et al.). In 2001, genetically recombinant bFGF 
was approved for clinical use in Japan under the trade name Fiblast Spray (Kaken 
Pharmaceutical Co. Ltd., Tokyo, Japan). Clinical trials conducted on second-degree burn 
wounds in Japanese adults and children showed accelerated rates of wound healing and 
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superior mechanical properties of the resultant scars when topical bFGF was initiated 
relatively soon after creation of the burn injury (1-4 days, mean 2 days) (Akita et al., 2006, 
Akita et al., 2008). Despite such promising results, concerns over the carcinogenic 
potential of topical FGF application remain; bFGF has been identified as a major autocrine 
stimulant in melanoma and, in combination with UV light, is associated with tumour 
progression (Lázár-Molnár et al., 2000, Berking et al., 2001). Further research is needed 
to corroborate existing evidence of beneficial effects of bFGF on wound healing and refute 
any associations with the progression of skin cancers. 
3.5.3 Keratinocyte Growth Factor (KGF) 
KGF is expressed within the dermis and hypodermis below the wound, whereas the 
KGF receptor is predominantly found on epithelial cells of the epidermis, suggesting a 
paracrine mediation of epithelial cell growth. Several animal and clinical studies have 
demonstrated the cytoprotective and epithelial regenerative properties of KGF (Wu et al., 
2011, Yazbeck et al., 2011, Spielberger et al., 2004). Such favourable effects depend on 
several mechanisms including cell proliferation, migration, differentiation, survival, DNA 
repair, and detoxifying enzyme induction, which collectively act to strengthen the 
integrity of the epithelium (Finch and Rubin, 2004). During the initial 24 h of normal 
human wound healing, KGF expression is up-regulated 100-fold and remains elevated for 
several days (Marchese et al., 1995). This up-regulation in KGF is significantly dampened 
in genetically diabetic and glucocorticoid-treated mice (Brauchle et al., 1995, Werner et 
al., 1994). In a porcine partial-thickness wound model, topical application of recombinant 
KGF demonstrated an accelerated rate of re- epithelialisation compared to controls not 
receiving KGF (Staiano-Coico et al., 1993). In a murine full-thickness wound healing 
model, keratinocyte proliferation and angiogenesis were significantly retarded in KGF 
knockouts compared to wild-type mice (Peng et al., 2011). These results suggest a further 
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role of KGF in the control of wound bed angiogenesis. However, the use of KGF in 
epithelial cancer patients raises concerns regarding potential tumourigenicity of KGF 
because epithelial cells express KGF receptors. Several studies have identified a potential 
association between the overabundance of KGF and tumour growth progression (Chung 
et al., 1992). Further studies are warranted to examine the nature and extent of KGF 
involvement in tumour development. 
3.5.4 Vascular Endothelial Growth Factor (VEGF)  
The VEGF family encompasses VEGF-A, VEGF-B, VEGF- C, VEGF-D, and PlGF. During 
wound healing, VEGF-A is highly expressed by keratinocytes within the wound bed to 
promote new blood vessel formation essential for tissue regeneration (Drinkwater et al., 
2002) and re-epithelialisation of wounds (Wise et al., 2012, Brem et al., 2009). VEGF is 
the major angiogenesis-promoting GF due to its combined ability to stimulate endothelial 
cell proliferation and migration (Ferrara and Henzel, 1989), basement membrane 
degradation (Unemori et al., 1992), tubular and luminal structure formation (Koolwijk et 
al., 1996), increased vascular permeability (Bates and Curry, 1996), and new vessel 
formation (Connolly et al., 1989). In a diabetic mouse model, mini-circle plasmid DNA 
encoding VEGF was successfully transfected into proliferating cells within wounded 
tissue, resulting in a high level of VEGF expression (Kwon et al., 2012). Wound healing 
rates were significantly accelerated in plasmid-exposed injuries compared to those 
exposed to empty vehicles. Similarly, vector-mediated VEGF transfer onto experimental 
murine burn wounds increased angiogenesis as well as epithelial proliferation and ECM 
maturation (Galeano et al., 2003). Despite extensive evidence for accelerated wound 
healing via increased blood vessel formation, the use of VEGF must be critically appraised 
within the context of potential negative effects; two relatively recent studies have 
reported associations between chronic burn injuries and the development of primary 
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cutaneous anaplastic large cell lymphoma (PCALCL) (Yeung et al., 2004, Morihara et al., 
2007). According to these reports, the growth of PCALCL is fuelled by VEGF production 
and secretion by atypical large lymphocytes. Furthermore, skin biopsies from the 
erythematous region surrounding the PCALCL have revealed rich neovascularisation 
secondary to VEGF overexpression. Although the differing effects of VEGF on cutaneous 
wounds require a cautious approach, it seems of equal importance to investigate its 
beneficial effects further in order to avoid premature rejection of a potentially useful GF. 
3.5.5 Insulin-Like Growth Factor (IGF) 
High levels of IGF-1 found within cutaneous wounds have been shown to accelerate 
epidermal wound healing and inhibit apoptosis pathways (Dasu et al., 2003, Spies et al., 
2001), whereas reduced expression of IGF-1 is associated with retarded wound healing 
(Gartner et al., 1992). For example, IGF-1 receptor knockout mice (IGF- 1r -/-) exhibited 
skin hypotrophy with fewer and smaller hair follicles (Liu et al., 1993). Wound healing by 
re-epithelialisation was accelerated by local overexpression of IGF-1, whereas no effects 
were observed on the underlying dermis (Semenova et al., 2008). In vitro studies, 
however, have found evidence for the stimulatory effects of IGF-1 on collagen and ECM 
production (Daian et al., 2003). Similarly, wound beds of IGF-1-depleted rats had 
significantly lower collagen content, as measured by the amount of hydroxyproline, a 
major component of collagen, compared to non-depleted animals, suggesting a reduced 
capacity for wound healing. Subsequent IGF-1 infusion returned concentrations to near-
normal levels (Mueller et al., 1994). Such contrasting evidence for a role in ECM and 
collagen production is indicative of a dose-dependent activation of dermal fibroblasts by 
IGF-1. In a porcine diabetic full-thickness excisional wound model, transplantation of IGF-
1-transfected keratinocytes increased local IGF-1 expression 900-fold, leading to 
significantly accelerated keratinocyte migration and wound closure (Hirsch et al., 2008). 
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Wound contracture, a possible confounder in the interpretation of wound closure rates, 
is not thought to have significantly influenced the wound healing process, because 
degrees of contractions were similar in transfected and control groups. Maintenance of 
appropriate IGF-1 concentrations within the wound bed is significantly important 
because overexpression has been linked to skin hyperplasia and tumour growth 
(DiGiovanni et al., 2000, Bol et al., 1997). 
3.5.6 Platelet-Derived Growth Factor (PDGF) 
PDGF is involved throughout all stages of normal wound healing. PDGF is released by 
degranulating platelets and activated macrophages within the wound fluid. Later in the 
proliferative stage, PDGF is responsible for the differentiation of fibroblasts into their 
contractile phenotype, the myofibroblasts which through attachments of their filopodia 
to components of the ECM, drag or contract the tissues together (Clark, 1993). Several 
animal studies have demonstrated accelerated wound closure in normal and patho-
physiological states when the wound bed was supplemented with exogenous PDGF (Uhl 
et al.). In a genetically diabetic mouse model (C57BL/Ks-J-db/db), large full-thickness 
skin wounds (1.5x1.5 cm2) created on the mid-back were exposed to recombinant human 
PDGF (Greenhalgh et al., 1990). At 21 days, more fibroblasts, enhanced capillary 
formation, and accelerated wound closure were observed in treated diabetic mice 
compared to littermates receiving empty vehicles. Furthermore, in vivo blockage of PDGF 
receptors with the PDGFR-β inhibitor imatinib mesylate resulted in delayed wound 
healing, reduced wound closure, and abnormal microvascular morphology, normally 
observed in PDGFR-β -/- mice, thus highlighting the pivotal role of PDGF in early wound 
healing (Rajkumar et al., 2006). However, similar results could not be obtained using the 
same animal model, same wound dimensions, but commercially available Regranex 
(Greenhalgh et al., 1990). In a recently published retrospective clinical study on the 
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healing efficiency of supplementary PDGF on diabetic heel ulcers larger than 4 cm (an 
independent predictor of limb loss), some beneficial effects were observed when the 
standard treatment regime (distal femoral bypass surgery, partial calcanectomy, intra-
operative negative pressure wound treatment) was boosted with PDGF (Goudie et al., 
2012)68]. PDGF is thought to modulate beneficially the ulcer microenvironment, thereby 
accelerating wound healing and closure. However, the small cohort, lack of 
randomisation and blinding, as well as the absence of a control population minimise the 
significance of these results. 
3.5.7 Transforming Growth Factor-β (TGF- β) 
TGF-β exists in three isoforms - TGF-β1, TGF-β2, and TGF-β3 - which are all involved 
in the process of wound healing. After acute injuries, TGF-β1 is highly expressed by 
keratinocytes, platelets, monocytes, fibroblasts, and macrophages (Faler et al., 2006). 
TGF-β acts in both autocrine and paracrine manners, inducing its own synthesis by target 
cells and activating nearby cells to synthesise and release other GFs involved in the 
healing process (Murphy et al., 2011). The autocrine action of TGF-β1 by fibroblasts 
sustains their activity beyond the initial inflammatory stimulus (Schmid et al., 1998) and 
is postulated to play a key role in myofibroblast differentiation (Tomasek et al., 2002). 
TGF-β2 expression is related to wound contracture and excessive collagen deposition, 
but has also been demonstrated to be a causative factor in scar formation (Shah et al., 
1995). Early foetal skin is well known for its ability to regenerate wounds completely 
without the formation of scar tissue, which is thought to be largely associated with a 
significantly reduced expression of TGF-β1, coinciding with highly elevated levels of TGF-
β3 (Lin et al., 1995). The exact underlying mechanism of action for scarless foetal wound 
regeneration has not been elucidated so far, leaving the respective roles of the TGF-β iso-
forms to be fully uncovered. 
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The results obtained with the use of GFs to accelerate wound healing, while 
encouraging on both experimental and clinical levels, must be interpreted cautiously, 
because the same factors are often implicated in exuberant tissue and tumour growth. 
More basic and preclinical research is necessary to indicate when GF concentration 
moves from being beneficial to becoming potentially harmful. Such ambiguous 
circumstances demand careful evaluation for more than one reason. 
First, it is of paramount importance that exposure to inappropriate amounts of GFs 
is prevented due to potentially carcinogenic tendencies in vivo, as previously mentioned. 
Any such long-term adverse effects must be excluded prior to commencing clinical trials. 
Only a few of the numerous GFs playing their part throughout the process of wound 
healing are approved by the Food and Drug Administration (FDA) and clinically available 
for the purpose of accelerating wound repair (e.g., Regranex, Kepivance). One may argue 
that worries about lasting adverse effects of GF use in the context of skin wound healing 
may be unfounded because their application is mostly local. Furthermore, GFs are rapidly 
degraded into natural metabolites by the wound fluid, thus eliminating any downstream 
effects. Such rapid elimination from the body is, however, avoidable via encapsulation 
techniques, enabling GFs to linger within the wound for longer prolonging their trophic 
effects. 
Second, determining beneficial effects on wound healing is ongoing. Selective GF 
treatment leads to accelerated rates of healing both in experimental and preclinical trials. 
Potential reasons for failure might be inappropriate routes of GF delivery or 
overabundance of GFs that cancel out the anticipated beneficial effects on wound healing. 
This, again, demonstrates the critical need to investigate the optimal GF concentrations 
to stimulate appropriately skin regeneration while avoiding the risk of overstimulation 
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and tumour formation or receptor down-regulation. Below, a critical discussion on the 
benefits and disadvantages of SC usage for tissue engineering purposes is provided. 
3.6 STEM CELL-SEEDED SKIN REGENERATION SCAFFOLDS 
Slow scaffold vascularisation is a critical limiting factor in skin wound regeneration 
due to inadequate supplies of nutrients and oxygen and a build-up of waste products 
within the tissues. SCs have the ability to self-renew and differentiate into lineage-
specific progenies. Despite their ability to acquire any cell type of an organism, 
embryonic SC usage is retarded by ethical considerations. Adult SCs, on the other hand, 
have several advantages: (i) the ability to differentiate into several lineages within a 
tissue; (ii) the relative ease of access; and (iii) less stringent regulatory concerns and a 
higher degree of public acceptance compared to embryonic SC use. The beneficial 
effects of adult mesenchymal stem cells (MSCs) in wound bed neovascularisation and 
accelerated healing has been demonstrated in several preclinical models (Rustad et al., 
2012, Wu et al., 2007). Yet, the mechanisms of action remain elusive; evidence for 
paracrine signalling subsists (Hocking and Gibran, 2010), although the role of MSC 
differentiation in wound healing is less clear, partially due to low engraftment efficiency 
of cells (Wagner et al., 2009). Thus, cell delivery vehicles have been applied to provide 
suitable cellular microenvironments and enhanced engraftment, survival and 
differentiation into appropriate mature cells (Rustad et al., 2012) (Fig. 3.3). Particular 
emphasis is placed on the integration of human adipose derived stem cells (hADSCs) 
into skin regeneration scaffolds due to their accessibility and facile in vitro expansibility. 
hADSCs are a source of MSCs that have shown a potential for therapeutic vascularisation 
due to the production of angiogenic GFs (Liu et al., 2011). This was demonstrated in an 
in vivo wound healing study using nude mice; two identical defects were created in the 
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dorsal skin of mice and exposed to either collagen gel preseeded with hADSCs or empty 
collagen vehicles (Kim et al., 2007). Angiogenic GF production was significantly 
enhanced in SC-seeded wounds compared to nonseeded wounds. Another study 
obtained similar results with ADSCs-impregnated microcarrier systems (Zhou et al., 
2011). Despite substantial preclinical evidence for a beneficial role of SCs in the wound 
healing process, one should approach the clinical use of MSCs cautiously because 
evidence suggests a contributing role in cancer SC maintenance (Dazzi and Horwood, 
2007). It remains to be seen how useful SC technology proves to be in clinical reality; 
the tendency to overplay the role of SCs for regenerative purposes, however, should not 
discourage scientists to evaluate further the substantial potential within the field of 
regenerative SC technology. 
3.7 NANO-ENGINEERED SCAFFOLDS FOR A BOTTOM-UP APPROACH TO WOUND 
REGENERATION 
Regenerative medicine aims at recuperating lost tissues by guiding cell growth and 
restoring original tissue architecture. This requires the presence of a scaffold because 
isolated cells are unable to re-establish their native structures due to a lack in 
extracellular guidance. Figure 3.3 shows a schematic representation of the ideal skin 
regeneration scaffold.  
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Figure 3.3. Schematic representation of the ideal scaffold to promote skin regeneration. Despite 
intense research efforts aiming at optimising available scaffolds, the proposed schematic has not 
been developed successfully yet. Abbreviations: AgNPs, silver nanoparticles; GFs, growth factors. 
 
Although various scaffolds for skin regeneration are already on the market (Table 
3.1), their clinical implementation remains riddled with flaws, ranging from poor take 
rates (Tremblay et al., 2005) and poor cosmesis to relatively high infection rates.  
 
Table 3.1. Characteristics of the 'ideal' skin substitute. 
 
 
Dermo-epidermal substitute  
(composite) 
References 
Cadaveric skin (non-
profit skin banks) 
Karoskin® (*) Apligraf® (*) 
Patient safety Potential for viral 
transmission 
Immune rejection 
Potential for viral 
transmission 
Immune rejection 
Potential for viral 
transmission 
 
Scaffold 
degradability 
Rejection rather than 
degradation. 
Rejection rather than 
degradation. 
1-2 months (Griffiths et al.) 
Duration of cover Temporary Temporary Temporary  
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Neo-dermis 
formation 
Dermis revascularizes 
and integrates into the 
wound bed. The 
epidermis is rejected 3-4 
weeks post-
transplantation. 
Dermis revascularizes 
and integrates into the 
wound bed. The 
epidermis is rejected 3-
4 weeks post-
transplantation. 
Delivers ECM 
components, cytokines 
and GF to the wound 
(Ehrenreich and 
Ruszczak, 2006, 
Eaglstein and 
Falanga, 1998, 
Kim et al., 2006, 
Wood et al., 2006) 
Shelf life 7-10 days if fresh. 
Unlimited if lyophilized. 
Unlimited if 
lyophilized. 
5-10 days  
Cost (/cm2)  
(in 2007) 
donated £0.60 £14.20 (Jones et al., 
2002) 
Mechanical 
stability 
Lyophilization improves 
mechanical stability 
significantly. 
Lyophilization 
improves mechanical 
stability significantly. 
Requires delicate 
handling 
 
Scaffold 
vascularisation 
(i.e. ‘take’) 
Cadaveric allografts ‘take’ 
initially, i.e. 
vascularization is 
observed however, 
subsequent graft 
rejection requires its 
eventual removal. 
‘Takes’ initially, i.e. 
vascularization is 
observed however, 
subsequent graft 
rejection requires its 
eventual removal. 
Take rates depend on 
the type of wound and 
are very variable 
ranging from 16%– 
41% 
(Tremblay et al., 
2005) 
Nº of stages 
necessary for 
completion 
Multiple as cadaveric 
grafts require eventual 
replacement. 
Multiple as cadaveric 
grafts require eventual 
replacement. 
1-stage process but 
needs co-grafting with 
autologous epithelial 
cells in full-thickness 
burns. 
 
 
 
 
Dermal substitute References 
Alloderm® (*) SureDerm® 
(*) 
Integra® (*) Dermagraft® (*) 
 
 
Patient safety Potential for viral 
transmission 
Potential for 
viral 
transmission 
n/a Potential for viral 
transmission 
 
Scaffold 
degradability 
Incorporates into 
wound bed 
Incorporates 
into wound 
bed 
Half-live, T = 30 
days 
Degrades by 
hydrolysis 
(Griffiths et al.) 
Duration of cover Permanent Permanent Semi-permanent Temporary  
Neo-dermis 
formation 
Repopulated by 
host cells, i.e. 
incorporates into 
host tissue. 
Repopulated 
by host cells, 
i.e. 
incorporates 
into host 
tissue. 
Neodermis 
formation 
complete in 15-
20 days 
Scaffolds degrade 
over 20-30 days. 
Fibroblasts 
simultaneously 
produce ECM 
components and GF 
(Ehrenreich and 
Ruszczak, 2006, 
Eaglstein and 
Falanga, 1998, 
Kim et al., 2006, 
Wood et al., 2006) 
Shelf life 2 years Up to 2 years 2 years Up to 6 months  
Cost (/cm2)  
(in 2007) 
£5.90 n/f £3.32 £7.14 (Jones et al., 
2002) 
Mechanical 
stability 
Stable due to 
presence of 
basement 
membrane. 
No adverse 
information 
regarding 
fragility and 
manual 
handling 
Easy handling Easy handling  
Scaffold 
vascularisation 
(i.e. ‘take’) 
Uncertain rates 
of vascularization 
No adverse 
information 
regarding 
Takes relatively 
long time for 
Take is facilitated by 
fibrovascular in 
growth and re-
(Tremblay et al., 
2005) 
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delayed or 
failed graft 
take. 
vascularization 
(10-14 d). 
epithelialization and 
wound closure by 
keratinocytes 
migration from 
wound edges. 
 
Nº of stages 
necessary for 
completion 
1-stage process 
(using ultra-thin 
split-thickness 
graft) 
2-stage 
process (using 
split-thickness 
graft) 
2-stage process 
(using split-
thickness graft) 
2-stage process if 
used in burn 
injuries (using split-
thickness graft) 
 
 
 
 
Epidermal substitute References 
MySkinTM (*) CellSpray® (*) 
Patient safety Autologous keratinocytes are co-
cultured with irradiated murine cells 
n/a  
Scaffold 
degradability 
< 29 days n/f (Griffiths et al.) 
Duration of cover Permanent Permanent  
Neo-dermis 
formation 
Only applicable in partial-thickness 
and graft donor side wounds, but not 
in full-thickness wounds 
Only applicable in partial-thickness 
and graft donor side wounds, but not 
in full-thickness wounds 
(Ehrenreich and 
Ruszczak, 2006, 
Eaglstein and 
Falanga, 1998, 
Kim et al., 2006, 
Wood et al., 2006) 
Shelf life 3 days n/f  
Cost (/cm2)  
(in 2007) 
n/f n/f (Jones et al., 
2002) 
Mechanical 
stability 
Easy handling and application due to 
a silicone support layer 
Very fragile and difficult to handle  
Scaffold 
vascularisation 
(i.e. ‘take’) 
Cannot be used for full-thickness 
wounds as dermal component 
missing. 
Uncertain rate of take as it depends 
on cell-cell and cell-ECM adhesion 
rather than vascularization. Higher 
risk of bacterial contamination 
leading to graft loss. 
(Tremblay et al., 
2005) 
Nº of stages 
necessary for 
completion 
Up to 12 individual applications 1-stage process  
Key: ECM, extra-cellular matrix; GF, growth factor; n/a, not applicable; n/f, not found; Nº, number; (*), commercialized 
product 
 
Efforts at increasing their effectiveness include bioactivation, that is, expanding 
their role from being a simple structural framework to a delivery vehicle for GFs, 
cytokines, or genes (Yang et al., 2012, Barrientos et al.). In this way, tissue regeneration 
can be actively promoted rather than merely passively suggested. This should, however, 
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not discourage research into more suitable scaffold architectures, because 
accumulating evidence highlights the importance of biocompatible scaffold materials, 
appropriate pore sizes, and cell-growth-promoting surface topographies (Wong et al., 
2011, Yildirimer et al., 2011). Although scientists agree on the importance of the 
extracellular microarchitecture for cell adherence and proliferation, studies have 
shown an abnormally elongated phenotype when cells were grown on microfibrous 
materials. Cells cultured on nanofibrous structures, however, demonstrated a 
phenotype resembling that of cells growing within natural environments. This may be 
explained by the close architectural approximation of nanofibrous materials to natural 
ECM and collagen fibrils, which themselves exhibit nanometre dimensions. Thus, a 
natural cell environment can be feigned and cells guided along normal morphogenic 
lines. Additionally, natural ECM fibrils serve as storage vehicles for SCs and bioactive 
factors to regulate cell migration, proliferation, and differentiation. The bottom-up ap-
proach allows for tight control over scaffold micro- and nanoarchitecture, porosity, as 
well as the sequential incorporation of bioactive elements which, in turn, influence 
cellular interactions via the creation of a beneficial biomimetic micro- and 
nanoenvironment. 
3.8 CONCLUSION AND FUTURE PERSPECTIVE 
The burden of cutaneous wounds is immense in both personal and financial terms. 
Clinically available and feasible treatment strategies are still lacking despite various skin 
substitutes being under thorough investigation. The emergence of nanotechnology 
combined with the latest SC technology and the ever-increasing appreciation of cell-
signalling pathways in both adult and foetal wound healing models have opened up new 
avenues for precise biotechnological wound bed manipulations for accelerated healing. 
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Cutting-edge developments within the area of tissue-engineered scaffolds lead the way 
into a new era of organ consciousness with the ultimate goal of tissue regeneration rather 
than replacement. 
Approved treatment strategies for skin wounds mostly aim to replace lost tissues 
rather than support intrinsic self-healing mechanisms. Technological advances now 
grant scientists the ability to manipulate precisely scaffold materials and engineering 
strategies within nanometre dimensions to create nanotopographies that mimic the 
natural ECM. The incorporation of SCs, GFs, and nanoparticles into scaffolds promotes 
the intricate interplay between naturally occurring cell-signalling factors to achieve full 
tissue regeneration. With such fast and current developments in nanotechnology and 
biomedical sciences, we are continuously improving skin regeneration and repair. The 
future trend of regenerative medicine in general, and tissue-engineering of skin in 
particular lies in: (i) the comprehension of intricate intercellular biochemical 
communications; (ii) the engineering of scaffold structures on a micro- and 
nanodimension; and (iii) the integration of GFs and SCs into such scaffolds to obtain a 
bioactive cocktail capable of active guidance in skin regeneration. Despite the presence 
of realistic benefits and dangers associated with GF or SC supplementation, ongoing re-
search into their exploitation is fundamental if regenerative medicine is to have a future. 
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4 SYNTHESIS AND CHARACTERIZATION OF 
BIODEGRADABLE POSS NANOCOMPOSITE 
POLY(Ε-CAPROLACTONE UREA)URETHANE 
(POSS-PCLU) 
4.1 SYNOPSIS 
The field of tissue engineering and regenerative medicine aims to create 
biocompatible scaffolds capable of supporting cell attachment and proliferation whilst 
providing a 3D structural framework for the wound bed. Natural polymers such as 
collagen, whilst excellent in terms of cytocompatibility, are known to exhibit relatively 
weak mechanical properties and rapid degradation profiles. Synthetic polymers, on the 
other hand, provide excellent control over rates of degradation and display superior 
mechanical strength. It has been hypothesized that hard segment contents influence the 
degradability of PUs. Here, a novel biodegradable PU based on a poly(ε-caprolactone 
urea)urethane (PCLU) backbone integrated with polyhedral oligomeric silsesquioxane 
(POSS) nanoparticles was synthesized. Percentage variations of hard segment content 
resulted in 3 different formulations. The relationship between increasing hard segment 
content and material properties was systematically assessed. 1H nuclear magnetic 
resonance (1H NMR) and attenuated total reflectance-Fourier transform infrared 
spectroscopy (ATR-FTIR) confirmed the molecular structure of POSS-PCLU. Increasing 
hard segment contents were reflected in increasing peaks at 1551 cm-1 and 1633 cm-1 
which corresponded to the hard segment urethane and urea groups, respectively. Both 
differential scanning calorimetry (DSC) and X-ray crystallography (XRD) results 
demonstrated the mostly amorphous nature of POSS-PCLU which predictably was not 
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affected by the hard segment contents. Mechanical strength, however, increased with 
increasing hard segment without affecting the general viscoelasticity of the PU. Surface 
analysis with scanning electron (SEM) and atomic force microscopy (AFM) revealed a 
highly micro- and nano-structured topography which was mainly attributed to the 
inclusion of POSS nanoparticles. Despite less favourable cell interactions on POSS-PCLU 
scaffolds as opposed to PCLU scaffolds, POSS is believed to have significant anti-
inflammatory properties important for in vivo applications.  
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4.2 INTRODUCTION 
At all times, tangible materials have been the subject of profound curiosity for 
humankind. Pre-Socratic thinkers including Thales (ca. 624-546 BC), Anaximenes (died 
ca. 525 BC) and Heraclitus (ca. 535-475 BC) speculated about the fundamental elemental 
origins of the visible world and were amongst the first to contemplate water, air and fire, 
respectively, as the basic building blocks constituting every aspect of life and nature while 
Empedocles (ca. 495-435 BC) first highlighted the importance of interaction of the, now 
4 elements, including earth. The particular importance of materials is further emphasized 
within the realms of archaeological classifications of ancient, pre-historic eras; the Stone 
Age, Bronze Age and Iron Age were each named after the prevailing hard material for the 
manufacture of basic implements and tools of each specific era (Rogers and Semaw, 
2009). More recently, man-made entities including polymers have gained substantial 
scientific recognition, being one of the most versatile and heavily exploited materials in 
daily use. Whilst reinforcement of such materials at the microscale (microcomposites) 
has already been shown to improve mechanical properties, integrating the polymer with 
nano-dimensional particles (nanocomposites) is postulated to have characteristics 
unanticipated by conventional laws of physics due to the quantum confinement effect 
(Kannan et al., 2005b) which maintains that the band gap width, which determines the 
energy needed to promote an electron from the valence to the conduction band and thus 
is proportional to the potential energy which can be emitted on the electron’s return to 
the valence band, is inversely proportional to the particle’s size. This quantum 
phenomenon underlies the principle that when a certain size (usually < 10 nm) is reached, 
energy levels exist not in continuous states but in discrete quanta, thus supporting the 
theorem of size-dependency. This concept of dimensional dependence further includes 
the physical arrangement of the material, i.e. its shape (Scholes and Rumbles, 2006).  
146 
 
In our laboratories, we have developed a novel biodegradable nanocomposite 
polymer based on a poly(ε-caprolactone urea)urethane (PCLU) backbone integrated with 
the silica nanoparticle polyhedral oligomeric silsesquioxane (POSS). POSS being the 
smallest of the silica nanoparticles with a mean diameter of 1.5 nm is believed to confer 
significant size-dependent advantages to any polymer system it may be introduced to. 
This has already been demonstrated with the non-biodegradable version of our 
nanocomposite polymer POSS-incorporated poly(carbonate urea)urethane (PCU) which 
has been transplanted into human patients during several compassionate cases in the 
forms of vascular bypass grafts, lacrimal drainage tubes and tracheal replacement 
scaffolds (Chaloupka et al., 2011, Jungebluth et al., 2011a). However, prior to being 
introduced to a clinical setting, biomaterials – particularly biodegradable ones – must 
undergo stringent quality control assessments ranging from surface property evaluations 
over determining their chemical composition to higher order structures such as glass 
transition temperatures, degree of crystallinity and mechanical properties. Following 
material characterization, in vitro and in vivo compatibility tests provide basic 
information regarding clinical suitability (Fig. 4.1).  
In the following sections, the techniques used in this thesis to evaluate the novel 
polymer POSS-PCLU will be explained briefly following which the methods will be 
introduced. In subsequent chapters, recurring methods will be referred back to chapter 
4 unless otherwise stated. 
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Figure 4.1. Diagrammatic illustration of the evaluation pathway for novel tissue engineering 
biomaterials. 
 
Scanning electron microscopy (SEM). This type of microscope utilises a focused 
beam of electrons which scans the sample surface to produce highly magnified images of 
the sample. The obtained signals result from interactions of the electron beam with atoms 
at or near the sample surface. This enables mapping of the surface topography with 
resolutions as high as or even better than one nanometre. For non-conducting samples 
such as POSS-PCLU, an ultra-thin layer of gold is sputter-coated onto the mounted 
specimen as otherwise scanning faults, unsatisfactory signals and other artefacts may 
disrupt the image. 
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Atomic force microscopy (AFM). AFM has even better resolution than SEM in the 
order of fractions of a nanometre. This is particularly useful in assessing the degree of 
POSS-extrusion onto the polymers surface, e.g. following different types of sterilization 
treatments (chapter 5). Essentially, a cantilevered tip with a feedback mechanism is used 
to scan the sample surface. Being in extreme proximity to the sample surface results in 
interaction between the tip and the surface which in turn deflects the cantilever. The AFM 
measures this deflection and a 2-dimensional spatial map of the surface nanotopography 
is created. 
Contact angle measurement (θ). The degree of biomaterial surface wettability is an 
important feature in the initial design and conception of a polymer system considering 
cell adhesion and proliferation are significantly influenced by it. Strongly hydrophobic (≥ 
90°) surfaces result in strong protein adsorption onto such surfaces which leads to a loss 
in biological activity (de Mel et al., 2013, Tan et al., 2013, Tashnizi et al., 2013, Madani et 
al., 2013), associated inhibition of integrin binding (Shoae-Hassani et al., 2013a) and less 
cell-surface interaction. Several studies have demonstrated a contact angle between 70° 
and 80° to be optimal for fibroblast growth and proliferation (Shoae-Hassani et al., 2013b, 
Guasti et al., 2013). 
1H Nuclear Magnetic Resonance Spectroscopy (1H NMR). NMR is used to determine 
the molecular structure of organic compounds. Just as electrons have a +1/2 and -1/2 
spin, certain atomic nuclei also have charged spins that create a magnetic field. Upon 
application of an external magnetic field, the nuclei orient themselves parallel (α) or 
antiparallel (β) to the applied field. With the α-spin having a lower energy state than the 
β-spin, the energy difference (ΔE) between those two spins depends on the applied 
magnetic field.  
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Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR). 
FTIR spectra provide information about what molecules are present in the sample, 
whether or not two samples are the same and what concentrations of molecules are 
contained within the sample. The latter may be determined via the absorbance measured 
using FTIR. Using Beer’s Law, 
𝐴 =  𝜀𝑙𝑐 
where A = absorbance, ε = absorptivity, l = path length, and c = concentration, the height 
or area of a peak in the absorbance spectrum correlates to the concentrations and can 
thus be used to determine molecular concentrations. The use of ATR over transmission-
IR spectroscopy alone is advantageous due to the limited path length into the sample 
required in ATR mode which avoids strong attenuation of the IR signal when travelling 
through a highly absorbing specimen. 
 Gel permeation chromatography (GPC). GPC is a molecular separation technique 
which uses columns packed with small, round and porous particles to separate molecules 
based on their size. The more association the molecule has with the stationary phase, the 
longer it takes to leave the column. Smaller molecules able to occupy most of the particles’ 
pores are thus associated with them for longer whilst the largest molecules do not fit into 
any pores and thus elute first. Medium-sized molecules, on the other hand, fit into some 
pores but not all and thus occupy only some whilst a fraction of medium-weight 
molecules elute out. GPC is further used to determine molecular weight distributions of 
polymers. On a typical weight-distribution curve, the number average molecular weight 
(Mn) marks the value at which there are equal numbers of higher and lower molecular 
weight molecules on each side. The importance of molecular weight values lies in the fact 
that they influence polymer properties including brittleness, toughness and elasticity. 
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 Differential scanning calorimetry (DSC). DSC is used to detect changes in polymer 
phase transition temperatures including glass transition (Tg) and melting temperature 
Tm. During polymer degradation, the detected Tg increases while Tm is lowered, providing 
an indication for the relative degree of degradation when comparing different polymers. 
Additionally, degradation of semicrystalline polymers such as POSS-PCLU results in 
phase separation of the amorphous and crystalline regions which, again, lead to changes 
in transition temperatures. 
 X-ray diffraction crystallography (XRD). XRD crystallography exploits the ability of 
crystalline substances to interact with X-rays resulting in a unique and reproducible 
diffraction pattern. It is a qualitative as well as quantitative method of identifying and 
characterising crystalline or semicrystalline polymers. It is a particularly useful tool for 
analysing degraded polymers as phase separation and crystallization induce changes in 
the XRD pattern. 
 Tensiometry. Assessment of mechanical properties remains a mainstay of polymer 
characterization. Evaluation of material toughness and elasticity being of particular 
importance for implantable devices such as tissue engineering scaffolds due to different 
properties being required for different applications. 
4.3 MATERIALS AND METHODS 
4.3.1 Polymer Synthesis 
 The polymer was prepared according to a previously published method (Kannan et 
al., 2006a). In brief, dry polycaprolactone diol (Mw 2000) and trans-
cyclohexanechloroydrinisobutyl-POSS were placed in a reaction flask equipped with a 
mechanical stirrer and nitrogen inlet. The mixture was heated to 135 °C to dissolve the 
151 
 
POSS nanocage and then cooled to 60 °C. To this, dicyclohexylmethane diisocyanate 
(Desmodur W, Bayer) was added and reacted under nitrogen at 70 °C for 90 minutes (min) 
to form a pre-polymer. Then, N,N-dimethylacetamide (DMAc) was added and the mixture 
cooled to 40 °C. A mixture of ethylenediamine and diethylamine in DMAC was added to 
allow chain extension of the pre-polymer. 1-Butanol in DMAc was added to the mixture 
to form an 18 % polyhedral oligomeric silsesquioxane-poly(ɛ-caprolactone 
urea)urethane (POSS-PCLU) solution. Polymers of three different percentage hard 
segments were synthesized by varying the amount of dicyclohexylmethane diisocyanate 
to obtain PUs of 24 %, 28 %, and 33 % hard segment. A control lacking POSS nanoparticles 
was synthesized to analyse the influence of silica nanoparticles on (i) in vitro 
cytocompatibility, (ii) in vivo biocompatibility, and (ii) any potential inhibitory effect of 
POSS nanoparticles on degradation. The polymer nomenclature was based on their main 
constituents and the weight percentage hard segment, as POSS-PCLU-24, POSS-PCLU-28, 
POSS-PCLU-33, and PCLU-24. All chemicals and reagents were purchased from Sigma 
Aldrich Ltd. (Gillingham, UK). Figures 4.2 and 4.3 schematically summarise the reaction 
steps and the composition is defined in Table 4.1. 
 
 
 
Figure 4.2. Synthesis of the aliphatic poly(ε-caprolactone urea)urethane prepolymer in a 2:1 ratio 
of 4,4'-methylenebis (cyclohexylisocyanate) to poly(ε -caprolactone)diol. 
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Figure 4.3. Chain extension reaction of the poly(ε-caprolactone urea)urethane prepolymer with 
ethylenediamine and integration of POSS nanoparticles as endcapped pendant chains. The final 
segmented PU consists of urea hard segments linked to PCL soft segment by urethane bonds. 
 
Table 4.1. Composition of the 4 different PUs. 
Key: POSS, polyhedral oligomeric silsesquioxane; PCLU, poly(ε-caprolactone urea)urethane; HMDI, 
dicyclohexylmethane diisocyanate  
 
4.3.2 Scaffold Fabrication 
Samples were fabricated by either casting or coagulation/phase inversion method 
to obtain non-porous films or porous sponges, respectively. Cast sheets were prepared 
by pouring diluted 15 wt. % POSS-PCLU polymer solution (~ 8 g) into a clean Petri dish 
(ᴓ 10 cm) and allowing solvent evaporation overnight at constant temperature (65 °C). 
Material POSS content 
(%) 
Diisocyanate 
(%) 
Polyol Chain extender 
PCLU-24 0 HMDI (24 %) 1-Butanol  Ethylenediamine/diethylamine 
POSS-PCLU-24 2 HMDI (24 %) 1-Butanol Ethylenediamine/diethylamine 
POSS-PCLU-28 2 HMDI (28 %) 1-Butanol Ethylenediamine/diethylamine 
POSS-PCLU-33 2 HMDI (33 %) 1-Butanol Ethylenediamine/diethylamine 
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Coagulated scaffolds were prepared by a sacrificial porogen leaching technique combined 
with a phase inversion coagulation method. The polymer solution was supplemented 
with 48 % (w/v) sodium bicarbonate (NaHCO3) particles (Brunner Mond, Cheshire, UK) 
and surfactant (Tween 20) to obtain a viscous slurry. This was poured over a surface 
modified stainless steel plate. Top surface modification was applied to avoid skin 
formation and increase percentage porosity. The polymer mixture was then extruded 
according to a protocol developed in-house. Overnight extrusion in sterile de-ionized 
water resulted in solvent exchange and NaHCO3 leaching and the fabrication of porous 
scaffolds. Washing over a period of 48 h using regular changes of sterile de-ionized water 
completely removed all remaining salt particles and DMAc, as confirmed by inductively 
coupled plasma optical emission spectrometry (Warwick Analytical Services, Coventry, 
UK). 
4.3.3 Scaffold Surface Modification 
Three distinct methods were evaluated to prevent an impermeable skin layer 
forming on the side facing the stainless steel plate. The aim was to obtain a uniformly 
porous and interconnected scaffold surface. 
4.3.3.1 Different Porogen Sizes 
NaHCO3 particles of two different diameters (65 µm vs. 140 µm) were selected and 
scaffolds were fabricated as per section 4.3.2. 
4.3.3.2 Pre-Modification of Stainless Steel Plates 
Stainless steel plates used for scaffold fabrication were pre-treated with a solution 
containing an excess of porogen particles. Evaporation of the liquid phase at 60 °C 
resulted in a rugged plate surface onto which the polymer mixture was poured. 
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4.3.4 Scaffold Characterization 
4.3.4.1 Surface Structure Analysis 
4.3.4.1.1 Scanning Electron Microscopy 
Microscopic scaffold features were evaluated using SEM digital photography at 
magnifications ranging from x 40 to x 1000. Cast or coagulated scaffolds were dried and 
post-fixed with 1% osmium tetroxide/1.5 % potassium ferricyanide for 1 h, unless 
otherwise stated. Scaffolds were then washed with de-ionised water and dehydrated 
using graded acetone series, unless otherwise stated. They were then mounted on 
aluminium stubs and sputter-coated with gold using an SC500 (EMScope) for electrical 
conductance. Photographs were taken using a Philips 501 scanning electron microscope. 
ImageJ (freeware) was used to analyse the specified parameters.  
4.3.4.1.2 Atomic Force Microscopy (AFM) 
Surface nanotopographies of cast polymer samples were measured using a non-
contact mode atomic force microscope (AFM, Bruker Dimensions 3100). Evaluation of 
the average surface roughness (Ra), root mean square roughness (Rq), and correlation 
length (ξ) were carried out on a surface area of 20 x 20 µm using Nanoscope Analysis 
software (Bruker Corporation, MA, USA). Commercially available AFM tips (radius of 
curvature 7 nm, PPP-NCH, Windsor Scientific) were used with intermediate contact mode. 
4.3.4.1.3 Hydrophobicity was assessed using Static Contact Angle Measurement (θ) 
Contact angle (θ) measurements were obtained using a goniometer (EasyDrop 
DSA20E, Kruss, Germany) equipped with a digital camera and image analysis software 
(DSA1 version 1.80, Kruss, Germany). De-ionized water (5 µL) was used as the wetting 
liquid which was deposited onto the samples using an automated syringe. Sessile drop 
method was used to analyse contact angles of the air-water-substrate interface of control 
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and sterilized cast samples which were measured three times in three samples of every 
group. 
4.3.4.2 First Order Structural Analysis 
4.3.4.2.1 1H Nuclear Magnetic Resonance (NMR) Spectroscopy 
The chemical structure and composition of all 4 PUs were determined by 1H NMR 
spectroscopy using a Bruker AV 400 NMR spectrometer. The NMR spectrum was 
obtained at room temperature in deuterated dimethyformamide (DMFd) (50 mg/mL) 
with tetramethylsilane (TMS) as an internal standard. 
4.3.4.2.2 Attenuated Total Reflectance (ATR) Fourier Transform Infrared (FTIR) Spectroscopy 
 Fourier Transform Infrared Spectra (FTIR) were obtained on a Jasco FT/IR 4200 
Spectrometer  equipped with a diamond attenuated total reflectance accessory (Diamond 
MIRacle ATR, Pike Technologies, US). A total number of 3 pieces per sterilization 
technique or control and 3 points on each scaffold were analysed. Spectra were produced 
from an average of 20 scans at 4 cm-1 resolution over a range of 600 cm-1 to 4000 cm-1 
wave numbers.  A background scan was performed prior to each sample measurement. 
4.3.4.2.3 Gel Permeation Chromatography (GPC) 
Average molecular weight of all 4 PUs was determined by gel permeation 
chromatography (GPC). The solvent phase was dimethylacetamide (DMAc) with 2 % LiBr 
serving as a stabiliser. The sample concentration was 2 mg/mL and the injection volume 
was 150 µL. The flow rate was set at 1 mL/min. The number and weight average 
molecular weights (Mn and Mw, respectively) were determined from the retention time 
using a calibration curve generated with polystyrene standards. The polydispersity index 
(PI) was obtained by Mw/Mn. 
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4.3.4.3 Higher Order Structural Analysis 
4.3.4.3.1 Differential Scanning Calorimetry (DSC) 
A Q2000 DSC (TA instruments LLC) was used to study glass transition (Tg), 
crystallization and melting behaviour of PUs. An indium standard (Tm = 156.6 °C and ΔH 
= 28.5 J/g) was used to calibrate the instrument and ensure accuracy and reliability of 
the obtained data. Approximately 4-8 mg of polymer sample were loaded into aluminium 
Tzero pans and hermetically sealed. An empty aluminium pan, matched in weight to the 
sample pan, was used as a reference. Experiments were performed at heating rates of 
10 °C/min from -80 °C to 200 °C for conventional DSC. Melting temperatures (Tm) and 
heat of fusion (ΔH) were determined from DSC scans. Endothermic peak temperatures 
were taken as Tm, and percentage crystallinity was calculated using the following 
equation: 
% 𝑐𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑖𝑡𝑦 = (
𝛥𝐻𝑚
𝛥𝐻𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡
)  𝑥 100% 
 
where ΔHm is the enthalpy of fusion of the sample and ΔHconstant is the enthalpy of fusion 
of a 100 % crystalline PCL reference (136 J/g) (Crescenzi, V.; Manzini, G.; Calzolari, G.; 
Borri 1972; Heijkants et al. 2005). 
4.3.4.3.2 X-ray Diffraction (XRD) Crystallography 
X-ray diffraction (XRD) data were recorded with a PW3830 (Philips, Netherlands) 
using a Cu Kα X-ray source operated at 40 mA, 40 kV with an angular increment of 0.05°/s . 
Measurements were taken from 0 to 40° on the 2θ scale. 
4.3.4.3.3 Tensiometry 
Tensile stress-strain properties were assessed according to British Standards (BS 
ISO 37:2005). Cast or coagulated POSS-PCLU samples were cut into dumbbell-shaped 
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pieces type 3 (shaft length 20 mm, width 4 mm, n=5) using a cutting press (Wallace 
Instruments, Surrey, UK). Thickness was measured using a digital electronic outside 
micrometer. Uniaxial tension was applied to either ends of the scaffolds until failure using 
an Instron-5565 tensile tester (Instron Ltd., Bucks, UK) equipped with a 500 N load, 
pneumatic grips with 1 kN capacity and at a rate of 100 mm/min. Bluehill software was 
used to analyse the scaffold’s tensile strengths at room temperature. Stress (MPa) was 
calculated by dividing the force generated during stretching by the initial cross-sectional 
area. Strain was calculated as the ratio of the change in length in reference to the original 
sample length (%). 
4.3.5 Scaffold Cytocompatibility 
4.3.5.1 Cell Culture 
Adult primary fibroblasts were isolated from human dermis (HDFa) and cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 1 mM L-glutamine, 10 % 
fetal bovine serum (FBS), 1 % penicillin/streptomycin and 1 % Fungizone (Invitrogen, 
Paisley, UK). HDFa were cultured to 80-90 % confluency, trypsinized and either re-plated 
or stored in 10 % DMSO/90 % FBS in liquid nitrogen until required.  
A scratch test was conducted in order to qualitatively assess cellular proliferation. 
HDFa were seeded into 24-well plates in excess to obtain rapid confluency. The sterile 
sharp end of a plastic pipette tip was used to create a longitudinal scratch along the cell 
layer. Tips were changed each time a scratch was made to prevent cells from the previous 
well being laid down in the fresh scratch. At 0 hour (h), 24 h and 72 h, dead cells were 
stained with methylene blue and cell migration into the scratch path was observed using 
an inverted light microscope. Experiments were performed in triplicates. 
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The optimal cell seeding density was assessed over a period of 14 days. HDFa were 
seeded into 24-well plates at densities of 2.5 x 104, 3.75 x 104 and 5 x 104 cells/cm2. 
Medium only wells served as controls. At 1, 3, 7 and 14 days, cell proliferative capacity 
was assessed using AlamarBlue® viability assay. 
Next, viability and proliferation were assessed on cells cultured on cast PCLU films, 
cast POSS-PCLU films and coagulated POSS-PCLU scaffolds. HDFa cells were seeded onto 
DMEM pre-soaked POSS-PCLU scaffolds at a density of 5 x 104 cells/150 µL/scaffold and 
incubated at 37 °C, 5 % CO2 for 2 h. Then, 1 mL culture medium was added and cells were 
incubated for seven days.  Previous tests determined 2 h sufficient for cell attachment 
(results not shown). A staggered seeding technique was utilized to ensure cell adhesion 
onto scaffolds rather than tissue culture plastic (TCP) (Noah et al., 2002). TCPs containing 
no scaffolds were seeded with an equal amount of cells (positive control) or medium only 
(negative control). Medium-soaked POSS-PCLU scaffolds not seeded with cells served as 
background noise which was subtracted from final results of cell-seeded scaffolds. Cells 
were incubated at 5 % CO2 in air at 37 °C and culture medium was changed every 2-3 
days for a total of 7 days.  
In order to demonstrate the material’s suitability as a tissue engineering platform, 
3D porous scaffolds were seeded with HDFa at a density of 5 x 104 cells/150 µl/scaffold 
and incubated at 37 °C, 5 % CO2.  
On days 1, 3, and 7, cell morphology was visualised using the F-actin stain 
fluorescein isothiocyanate (FITC)-phalloidin and nuclei counterstained with Propidium 
Iodide (PI) (both Sigma-Aldrich, Dorset, UK). Cell viability and proliferative capacity were 
assessed using Live/Dead® stain and AlamarBlue® assay, respectively.  
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4.3.5.2 Assessment of In Vitro Cytocompatibility and Cellular Proliferation using 
AlamarBlue® Cell Proliferation Assay 
Cell metabolism was assessed using AlamarBlue®assay (Invitrogen, Paisley, UK). 
HDFa were grown on cast or coagulated POSS-PCLU scaffolds and incubated for 1, 3 and 
7 days. At each time point, media and non-adherent cells were removed with sterile 
phosphate buffered saline (PBS, 0.1 M, pH 7.4). AlamarBlue® solution in normal culture 
medium (ratio of 1:10) was added to each scaffold and incubated in 5 % CO2 and 37 °C 
for 4 h. Fluorescent readings were recorded by Fluoroskan Ascent Fluorescence 
Microplate Reader (Thermo ScientificTM, Hudson, US) with excitation at 530 nm and 
emission at 590 nm. Fluorescence readings for culture medium only were used for 
baseline corrections. Cell viability in terms of % of control cells grown on TCP is derived 
from the following equation (Mullick Chowdhury et al., 2013): 
% 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
𝐹𝑡𝑒𝑠𝑡 − 𝐹𝑏𝑙𝑎𝑛𝑘
𝐹𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − 𝐹𝑏𝑙𝑎𝑛𝑘
 𝑥 100 
where Ftest is the fluorescence of cells grown on test surfaces, Fblank is the fluorescence of 
medium only (no cells), and Fcontrol is the fluorescence of cells grown on TCP. 
4.3.5.3 Live/Dead® Cell Survival Assay 
Cell viability on cast scaffolds was assessed at days 1, 3, and 7 using the Live/Dead® 
fluorescence assay (Invitrogen, Paisley, UK) according to the manufacturer’s instructions 
and the number of attached live and uniformly green stained and non-viable/dead, 
pyknotic red cells was assessed immediately upon staining using an Eclipse C1 Plus 
Confocal microscope (Nikon, Surrey, UK) with a x 10 objective lens.  
4.3.5.4 Cytoskeletal Staining  
Cell attachment to cast scaffolds and their morphology were studied using FITC-
labeled phalloidin according to the manufacturer’s instructions. Cells grown on cast films 
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for 1, 3, and 7 days were fixed using 4% paraformaldehyde (PFA) in PBS, permeabilized 
with 0.1 % Triton-X 100 in PBS for 20 min and then blocked with 1 % bovine serum 
albumin (BSA) in PBS for 45 min. Cells were exposed to a 1:40 ratio FITC-phalloidin 
mixture in PBS supplemented with 0.1 % (w/v) BSA for 45 min for visualization of F-actin. 
Nuclei were counterstained using propidium iodide (PI) stain. Images were taken using 
an Eclipse C1 Plus Confocal microscope (Nikon, Surrey, UK) with a x 20 and x 40 objective 
lens. 
4.3.6 Statistical Analysis 
All data are presented as mean ± standard deviation (SD). Experiments were 
repeated 6 times unless stated otherwise. Data comparisons were carried out by one-way 
ANOVA analysis of variance. Significant differences between experimental groups were 
determined using Bonferroni’s test of multiple comparisons or Dunn’s multiple 
comparison post-test in the case of surface roughness analysis. A p-value of < 0.05 was 
considered statistically significant.  
4.4 RESULTS AND DISCUSSION 
4.4.1 Synthesis and Molecular Characterization of POSS-PCLU Scaffolds  
The chemical structures of POSS-PCLU PUs were verified by 1H NMR and FTIR 
spectroscopy (Fig. 4.4 and 4.5). The chemical shift at 8.2 ppm was referred to the solvent 
peak of deuterated DMF. The signals at 4.1 ppm were attributed to the urethane linkage 
generated from the reaction between hydroxyl groups and isocyanate groups in HMDI (–
OH + –NCO → –NHCOO–) (Li et al., 2012). The peaks at 3.9 ppm correspond to CO–O–CH2 
in PCL diol (Nair and Ramesh, 2013), and the singlet at 3.64 ppm (OCH2CH2O) is assigned 
to the diethyl ether bond linking the esters in PCL diol (Loh et al., 2008). The multiplet 
observed at 2.9 ppm (-NH-CH2-) relate to the secondary amines within the urea hard 
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segment (Sarkar et al., 2009). The multiplet at 1.6 ppm (OCH2CH2CH2CH2CH2CO) 
represents the PCL soft segment which corresponded to the hard segment content of the 
PUs. The integral value at 1.6 ppm of POSS-PCLU-24 with higher soft segment content 
was correspondingly higher compared to that of POSS-PCLU-33 (Fig. 4.4 inset box). 
 
 
Figure 4.4. 1H nuclear magnetic resonance (NMR) spectrum of a representative POSS-PCLU PU. 
Inset is a magnification of the chemical shift at 1.6 ppm of POSS-PCLU-24 (top) and POSS-PCLU-33 
(bottom). 
 
Material surface chemistries of PCLU-24 and POSS-PCLU-24, POSS-PCLU-28 and 
POSS-PCLU-33 were analysed using attenuated total reflectance (ATR)-Fourier 
transform infrared (FTIR) spectroscopy and the spectra were overlaid for comparison 
(Fig. 4.5).  
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Figure 4.5. Overlaid attenuated total reflectance (ATR)-Fourier transform infrared (FTIR) 
spectrograph of cast PCLU-24, POSS-PCLU-24, POSS-PCLU-28 and POSS-PCLU-33 samples. Both 
urethane and urea groups at 1551 cm-1 and 1633 cm-1, respectively, predictably increase with 
increasing hard segment content. The peak at 1094 cm-1 represents the siloxane (Si-O-Si) bonds 
and is not present for PCLU-24 which lacks POSS nanoparticles. 
 
All polymers exhibit common peaks at 2929 cm-1 and 2861 cm-1 which correspond 
to the alkyl groups of the hard segment, HDI. The peaks at 1726 cm-1 and 1159 cm-1 
represent the carbonyl (C=O) region of non-hydrogen-bonded urethane and the ester (O-
C-O) absorbance of the soft segment, respectively. The heights of the latter two peaks are 
negatively correlated with increasing hard segment content. In the case of the C=O bond 
of the non-hydrogen-bonded urethane bonds, the lower height with higher percentage 
hard segment is due to the fact that in high hard segment polymers, most urethane bonds 
are hydrogen-bonded, leaving a smaller fraction of urethane bonds non-bonded. 
With increasing hard segment content, the spectral peaks corresponding to 
hydrogen-bonded urethane (1633 cm-1) and urea (1551 cm-1) bonds increase in height 
providing a qualitative measure of bond content. Both PCLU-24 and POSS-PCLU-24 
containing the lowest amount of hard segment demonstrate relatively smaller peaks 
compared to the polymers of higher hard segment content. Similarly, polymers 
1633 cm-1 
1551 cm-1 
1094 cm-1 
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containing POSS nanoparticles exhibit a high peak at around 1094 cm-1 whilst PCLU-24 
does not.  
The molecular weight and distribution were analysed using GPC. Figure 4.6 
illustrates a representative molecular weight distribution curve for the polymers.  
 
Figure 4.6. Representative molecular weight distribution curve of PCLU and POSS-PCLU polymer 
samples. 
 
The symmetrical bell shape and narrow distribution demonstrate successful and 
complete polymerization. The molecular weights of the obtained PUs range from 11.5 x 
104 to 11.9 x 104 g/mol with molecular weight distributions between 1.4 and 1.7. (Table 
4.2). 
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Table 4.2. Composition, number average molecular weight (Mn) and polydispersity indices 
(PDI) of PCLU and POSS-PCLU PUs. 
Materials Mn (x 104) a Mw/Mn a 
PCLU-24 11.5 1.7 
POSS-PCLU-24 11.9 1.4 
POSS-PCLU-28 - - 
POSS-PCLU-33 - - 
Key: POSS, polyhedral oligomeric silsesquioxane; PCLU, poly(ε-caprolactone urea)urethane 
a Mn and Mw/Mn were determined by GPC. - = Values could not be obtained as samples did not dissolve in DMAc. 
 
 
4.4.2 Thermal Properties of POSS-PCLU Polyurethanes 
The thermal properties of PCLU-24 and POSS-PCLU of varying hard segment 
content are summarised in Table 4.3.  
 
Table 4.3. Thermal properties of POSS-PCLU PUs. 
Material Tg (°C) a χ (%) a 
Soft segment Hard segment 
PCLU-24 - 54.8 51.1 - 
POSS-PCLU-24 - 52.9 40.8 - 
POSS-PCLU-28 - 55.4 52.6 - 
POSS-PCLU-33 - 55.5 53.3 - 
Key: POSS, polyhedral oligomeric silsesquioxane; PCLU, poly(ε-caprolactone urea)urethane 
a Tg and χ were determined by DSC 
 
The DSC heating curves of the 4 different PUs all reveal a soft segment glass 
transition temperature (Tg) between – 52.9 °C to – 55.5 °C and a hard segment Tg between 
+ 40.8 °C and + 53.3 °C (Fig. 4.7).  
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Figure 4.7. DSC heating curve of PCLU-24, POSS-PCLU-24, POSS-PCLU-28 and POSS-PCLU-33. Two 
distinct glass transitions, Tgs (soft segment) and Tgh (hard segment), can be seen. 
 
In general, the soft segment Tg of both PCLU-24 and POSS-PCLU were independent 
of the hard segment content (24 %, 28 %, 33%) indicating limited hard segment mixing 
within the soft domain. The presence of Tg of both soft and hard segments alongside a 
lack of exothermic or endothermic peaks suggests a mostly amorphous polymer, hence 
no crystal formation was observed and percentage crystallinity was not calculated. This 
observation was supported by results obtained by XRD crystallography which is in 
accordance with previous reports (Bogdanov et al., 1999) (Fig. 4.8). 
 
 
Figure 4.8. XRD pattern of non-degraded PU samples of varying hard segment contents. 
 
Soft segment Tg 
Hard segment Tg 
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4.4.3 Microstructure and Surface Properties of POSS-PCLU Scaffolds  
Scaffold micro- and nanotopographies were analysed using scanning electron 
microscopy (SEM), atomic force microscopy (AFM) and contact angle measurements. The 
SEM image of a salt-leached POSS-PCLU scaffold edge demonstrates a highly porous and 
interconnected microstructure with pore dimensions of approximately 140 µm (Fig. 4.9 
(A)).  
 
Figure 4.9. (A) Environmental scanning electron microscopy image of a salt-leached POSS-PCLU 
scaffold edge. Homogenously distributed pores and high pore interconnectivity are important 
features for tissue engineering scaffolds to allow for diffusion of nutrients, waste and to promote 
the formation of a vascular network. (B) Top down view of a cast POSS-PCLU scaffold. Individual as 
well as small aggregates of POSS nanocages extrude onto the surface during solvent evaporation 
and can be seen as microscopic white dots. Magnification x 80 (A) and x 100 (B). Scales as shown. 
 
Pores were found to be homogenously distributed throughout the scaffold with 
slight variations in pore sizes likely due to a degree of porogen clumping during the 
fabrication process. Some significantly smaller pores are likely attributable to entrapped 
air bubbles which can serve as pore nucleation sites during polymer mixing (Chung et al., 
2012). Non-porous cast POSS-PCLU scaffolds demonstrate a smooth surface with 
microscopic aggregates identified as white spots on the SEM image (Fig. 4.9 (B)). These 
micro-aggregates are hypothesized to represent individual or grouped POSS 
nanoparticles which are extruded onto the surface during solvent evaporation (Misra et 
(A) (B) 
536.8 µm 
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al., 2007, Fina et al., 2005). This theory is supported by the fact that PCLU-24 do not 
exhibit any white microaggregates. 
Contact angle measurements of cast POSS-PCLU scaffolds reveal an inherent 
hydrophobic character with all POSS-containing PUs demonstrating a contact angle of > 
90° (Fig. 4.10).  
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Figure 4.10. (A) Contact angle measurement of a cast POSS-PCLU disc demonstrates relative 
surface hydrophobicity (θ > 90°). (B) Comparison of contact angle between cast discs of the 4 
different polymer compositions. There is no statistically significant difference in θ between 
polymers of different hard segments but a significantly reduced contact angle can be observed in 
PCLU-24 which lacks POSS nanoparticles. * = p < 0.05. Values are given as mean ± one SD. 
 
No significant differences were found between polymers of different hard segment 
concentration (p > 0.05) but lack of POSS nanoparticles resulted in a more hydrophilic 
nature with a contact angle of 86.4° as demonstrated by cast PCLU-24 discs. This is 
significantly more hydrophilic than any POSS-containing PU (p < 0.05). Several previous 
study have demonstrated the change to a more hydrophobic character upon addition of 
POSS nanoparticles (Fina et al., 2005, Misra et al., 2007). 
* * * 
(A) (B)              
 
θ 
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 These results were further corroborated by surface roughness measurements using 
atomic force microscopy (AFM) (Fig. 4.11). The scaffold surface on a nano-level as well as 
the roughness profiles exhibited a random pattern of peak heights with relatively high 
mean surface roughness (Ra) and root mean square roughness (Rq) (54.1 nm and 89.1 nm, 
respectively) which corresponded to the contact angles of POSS-PCLU scaffolds. Such 
nanoscale roughness is hypothesized to stem from the extrusion of POSS-nanocages 
(average diameter including functional groups = 3.5 nm) onto the surface during the 
initial scaffold fabrication step. 
 
Figure 4.11. Atomic force microscopy (AFM) image illustrating a textured nanotopography of cast 
POSS-PCLU scaffolds. Multiple peaks provide points of attachment for cellular focal adhesion 
points. 
 
 
4.4.4 Mechanical Properties of POSS-PCLU Scaffolds 
An overlay of the stress versus strain and Young’s modulus versus strain curves of 
PCLU-24, POSS-PCLU-24, POSS-PCLU-28 and POSS-PCLU-33 are presented in Figure 4.12.  
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Figure 4.12. Overlaid stress versus strain and Young’s modulus versus strain curves of PCLU and 
POSS-PCLU PUs at room temperature. 
 
The characteristic values derived from these curves are summarised in Table 4.4.  
 
Table 4.4. Mechanical properties of PCLU and POSS-PCLU PUs. 
Material Young’s Modulus (MPa) Strain at break (%) Tensile strength (MPa) 
PCLU-24 0.03 348.50 9.88 
POSS-PCLU-24 0.03 364.48 10.24 
POSS-PCLU-28 0.04 337.72 13.52 
POSS-PCLU-33 0.06 355.45 20.66 
Key: POSS, polyhedral oligomeric silsesquioxane; PCLU, poly(ε-caprolactone urea)urethane 
 
In general, all samples displayed extension behaviour typical of semicrystalline 
polymers (Foks et al., 1991, Young and Lovell, 1991). At small strains, all PUs exhibited a 
steep linear slope culminating in a yield point for necking at around 20 % (2.5 MPa) after 
which further stretching results in irreversible plastic-like deformation. This was 
followed by a period of relatively linear elongation up to a strain of 150 % where an 
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upswing can be observed in all curves which is attributable to strain-induced 
crystallization of the soft segment portion. In general, a dependence of the permanent 
deformation stress and strain on the hard segment content can be observed which is in 
agreement with results obtained by other groups (Heijkants et al., 2005). With increasing 
hard segment content, the yield stress and ultimate tensile stress increase whilst the 
strain at break decreases. No significant differences in tensile strength could be observed 
between PUs with the same hard segment content but with (POSS-PCLU-24) or without 
(PCLU-24) POSS nanoparticle inclusion. This stands in contrast to previous findings (Gu 
et al., 2011) but is likely explained by the significantly smaller percentage of POSS 
included into our polymers (2 % versus 20 %). The values for Young’s modulus, a 
measure for material stiffness, and yield stress are positively correlated with the hard 
segment content due to higher volume fractions and greater order in the hard segments 
(Lamba et al., 1998).      
4.4.5 In Vitro Cytocompatibility 
A light microscopy image of subconfluent HDFa cultured on TCP demonstrates the 
typical fibroblast morphology (Fig. 4.13). Elongated cell bodies give rise to two or more 
filamentous projections called filopodia which are slender cytoplasmic extensions 
anchoring the cells to the tissue culture plastic (or substrate) via focal adhesion points. 
They contain actin filaments cross-linked into actin-binding proteins which help in 
cellular locomotion (Mattila and Lappalainen, 2008, Hanein et al., 1997). Wound healing 
involves the stimulation of filopodia by environmental cues such as growth factors 
resulting in correct growth orientation (Bentley and Toroian-Raymond, 1986). The 
fibroblasts in demonstrate filopodial extension towards each other as well as towards the 
less confluent areas towards the bottom right of the image.  
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Figure 4.13. Light microscopy image of adult human dermal fibroblasts growing on tissue culture 
plastic. Magnification x 20. 
 
In order to assess cell proliferative and migratory capacity more dynamically and 
over an extended period, a scratch test was conducted. A scratch assay is a widely used 
technique for investigating wound healing since manually created ‘wounds’ can be seen 
to close and ‘heal’ by cellular migration and proliferation of cells. At 0 h, a cell-free central 
scratch can be observed with live cells along the scratch margins (Fig. 4.14 (A)).  
 
 
Figure 4.14. Scratch test qualitatively assessing cellular proliferation. Cells grown on tissue 
culture plastic, counterstained with Methylene Blue and imaged with light microscopy. 
Magnification x 4. 
At 24 h, cells can be seen to migrate towards the centre of the gap (Fig. 4.14 (B)) 
and at 72 h, cells have migrated enough to fill the entire gap (Fig. 4.14 (C)). Trypan blue 
stains dead cells blue as the dye penetrates broken cell membranes but not intact ones. 
(A) 0 h (B) 24 h (C) 72 h 
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In Figure 4.14 (C), very few cells are stained blue (arrow), indicating normal cell growth 
and migration. 
Next, the optimal cell seeding density was assessed in 24-well plates over a period 
of 14 days. Usually, mammalian cells exhibit a characteristic semi-logarithmic growth 
pattern in vitro with an initial lag phase after seeding followed by an exponential growth 
phase (the log phase). Consumption of growth medium during the log phase and/or 
occupation of all available substrate results in the cells entering the stationary phase (the 
plateau phase) where proliferation stagnates or ceases. Ideally, cells should be 
subcultured prior to the plateau phase in order to prevent slowing of cell proliferation 
and changes in gene expression. We seeded HDFa in increasing concentrations (2.5 x 104, 
3.75 x 104 and 5 x 104 cells/cm2) into the wells of a 24-well plate and cultured the cells 
over a period of 14 days. Normal medium containing no cells served as a control. Cell 
viability measurements taken at 1, 3, 7 and 14 days revealed a logarithmic increase in cell 
activity as expected (Fig. 4.15). Even at day 14, the plateau phase was not reached for any 
concentration, likely due to low starting densities. For subsequent cell studies, a seeding 
density of 2.5 x 104 cells/cm2 was chosen. 
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Figure 4.15. Evaluation of optimal cell seeding density on tissue culture plastic using three 
different cell seeding concentrations. Values are given as mean ± one SD. 
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Basic cytocompatibility studies on both cast and coagulated POSS-PCLU scaffolds 
demonstrated good cell adherence and proliferation as well as healthy morphologies as 
expected. Staining with FITC-phalloidin revealed the cytoplasmic actin cytoskeleton 
responsible for maintaining cell shape and locomotion (Fig. 4.16 (A) and (B)). Depending 
on the surface topography, cell morphology, degree of spreading and alignment may vary. 
The relationship between surface micro- and nanotopography and cell shape will be 
discussed in more detail in chapter 5. Live/Dead® staining on HDFa cultured on cast 
POSS-PCLU films revealed mostly healthy living cells (Fig. 4.16 (C)) and very few dead 
cells (Fig. 4.16 (D)).  
 
 
Figure 4.16. Top panel: Confocal laser scanning microscopy images of human dermal fibroblasts 
cultured on cast POSS-PCLU discs and stained for F-actin with fluorescein isothiocyanate (FITC)-
labelled phalloidin. Nuclei are counterstained with propidium iodide. Bottom panel: Human 
dermal fibroblasts stained with (C) calcein AM (green) are live, whereas cells stained with (D) 
ethidium homodimer-1 (red) are dead. 
 
In order to assess the material’s suitability as a tissue regeneration scaffold, 
coagulated sponges were fabricated and seeded with HDFa (Fig. 4.17). Numerous cell 
nuclei can be seen to adhere to porous POSS-PCLU scaffolds.  
(A) 
(B) 
(C) (D) 
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Figure 4.17. Confocal laser scanning microscopy image of human dermal fibroblasts seeded onto 
porous POSS-PCL scaffolds after seven days of culture. Nuclei are counterstained with propidium 
iodide. 
 
Viability compared to cast POSS-PCLU appears to be slightly higher at days 1 and 3 
(Fig. 4.18) which is likely due to the entrapment effect of cells within the porous scaffold 
structure. Viability was significantly higher on cast PCLU (p < 0.05), possibly due to a 
more hydrophilic nature secondary to lacking POSS nanoparticles. Surface 
hydrophobicity is a known cell-repellent feature (Srinivasa Reddy et al., 2013), 
suggesting a removal of POSS nanoparticles from the PCLU system may benefit cell 
attachment and growth. From a more holistic point of view, however, POSS inclusion 
imparts tremendous benefits including superior mechanical characteristics, 
functionalisability and non-immunogenicity, rendering the overall nanocomposite 
polymer more versatile (Ahmed et al., 2011b, Bakhshi et al., 2011, de Mel et al., 2009, 
Ghanbari et al., 2011a, Ghanbari et al., 2011b, Ghanbari et al., 2010, Kannan et al., 2007b). 
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Figure 4.18. Cell cytocompatibility on tissue culture plastic (TCP), cast non-porous PCLU films, 
cast non-porous POSS-PCLU films and porous POSS-PCLU scaffolds over a period of 7 days as 
measured using AlamarBlue®. * = p < 0.05. Values are given as mean ± one SD. 
 
4.5 CONCLUSION 
Here, we have developed and characterized a novel biodegradable nanocomposite 
polymer system as a candidate material for tissue engineering purposes. Molecular 
characterization demonstrated POSS-PCLU polymers to be mostly amorphous as 
corroborated by Tg measurements. Mechanical analyses revealed a relationship between 
the hard segment content and tensile properties. No significant differences in tensile 
strength could be observed between PUs with the same hard segment content but with 
(POSS-PCLU-24) or without (PCLU-24) POSS nanoparticle inclusion. Surface analyses 
demonstrated microscopic POSS aggregates which are hypothesized to confer enhanced 
cytocompatibility and non-immunogenicity to the polymer system. 
* 
* 
* 
* 
* 
* 
* 
* * 
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5 AN OPTIMIZED STERILIZATION METHOD 
FOR BIODEGRADABLE POSS-PCLU 
5.1 SYNOPSIS 
The field of tissue engineering is rapidly evolving, generating numerous 
biodegradable materials suited as regeneration platforms. Material sterility is of 
fundamental importance for clinical translation, yet, few studies have systematically 
researched the effects of different sterilization methods on biodegradable material 
systems. Heat, chemical or radiation treatments can alter material topographies and 
surface chemistries, thereby inadvertently influencing cellular morphometry and 
function. Here, we exposed a novel bioabsorbable nanocomposite based on polyhedral 
oligomeric silsesquioxane-modified poly(ε-caprolactone urea)urethane (POSS-PCLU) to 
autoclave, microwave, antibiotics and 70 % ethanol sterilization and systematically 
correlated differences in material characteristics to the attachment, viability, 
proliferative capacity and shape of human dermal fibroblasts (HDFa). Nanotopographical 
profiling of autoclaved or microwaved surfaces revealed relatively deep nano-grooves, 
increasing total surface area, roughness and hydrophobicity which resulted in 
significantly fewer adherent cells. Antibiotics or 70 % ethanol-treated surfaces displayed 
shallower nano-grooves and a more hydrophilic character and significantly greater 
cellular adhesion (p < 0.05). In fact, relative cell proliferation on ethanol-treated films 
surpassed that of cells grown on every other surface by a factor of 9 over 7 days. F-actin 
staining demonstrated spindle-like morphologies characteristic of HDFa when grown on 
ethanol-treated films as opposed to cells grown on other films which were significantly 
more spread out (p < 0.05).  
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5.2 INTRODUCTION 
The application of synthetic scaffolds for tissue engineering and regeneration is a 
rapidly expanding field with enormous clinical potential as demonstrated with the 
world’s first synthetic trachea transplantation as well as in-human vascular bypass graft 
and lacrimal duct insertion using the non-biodegradable nanocomposite material POSS-
PCU (Chaloupka et al., 2011, Jungebluth et al., 2011a). For a number of applications such 
as developmental and paediatric organ malformations, however, biodegradable scaffold 
systems are more favourable due to the potential of such scaffolds to ‘grow’ with the 
young patients. Additionally, biodegradable materials have demonstrated substantial 
clinical potential in tissue engineering of skin regeneration platforms where initial 
structural stability is essential to prevent wound bed contraction but subsequent gradual 
degradation necessary to free space for the ingrowing new skin (Mansilla et al., 2010, 
Kuppan et al., 2011). Polyhedral oligomeric silsesquioxane-modified poly(carbonate 
urea-urethane)caprolactone (POSS-PCLU) is a novel bioabsorbable nanocomposite 
material suited as a platform material for  tissue regeneration applications (Ahmed et al., 
2011b, Kannan et al., 2006c, J.Armstrong et al., 2004, Salacinski et al., 2005, Kannan et al., 
2005b, Jungebluth et al., 2011b, de Mel et al., 2009). POSS-PCLU scaffolds can be 
fabricated in a number of ways including casting, coagulation using a salt leaching 
method, 3-D printing and electrospinning in order to suit individual applications. This 
versatility renders bioabsorbable POSS-PCLU a highly desirable platform material for 
tissue engineering of temporary implantable devices. However, a frequently 
underestimated, albeit highly relevant aspect in the development of implantable devices 
is the ability to ensure impeccable sterility. As micro-organismal contamination tends to 
falsify in vitro studies as well as elicit a potentially exuberant immune reaction towards 
such devices in the human, sterility remains a fundamental prerequisite for the transition 
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of tissue engineered scaffolds into the clinical arena. Sterilization is defined as the 
destruction of all forms of life by heat, chemical or radiation treatment (Ninemeier, 2003). 
Conventional laboratory-based sterilization techniques include high pressure steam 
sterilization (autoclaving) and exposure to microwaves. Whilst effectively removing 
surface-adherent bacteria, these methods often irreversibly damage hydrolytically 
unstable materials leading to material melting, collapse of internal porous architectures, 
unpredictable changes in mechanical and surface properties as well as altered rates of 
biodegradation. Chemical means of microbial removal such as exposure to 70 % ethanol 
or antibiotics, whilst strictly speaking not considered sterilising agents, have been 
routinely adopted as antimicrobial agents for laboratory cell studies (Shearer et al., 2006).   
Besides the sterilizing effect, exposure to heat sources or potentially abrasive 
chemicals influences surface topographies (e.g. surface roughness) and can thereby 
significantly change cell-substrate interactions and cell function (Ma et al., 2007, Kikuchi 
and Okano, 2005, Flemming et al., 1999). Changes in cellular attachment, motility, 
proliferation and differentiation (Tonazzini et al., 2010) have been shown to be brought 
about by modulating material surface tension and chemical and mechanical properties 
(Rehfeldt et al., 2007). It is a recognized fact that 3D topographical features of polymers 
(Washburn et al., 2004), oxides (Winkelmann et al., 2003), carbon nanofibers (Price et al., 
2004) and metals (Khang et al., 2008) are related to cyto- and biocompatibility of the 
respective materials. Surface topographies ranging within the nanometer scale are 
thought to facilitate cell-substrate interactions by mimicking the biological cues present 
on ECM components of natural tissues (Chen et al., 2013b, Loesberg et al., 2007, Pan et 
al., 2013, Miller et al., 2004). Since focal adhesion proteins located on the outer surface of 
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the cell membrane (e.g. integrins) have a diameter measuring ~10-15 nm, cell-substrate 
adhesion is enhanced by nanoscaled surface topographies (Hussain and Siedlecki, 2004). 
 The aim of this work was to systematically investigate (i) the effectiveness of 4 
different, easily accessible sterilization methods for bioabsorbable POSS-PCLU material, 
and (ii) the influence of these sterilization methodologies on surface topography and 
chemistry as well as cell-substrate interactions.  
5.3 MATERIALS AND METHODS 
5.3.1 Polymer Synthesis 
Please refer to section 4.3.1. 
5.3.2 Manufacturing of Scaffolds 
Please refer to section 4.3.2. 
5.3.3 Scaffold Sterilization Techniques 
5.3.3.1 Autoclave Sterilization 
Samples were exposed to saturated steam at 121°C for 15 min at pressures of 115 
kPa (Classic Prestige Medical autoclave, Prestige Medical Limited, Blackburn, UK). Prior 
to use, samples were cooled to room temperature for 12-24 h.  
5.3.3.2 Microwave Sterilization 
Samples were completely submerged in de-ionized water and placed into an 
unmodified domestic microwave and exposed to highest power radiation (750 Watt) for 
a total of 30 seconds (sec) (Cardoso  2007). Samples were allowed to cool down before 
use. 
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5.3.3.3 Treatment with Antibiotic/Antimycotic solution 
Samples were placed in a 5 % (v/v) antibiotic antimycotic solution (10 000 U/mL 
penicillin G, 10 mg/mL streptomycin sulphate, and 25 mg/mL amphotericin B [Sigma-
Aldrich, Dorset, UK]) in PBS for 24 h at 4 °C. Samples were washed 3 times with PBS under 
agitation before use. 
5.3.3.4 Treatment with 70 % Ethanol Solution  
Samples were ethanol-treated according to a method published by Kweon (Kweon 
et al., 2003). Samples were soaked in 2 changes of 70 % ethanol over 30 min under 
agitation, and subsequently washed in 4 changes of PBS solution over 2 h.  
5.3.3.5 Control Samples 
Non-sterilized samples served as a control for all tests. 
5.3.4 Sterilization Efficiency 
Sterility testing was performed according to British Standards (ISO 11737-2:2009) 
on cast and coagulated samples immediately following sterilization. The samples were 
immersed in normal cell culture medium to cultivate micro-organisms and maintained at 
37 °C for 7 days. Untreated scaffolds were used as the positive control and sterile medium 
alone served as the negative control. Samples were assessed daily for any turbidity which 
denotes infection and inefficient sterilization. All experiments were conducted in 
triplicates. 
5.3.5 Scaffold Characterization 
5.3.5.1 Scaffold Shrinkage 
Changes in scaffold diameter post-sterilization were used as an indicator for 
sterilization-induced scaffold degradation. Diameters were measured pre- and post-
sterilization using a calliper.  
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5.3.5.2 Scaffold Surface Micro- and Nanotopographical Assessment 
5.3.5.2.1 Scanning Electron Microscopy 
Please refer to section 4.3.4.1.1. 
5.3.5.2.2 Atomic Force Microscopy 
Please refer to section 4.3.4.1.2. 
5.3.5.3 Surface Wettability Measurement using Contact Angle (θ) 
Please refer to section 4.3.4.1.3. 
5.3.5.3.1 Attenuated Total Reflectance Fourier Transform Infrared (ATR/FTIR) 
Spectroscopy 
 Please refer to section 4.3.4.2.2. 
5.3.5.4 Mechanical Properties of Scaffolds 
Please refer to section 4.3.4.3.3. 
5.3.6 Cell Behaviour on Sterilized Surfaces 
Primary fibroblasts were isolated from human dermis (HDFa) and cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 1 mM L-glutamine, 10 % 
fetal bovine serum (FBS), 1 % penicillin/streptomycin and 1 % Fungizone (Invitrogen, 
Paisley, UK). HDFa were cultured to 80-90 % confluency, trypsinized and either re-plated 
or stored in 10 % DMSO/10 % FBS in liquid nitrogen until required.  
To allow for isolated assessment of sterilization-induced variations in surface 
topography and the influence on cell adhesion and proliferation, HDFa cells were seeded 
onto DMEM pre-soaked and non-porous cast POSS-PCLU scaffolds at a density of 5 x 104 
cells/150 µL/scaffold and incubated at 37 °C, 5 % CO2 for 2 h. Then, 1 mL culture medium 
was added and cells were incubated until the pre-determined time points.  Previous tests 
determined 2 h sufficient for cell attachment (results not shown). A staggered seeding 
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technique was utilized to ensure cell adhesion onto scaffolds rather than tissue culture 
plastic (TCP) (Noah et al., 2002). TCPs containing no scaffolds were seeded with an equal 
amount of cells (positive control) or medium only (negative control). Medium-soaked 
POSS-PCLU scaffolds not seeded with cells served as background noise which was 
subtracted from final results of cell-seeded scaffolds. Cells were incubated at 5 % CO2 in 
air at 37 °C and culture medium was changed every 2-3 days for a total of 7 days.  
In order to demonstrate the material’s suitability as a tissue engineering platform, 
3D porous scaffolds were seeded with HDFa at a density of 5 x 104 cells/150 µL/scaffold 
and incubated at 37 °C, 5 % CO2 and cellular viability, proliferative capacity as well as 
migration into the scaffold’s internal architecture were analysed.  
On days 1, 3, and 7, cell morphology was visualised using the F-actin stain fluorescein 
isothiocyanate (FITC)-phalloidin and nuclei counterstained with Propidium Iodide (PI) 
(both Sigma-Aldrich, Dorset, UK). Cell viability and proliferative capacity were assessed 
using Live/Dead® stain and AlamarBlue® assay, respectively.  
5.3.6.1 Assessment of Cell Viability using AlamarBlue® Cell Proliferation Assay 
Please refer to section 4.3.5.2. 
5.3.6.2 Live/Dead® Cell Survival Assay 
Please refer to section 4.3.5.3. 
5.3.6.3 Cytoskeletal Staining 
Please refer to section 4.3.5.4. 
5.3.7 Statistics 
Please refer to section 4.3.6. 
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5.4 RESULTS AND DISCUSSION  
Tissue engineering of implantable biodegradable devices is increasingly advocated 
as an elegant solution to restore the diseased or imperfect human body to a pre-morbid 
state (Lavik and Langer, 2004, Vacanti and Langer, 1999, Langer and Vacanti, 1993). In 
particular, the paediatric population is thought to benefit from absorbable devices as is 
the field of skin reconstruction. Tissue engineered devices are often highly porous and 
therefore, by nature, display large surface areas with known incidences and histories for 
clinical infections (Kuijer et al., 2007). Further, it has been shown that bacteria can remain 
dormant within the internal scaffold structure, only to manifest as pathogenic biofilms 
after implantation (Drenkard and Ausubel, 2002). Material sterility is of fundamental 
significance for all implantable biomedical devices and is a particularly important 
consideration for all bioabsorbable materials (Holy et al., 2001). Here, we introduced a 
novel biodegradable nanocomposite polymer based on a diisocyanate hard segment and 
a poly(urea urethane)caprolactone soft segment incorporating POSS nanoparticles for 
use as a tissue engineering scaffold. Major advantages of using a PCLU backbone as tissue 
engineering platforms include its inherent biocompatibility, non-immunogenicity and 
slow degradation into non-toxic metabolites. Unmodified POSS-PCLU, however, has a 
relatively hydrophobic nature which increases non-specific protein adsorption leading to 
poor cell attachment and proliferation (Cheng and Teoh, 2004). Several researchers 
investigated surface modification strategies including collagen and acrylic acid 
functionalisations in order to enhance cell adhesion and improve biocompatibility of PCL 
(Bae et al., 1999, Cheng and Teoh, 2004, Hutmacher, 2000). However, one fundamental 
aspect that most studies relating to biodegradable scaffolds fail to mention is the 
necessity for a terminal sterilization step. Depending on the sterilization method used, 
the biomaterial surface may undergo different degrees of modiﬁcations which may 
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inﬂuence cell-biomaterial interactions (Zhang et al., 1996, Baier et al., 1982). This may 
render any prior surface modifications obsolete resulting in unpredictable material 
properties. In this study, we present a one-step method to achieve both sterilization and 
enhance biocompatibility after the initial synthesis of the scaffold; a technique termed 
post-production processing.  
5.4.1 Effectiveness of Different Sterilization Techniques by Immersion in Culture 
Medium 
Table 5.1 summarizes the results of the sterility tests. An incubation period of 7 days 
allowed sufficient time for any potential microbial migration. 
 
Table 5.1. Sterility testing of cast and coagulated samples by immersion in culture 
medium for 7 days post-sterilization. Experiments were carried out in triplicates. Key: -ve 
control, medium only; +ve control, contaminated samples; x, no growth present; , growth 
present. 
 
After 7 days, all non-sterilized cast and coagulated control samples showed signs of 
infection and bacterial growth whereas medium-only controls did not exhibit turbidity, 
thus proving the feasibility of this testing technique. The results predictably showed 
Number of Repeats 
 Sterilization Technique 1 2 3 
Cast Autoclave x x x 
Microwave x x x 
Antibiotics x x  
70 % Ethanol x x x 
-ve control x x x 
+ve control    
Coagulated Autoclave x x x 
Microwave x x  
Antibiotics x x  
70 % Ethanol x x x 
-ve control x - - 
+ve control  - - 
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efficient microbial removal on non-porous, cast films using autoclave, microwave and 70 % 
ethanol sterilization; all of which have been proven effective in numerous studies (Holy 
et al., 2001, Machado et al., 2011, Athanasiou et al., 1996). However, extensive polymer 
deformation and shrinkage due to melting of the heat-sensitive POSS-PCLU were 
observed in the coagulated samples.  
Exposure to microwaves for 30 sec sterilized cast samples. Porous scaffolds, 
however, were only inconsistently sterilized using microwave irradiation, retaining 
contaminants within some core structures that only surfaced days later to cause infection. 
Such delayed infection is indicative of incomplete microbial eradication due to 
microwave scattering along the rough polymer surface and wave reflection due to 
incomplete air elimination within the internal structures (Ulaby et al., 1978). The 
presence of such attenuating factors reducing microwave intensity has been confirmed 
in previous studies (Harvey, 1963, Skolnik, 1970). It has been suggested that the presence 
of water vapour favours microwave absorption, thereby attenuating its intensity. 
Conventionally, microwaves have been used in the disinfection of denture base resins 
(Machado et al., 2011) and the sterilization effect is thought to be due mainly to the 
heating effect. Studies investigating microwave sterilization of glass culture tubes 
demonstrated microbial growth when tube stoppers were purposefully opened to the 
ambient pressure, indicating a major role of pressurised steam in the killing of micro-
organisms (Fitzpatrick et al., 1978).  
Antibiotic treatment resulted in unreliable sterilization and clouding of the 
incubation medium for both cast and coagulated samples. To the best of our knowledge, 
antibiotic antimycotic solutions have only been used as sterilizing agents in a study by 
Shearer  who recommended exposure over a period of 24 h (Shearer et al., 2006). 
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Contrary to Shearer’s results, our investigation showed inefficient sterilization using 
antibiotic solutions. 
Immersion of samples in two changes of 70 % ethanol over 30 min and subsequent 
washing with 4 changes of sterile PBS over 2 h resulted in effective removal of micro-
organismal contaminants from both cast and coagulated samples. Exposure to 60-80 % 
ethanol is considered disinfectant rather than sterilizing due to its inability to destroy 
hydrophilic viruses or bacterial spores (Holy et al., 2001). However, ease of use and 
apparent effectiveness make ethanol a favourable tool for in vitro studies. Further, it has 
been demonstrated that ethanol treatment of a poly-L-lactide-co-glycolide polymer did 
not affect the molecular weight (Mw) of the polymer (Holy et al., 2001).  
5.4.2 Sterilization Induced Microscopic Changes in Scaffold Architecture and 
Topography 
Surface micro- and nanotopographies of unsterilized and sterilized POSS-PCLU 
sheets were analysed using SEM (Fig. 5.1 and 5.2), FTIR spectroscopy (Fig. 5.3), 
goniometry (Fig. 5.4) and AFM (Fig. 5.5). Whilst all sterilization methods bar antibiotic 
solution had sterilizing effects, structural damage was evident in all cases. The SEM image 
of an unsterilized coagulated sample surface (Fig. 5.1 (E)) exhibits sub-micron scale tufts 
of polymer imprinted during the surface modification step of scaffold synthesis. Changes 
to this surface microtopography post-sterilization are suggestive of damage induced by 
these treatments. Surface tufts were lost after using autoclave, microwave and 70 % 
ethanol sterilisation with polymer melting and irregular re-formation into larger and 
flatter ridges (Fig. 5.1 (A), (B) and (D)).  
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Figure 5.1. Representative SEM images of coagulated sterilized (A-D) and control (E) scaffold 
surfaces. Magnification x 320. Scale 50 µM. 
 
Exposure to high pressure steam sterilization and microwaves expectedly resulted 
in extensive morphological damage of hydrolytically unstable POSS-PCLU (Rainer et al., 
2010) indicative of partial dissolution of the polymer surface tufts due to hydrolysis. 
Subsequent fusion of polymer tufts into larger and flatter ridges is thought to be mainly 
driven by high polymer concentration at the polymer-moisture interface (Shearer et al., 
2006). Antibiotic treatment seemed to have the least effect on surface melting (Fig. 5.1 
(C)). However, the complete loss of internal porous structure observed on transverse cut 
SEM images was unexpected as antibiotic solution reportedly does not damage 
morphological or chemical characteristics of scaffolds (Richards et al., 1991). SEM images 
of vertically cut edges of an unsterilized coagulated scaffold revealed a spongy internal 
architecture characterized by numerous interconnected pores (Fig. 5.2 I (E)), whilst all 
sterilization methods resulted in a reduction (Fig. 5.2 I (D)) or complete loss of the porous 
internal architecture (Fig. 5.2 I (A), (B) and (C)). 
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Figure 5.2. (I) Representative SEM images of cut scaffold edges. Magnification x 80. Scale 250 µm. 
Image analysis with ImageJ (freeware). (II) All sterilization methods significantly affected scaffold 
thickness (p < 0.001) with a mean loss of 50.5 %. Most pronounced loss was observed in antibiotic 
treated scaffolds (C, mean loss of 68 %). Values are given as mean ± one SD. 
 
Scaffolds treated with 70 % ethanol were found to retain the porous internal 
architecture best compared to other sterilization methods (Fig. 5.2 I (E) and (F)) which 
is in accordance with the literature (Holy et al., 2001, Karp et al., 2003). Loss of scaffold 
thickness was statistically significant for all sterilization methods (Fig. 5.2 II, *p < 0.001, 
mean loss of thickness = 50.5 %) but was most pronounced in scaffolds treated with 
antibiotic solutions (Fig. 5.2 II (C)). Preserving internal porosity post-sterilization is of 
* * 
(I) 
(II) 
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fundamental importance for the in- and efflux of nutrients and waste products to and 
from the cells (Noah et al., 2002). 
5.4.3 Chemical Bond Scission Demonstrated by ATR-FTIR 
 Material surface chemistry and sterilization induced changes were analysed using 
FTIR spectroscopy. Figure 5.3 shows an FTIR spectrum overlay of individual 
representative cast POSS-PCLU surfaces sterilized using each technique.   
 
Figure 5.3. Overlaid attenuated total reflectance-Fourier transform infrared spectrum of cast 
sterilized and control samples. Particularly high temperature steam sterilization (autoclaving) 
induced a broadening of the OH peak at around 3550 cm-1. No reductions in peak intensity were 
observed at the methylene bridge at 2932 cm-1 or the carbonyl region (1729 cm-1) indicating the 
presence of both ester and urethane linkages and an intact hard segment.  
 
 All sterilization methods and in particular high temperature steam sterilization 
(autoclaving) induced an increase and broadening of the OH absorption peak at 3550 cm-
1 suggestive of an accumulation of carboxylic and hydroxyl groups secondary to the 
hydrolytic degradation of the soft segment of PCLU. Multiple cycles of high temperature 
steam sterilization confirmed a gradual increase in the OH band, indicative of successive 
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hydrolysis of the polymer (results not shown). No reductions in peak intensity were 
observed at the methylene bridge at 2932 cm-1 or the carbonyl region at 1729 cm-1 
indicating the presence of both ester and urethane linkages and an intact hard segment. 
However, some evidence of hard segment exposure was evident with slight increases in 
peaks at 1632 (urethane carbonyl), 1560-1530, 1350, 1233, 992 and 793 cm-1.  
 Soft segment breakdown is known to play a major role in chemical aging of 
thermoplastic PUs and negatively affects mechanical properties including tensile stress 
and maximal strain (Servay et al., 2000). Here, mechanical analysis post antibiotic 
treatment revealed significantly lower breaking strains of cast polymers, indicative of 
soft segment scission. TPUs are phase separated block copolymers and owe their 
elasticity to their biphasic morphology, i.e. a rigid and soft phase. While the soft segment 
provides the material with flexibility, the hard segment physically cross-links the phases 
to allow for elastic recovery (Servay et al., 2000). Thermal oxidation of the methylene 
bridge of the MDI and subsequent breakage of the material’s hard segment has been 
observed at temperatures above 150 °C (Servay et al., 2000). However, in our studies, 
temperatures did not exceed 121 °C and thus no reductions in peak intensity were 
observed at the methylene bridge at 2932 cm-1 or the carbonyl region (1729 cm-1) 
indicating the presence of both ester and urethane linkages. However, some evidence of 
hard segment exposure was evident with slight increases in peaks at 1632, 1560-1530, 
1350, 1233, 992 and 793 cm-1 as similarly reported by Chan-Chan  (Chan-Chan et al., 
2010b). 
5.4.4 Surface Roughness Changed Significantly as Demonstrated with Contact Angle and 
AFM 
Sterilized and non-sterilized cast samples were also characterised in terms of 
wettability and nanotopograph. Contact angle measurements of non-sterilized control 
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samples demonstrated an inherent hydrophobic character of the POSS-PCLU polymer 
surface (θ = 114°, Fig. 5.4.).  
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Figure 5.4. Contact angle (θ) measurements on cast sterilized (A-D) and control (E) POSS-PCL 
samples. Values are given as mean ± one SD. 
 
All sterilization methods induced a significant reduction in surface hydrophobicity 
which, according to the Wenzel phenomenon is due to a reduction in surface roughness 
which results in a smaller surface area and thus increases hydrophilicity (Wenzel, 1936) 
(Fig. 5.4, p < 0.05). Polymers treated with antibiotics and 70 % ethanol exhibited the most 
extreme loss in θ (mean loss of 23.7 % and 21.9 %, respectively) whilst exposure to 
microwaves had the least effect on contact angle (mean loss of 13.9 %). Treatment with 
antibiotics and 70 % ethanol resulted in the most hydrophilic surfaces with θ of 87° and 
89°, respectively. 
* 
* 
* 
* 
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The results obtained by goniometry were further corroborated by surface 
roughness measurements using AFM (Table 5.2 and Fig. 5.5 (II) + (III)).  
Table 5.2. Surface topographical properties of cast sterilized POSS-PCL samples. Key: AFM, 
atomic force microscopy; θ, contact angle; a, mean surface roughness (the arithmetic 
average of the absolute values of all points of the profile); b, root mean square roughness 
(RMS, the root mean square of the values of all points of the profile); c, correlation length (ξ, 
measure of how microscopic variables at different positions are correlated); * = p < 0.05. 
 
Figure 5.5 (I) shows the scaffold surfaces on a nano-level as well as the roughness 
profiles of sterilized and control surfaces. All surfaces exhibited a random pattern of peak 
heights with antibiotic or 70 % ethanol-treated surfaces demonstrating an overall 
shallower appearance of grooves compared to those of autoclaved or microwaved 
surfaces. Ra as well as Rq were highest in non-sterilized samples (Ra = 54.1 nm and Rq = 89 
nm) whilst ξ of unmodified surfaces was in the mid-range (ξ = 14.6 nm) (Table 5.2). Such 
nanoscale roughness is hypothesized to stem from the extrusion of POSS-nanocages 
(average diameter including functional groups = 1.5 nm) during the initial polymer 
synthesis step.  
Based on the AFM data, Ra and Rq decreased in a parallel fashion to the reductions 
observed in contact angle measurements. Although one-way ANOVA did not yield a 
significant difference amongst most data sets of Ra and Rq, samples exposed to antibiotic 
solution experienced the most pronounced and statistically significant loss in Ra (50 % 
reduction compared to control, p < 0.05). 
 
 
 
 
AFM 
Sterilization Technique θ (°) Ra (nm)a Rq (nm)b ξ (nm)c 
Autoclave 93* 42.9 67.1 4.2* 
Microwave 98* 44.0 89.0 45.8* 
Antibiotics 87* 27.4* 74.7 31.8* 
70 % Ethanol 89* 47.1 67.7 5.5* 
Control 114 54.1 89.1 14.6 
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Figure 5.5. (I) Representative AFM images of cast sterilized (A-D) and non-sterilized control (E) 
POSS-PCL sheets. Dimensions 20x20µm. (II) Statistical analyses of mean surface roughnesses (Ra). 
(III) Root mean square roughness (Rq) analysis. All values are given as mean ± one SD. 
 
Rq, whilst generally following a falling trend upon sterilization which indicates 
surface melting and irregular reformation on a nanoscale level as already demonstrated 
macroscopically using SEM (Fig. 5.1), did not exhibit statistically significant reductions in 
(II) (III) 
(I) 
(A) Autoclaved 
(D) 70% Ethanol 
(B) Microwave (C) Antibiotics 
(E) Control 
* 
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values compared to control surfaces. ξ of sterilized surfaces differed significantly from 
control surfaces with microwave and antibiotic solution-exposed samples exhibiting a 
significantly increased ξ value (+68.1 % and +54.1 %, respectively) and autoclaved or 70 % 
ethanol-treated surfaces demonstrating a significant reduction in ξ (-71.2 % and -62.3 %, 
respectively). In summary, changes in contact angles corresponded to nanotopographical 
changes in roughness as demonstrated by AFM. 
As depicted in Fig. 5.5, the roughness profiles of sterilized and control surfaces 
exhibit a random pattern of peak heights. Comparing the pattern of grooves along the 
length of the polymer surface, it is evident that antibiotic or 70 % ethanol treatment 
created an overall shallower appearance of grooves compared to those of autoclaved or 
microwaved surfaces. This is congruent with the lower contact angles of antibiotic or 
ethanol treated surfaces. 
Consider the schematic in Fig. 5.6. A water droplet on a hydrophilic surface forms a 
low internal contact angle.  
 
 
Figure 5.6. (I) Water drop on a hydrophilic surface forms a low internal contact angle. (II) 
Superhydrophobic non-wetting surfaces form a quasi-drop with a high internal contact angle. (III) 
A drop on a solid surface decorated with pillars with air filling the interpillar spaces. Yoshimitsu 
observed that the drop can sit on top of these pillars – the so-called ‘fakir regime’ – corresponding 
to an apparent contact angle larger than 150° (superhydrophobic behaviour) (Yoshimitsu et al., 
2002). If the pillar height is shortened, the water contact angle decreases, because air is no longer 
trapped below the drop. Adapted from Quéré (Quéré, 2002). 
(I) (II) 
(III) 
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A superhydrophobic surface, on the other hand, will form a quasi-drop with a high 
contact angle. A drop on a surface decorated with pillars long enough to trap air within 
the interpillar spaces (Cassie model) (Dettre and Johnson, 1963, Bico et al., 1999) will 
display an apparent contact angle of larger than 150°, as observed by Yoshimitsu  
(Yoshimitsu et al., 2002). The water drop consequently behaves as fakirs do on a bed of 
nails. Conversely, if the pillar height is shortened, as observed in our study with ethanol 
and antibiotic treatment of polymer surfaces, air can no longer be trapped in between the 
pillars and the water contact angle decreases, giving rise to a more hydrophilic surface 
(Quéré, 2002). Studies have shown that the topographical height threshold for fibroblast 
alignment lies at around 35 nm, below this value contact guidance no longer exists 
(Loesberg et al., 2007) giving rise to misaligned, broader cell morphologies. 
Apart from pillar height, a further determining surface parameter is the correlation 
length (ξ). In order to quantitatively describe spatial variations of surface parameters at 
ultrastructural levels, ξ analysis was carried out. ξ, a characteristic parameter of the 
covariance function was employed to estimate the fluctuations in surface roughness 
induced by different sterilization methods. ξ describes how microscopic variations in 
relative positions change the correlation patterns between such positions. E.g. if the 
distance between point A and point B is smaller than an arbitrary threshold ξ, then the 
interactions between A and B cause these points to be correlated. Peak-to-peak distance 
of surface micro- and nanostructures is known to influence cell-substrate behaviour, cell 
adhesion and proliferation. Studies analysing cellular responses to different surface 
structures demonstrated that smoother surfaces better supported cell attachment and 
subsequent proliferation compared to cells grown on nanorough surfaces (Chen et al., 
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2012, Baharloo et al., 2005). This is in accordance with our cell proliferation and cell 
spreading results (see below). HDFa grown on surfaces treated with 70 % ethanol 
demonstrated highest proliferative capacity in accordance with surface topographical 
properties (θ = 89°, Ra = 47 nm, Rq = 68 nm, ξ = 5.5 nm). As can be seen in Fig. 5.9, cell 
morphology was influenced by surface topography. Surfaces with relatively higher ξ such 
as microwave or antibiotic treated surfaces (ξ = 46 nm, and 32 nm, respectively) 
demonstrated more widely spread individual cells compared to the phenotypically more 
fibroblast-like spindle shaped cells seen on surfaces with lower ξ (70 % ethanol treated 
surfaces ξ = 5.5 nm). Different surface topographies have previously been shown to 
markedly alter cell morphology of fibroblasts with smoother surfaces being more 
favourable for fibroblast proliferation (Chou et al., 1995, Könönen et al., 1992). Rough 
surfaces, on the other hand, were seen to provide multiple points of attachment (Wieland 
et al., 2002) which may influence the relatively broader spread of cells cultured on 
microwave or antibiotic treated surfaces.   
ξ of surfaces exposed to antibiotics or microwaves were found to be relatively 
higher compared to ξ of control surfaces (31.8 nm, 45.8 nm, and 14.6 nm, respectively).  
A statistically significant reduction in surface roughness was observed in polymer 
sheets treated with antibiotic solution (p < 0.05), but not for any other method of 
sterilization when compared to the unsterilized control sheet. Such findings diverge from 
earlier studies into effects of different polymer sterilization methods which found 
antibiotic treatment to significantly increase surface roughness of a poly(D,L-lactic-co-
glycolic acid) flat sheet (Shearer et al., 2006). Such observations are suggestive of 
polymer-specific degradation modes towards the same treatment and thus display a non-
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predictability in terms of which sterilization method is most effective while being least 
harmful.  
5.4.5 Mechanical Characteristics of Sterilized Scaffolds 
Figure 5.7 (I) illustrates a representative stress-strain curve of a cast POSS-PCL 
sample. No differences in tensile strength were observed between differently sterilized 
scaffolds fabricated using the same technique (Fig. 5.7 (II) cast samples: top; coagulated 
samples: bottom), refuting earlier studies (Selim et al., 2011). Coagulated samples 
expectedly had significantly lower tensile properties compared to cast samples (Table 5.3; 
p < 0.05). Maximal stress at break was found to be reduced in cast samples treated with 
all sterilization methods.  
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Figure 5.7. (I) A representative stress-strain curve of a cast POSS-PCLU sample. (II) A comparison 
of stress-strain curves of cast (top) and coagulated (bottom) scaffolds. Different fabrication 
techniques result in vastly different elastic moduli (E). Mean elastic modulus (Ē) of cast scaffolds = 
0.05 MPa vs Ē of coagulated scaffolds = 0.003 MPa (p < 0.05). (III) Treatment of cast samples using 
antibiotic solution reduced maximal stress values significantly compared to unsterilized controls 
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(C; p < 0.05). (IV) Young’s modulus was not significantly affected by any sterilization method (C). 
Values are given as mean ± one SD. 
 
Antibiotic treatment resulted in the most pronounced and statistically significant 
reduction in breaking stress (Fig. 5.7 (III), p < 0.05), opposing a study conducted by 
Shearer  who exposed coagulated and electrospun Poly(D,L Lactic-Co-Glycolic Acid) 
scaffolds to a 1 % (v/v) antibiotic antimycotic solution (Shearer et al., 2006). The 
observed differences may be due to dosage-dependent effects of antibiotics and/or 
differences in susceptibility of different polymers.  
Table 5.3. Morphological and mechanical characteristics of differently sterilized POSS-
PCLU scaffolds compared to human skin. Loss of scaffold diameter was assessed in porous 
samples. Mechanical properties of cast sheets were analysed to eliminate any potential 
variations induced by random pore distribution of the coagulated scaffolds, thus 
highlighting the mechanical properties of the pure polymer. Compared to human skin, 
coagulated scaffolds were significantly more elastic (E = 0.01 vs E = 0.003, respectively; p < 
0.05, paired t-test). Key: E. Young’s modulus; d, diameter. 
Sample Sterilization 
Technique 
Thickness 
(mm) 
Loss in d 
(% of 
control) 
Max. Tensile 
Strength (MPa) 
Elongation at 
Break (%) 
Young’s 
Modulus 
(MPa) 
Cast Autoclave 0.28 ± 0.03 - 41.98 ± 9.90 919.80 ± 105.40 0.02 
Microwave 0.23 ± 0.02 - 47.61 ± 5.74 893.03 ± 34.19 0.02 
Antibiotics 0.27 ± 0.04 - 42.59 ± 4.08 890.68 ± 70.18 0.02 
70 % Ethanol 0.25 ±0.012 - 54.31 ± 4.20 920.45 ± 68.81 0.02 
Control 0.26 ± 0.02 - 45.04 ± 8.40 898.54 ± 112.10 0.02 
       
Coagulated Autoclave 0.93 ± 0.04 22.0* 1.34 ± 0.12 568.07 ± 27.42 0.01 
Microwave 0.73 ± 0.03 10.0 1.63 ±0.14 579.34 ± 16.59 0.01 
Antibiotics 0.98 ± 0.07 2.0 1.25 ± 0.11 496.48 ± 33.53 0.01 
70 % Ethanol 0.95 ± 0.05  7.5 1.14 ± 0.07 535.89 ± 29.69 0.01 
Control 0.83 ± 0.12 - 1.68 ± 0.55 512.34 ± 60.48 0.01 
       
Human skin 
(Pailler-Mattei 
et al., 2008, 
Edwards and 
Marks, 1995)  
n/a 1.00 – 3.00   21.50 ± 8.40 54.00 ± 17.00 0.01 – 0.02 
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5.4.6 In Vitro Cell Viability and Proliferation  
The percentage cell viability versus time and sterilization condition is represented 
as a bar chart in Figure 5.8. Viability of cells grown on normal TCP serves as the control 
total viability (i.e. 100 %). The general trend demonstrated increased cell adhesion and 
metabolic viability at each consecutive time point. However, AlamarBlue® metabolic 
assay demonstrated an initial lag in percentage viability of cells grown on 70 % ethanol 
treated films which is compensated for on day 7. 
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Figure 5.8. Percentage viability of HDFa grown on sterilized cast discs compared to cells grown on 
tissue culture plastic over a 7 day period assessed using AlamarBlue® cell viability assay. * = p < 
0.05. Values are given as mean ± one SD. 
 
In fact, relative cell proliferative capacity on ethanol treated films surpassed that of 
cells grown on every other surface (apart from TCP) by a factor of 9 over a period of seven 
days. Similarly, cell viability was found to be well supported by films treated with 
antibiotic solution. Autoclave treatment resulted in a cell-repellent surface with minimal 
to no cell adhesive capacity and significantly reduced cell viability. Exposure of films to 
microwaves supported cell proliferation but significantly less so compared to treatment 
with both antibiotic and 70 % ethanol solution (p < 0.05). These results demonstrated 
* * 
* 
* 
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that optimal adhesion and alignment of HDFa onto differently sterilized POSS-PCLU 
polymer occurs with surfaces showing a combination of moderate wettability and 
relatively short peak-to-peak distance. It has previously been demonstrated that the cut-
off contact angle for good cell attachment and spreading is θ ≤ 90° (Förch et al., 2009). In 
terms of tissue engineering platforms, surface wettability of below 90° is regarded a 
highly important cue for the attachment of cells and the subsequent induction of tissue 
growth and regeneration (Olbrich et al., 2007, Yang et al., 2002). The enhanced adhesion 
of cells onto ethanol treated samples can be ascribed to the different surface chemistries, 
indicating a preference of cells for hydrophilic structures as ethanol treated films 
exhibited relatively more hydrophilic properties (θ < 90° in both cases). Surface 
wettabilities of under 90° are known to promote cell adhesion and proliferation by 
increasing surface free energy (Ishizaki et al., 2010, Zhao et al., 2010). Zhao  previously 
demonstrated smaller water contact angles and higher values for surface free energy 
upon sterilization with ethanol compared to autoclaving (Zhao et al., 2010). These results 
are corroborated here. FTIR results demonstrated that hydrolysis of the soft segments 
converted the ester groups on the surface to hydrophilic hydroxyl and carboxyl groups 
which were favourable for cell attachment (Ng et al., 2001). 
Live/Dead® images of cells cultured on sterilized cast films are shown in Figure 5.9. 
Films exposed to any of the sterilization methods demonstrated acceptable initial cell 
attachment (day one) but cell adhesion visibly declined on day 1 on autoclaved surfaces 
which was in accordance with AlamarBlue® studies (Fig. 5.8). All except autoclaved 
surfaces supported cell growth throughout the entire study period of 7 days. Autoclaved 
surfaces displayed an inherently cell-repellent character with minimal initial cell 
adhesion and no proliferation throughout the entire study period. In terms of cell 
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morphology, only cells grown on 70 % ethanol-treated films exhibited spindle-like 
morphologies typical for fibroblasts, similar to cells grown on control TCP. 
 
Figure 5.9. Representative laser scanning confocal microscopy images of HDFa cells grown on cast 
sterilized POSS-PCLU discs stained with Live/Dead® stain.  
 
Generally, few or no dead cells (red) were visible on all sterilized or control surfaces. 
Films treated with 70 % ethanol supported cell adhesion and proliferation best.  
5.4.7 Cell Morphology and Attachment 
Confocal laser scanning microscopy images indicated that fibroblasts developed 
different morphologies when grown on differently sterilized surfaces (Fig. 5.10 (I)). Cells 
grown on surfaces sterilised with microwaves or antibiotic solution exhibited a more 
spread out phenotype compared to cells grown on autoclaved surfaces or those exposed 
to 70 % ethanol which demonstrated an aligned and elongated spindle-like character. 
Due to a significantly higher ξ (peak to peak distance) of these surfaces, both microwaved 
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and antibiotic treated scaffolds provided more spread out points of attachment, thus 
anchoring the cells over a larger surface area (Fig. 5.10 (II), p < 0.05).   
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Figure 5.10. (I) Representative confocal images of HDFa cultured on sterilized cast POSS-PCLU 
films for 7 days. Filamentous actin (F-actin) was visualised with FITC-phalloidin and nuclei 
counterstained with propidium iodide. (II) Planar surface area calculations support the hypothesis 
that different sterilization methods induce changes in surface topographies which can influence 
cell spreading and alignment. * indicates statistically significant differences (p < 0.05). Values are 
given as mean ± one SD. 
 
5.4.8 POSS-PCLU Scaffolds as Tissue Engineering Platforms 
 The ability of this novel polymer system to act as a tissue engineering scaffold was 
subsequently analysed on coagulated spongy POSS-PCLU scaffolds (Fig. 5.11). Scaffolds 
* 
* 
* 
* 
(I) 
(II) 
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were sterilized and subsequently seeded with HDFa at a density of 5 x 104 cells/scaffold. % 
cell viability of control cells (grown on TCP) was derived from AlamarBlue® metabolic 
assay and found to steadily increase over a period of seven days (Fig. 5.11 (I)). 
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Figure 5.11. (I) Analysis of % cell viability on porous POSS-PCLU scaffolds compared to cells 
grown on tissue culture plastic. Antibiotic treated surfaces were excluded from statistical analysis 
due to recurrent contamination. * = p < 0.05. Values are given as mean ± one SD. (II) Z-stack of a 
porous POSS-PCLU scaffold and (III) Integra® dermal regeneration template seeded with HDFa 
and cultured for 7 days.  
(I) 
* 
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 Autoclaved surfaces exhibited the least cytocompatible surface with % viabilities of 
less than 30 % at day seven. Similarly, surfaces exposed to microwaves had relatively 
stagnant cell growth and % viability also remained under 30 % of control. As expected, 
surfaces treated with 70 % ethanol had significantly higher cell proliferation (p < 0.05). 
Surprisingly, however, there was significantly higher metabolic activity within antibiotic 
treated scaffolds. Subsequent immersion of aliquots of used culture medium into fresh 
sterile medium confirmed a suspected infection in the scaffolds treated with antibiotic 
solution. The results obtained with antibiotic treated scaffolds were therefore removed. 
 All other media remained clear of infection after 72 h. In order to visualise cellular 
penetration depth into the porous architecture of scaffolds, cells were cultured for seven 
days on 70 % ethanol sterilized sponges and nuclei were visualised with PI. Confocal 
imaging in conjunction with z-stacking demonstrated excellent cellular penetration into 
the internal architecture of the porous POSS-PCLU sponges (Fig. 5.11 (II)). A preliminary 
comparative study investigating the difference in cell adhesion and proliferation on 
POSS-PCLU scaffolds and Integra® dermal regeneration template (bovine collagen matrix, 
current clinical gold standard) demonstrated better adhesion and proliferative capacity 
as well as deeper migration of HDFa into POSS-PCLU scaffolds (Fig. 5.11 (II) versus (III)). 
5.5 CONCLUSION 
Cast and coagulated biodegradable POSS-PCLU scaffolds were exposed to 4 
different sterilizing methods and their suitability as post-production processing tools to 
enhance biocompatibility were assessed. Autoclave and microwave treatments 
successfully sterilized cast POSS-PCLU films but significantly damaged the 3D porous 
structures of coagulated scaffolds. Additionally, autoclaved polymer surfaces displayed a 
hydrophobic, cell-repellent surface, overall making high pressure steam treatment an 
208 
 
unsuitable sterilization choice. Antibiotic antimycotic solution was ineffective in 
removing all micro-organisms and can therefore be excluded as a sterilizing agent. 
Exposure of both cast and coagulated scaffolds to 70 % ethanol resulted in the best 
overall sterilization efficiency combined with the least destructive effect on porosity and 
enhanced cytocompatibility. Ethanol treatment induced favourable surface 
topographical changes which positively influenced cell attachment, morphology, 
alignment as well as viability and proliferation. The present sterilization technique using 
70 % ethanol can pave the way for future tissue engineering using bioabsorbable POSS-
PCLU nanocomposite materials as regenerative platforms by addressing two current 
obstacles at once. 
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6 EFFECT OF HARD SEGMENT CHEMISTRY ON 
LONG-TERM IN VITRO OXIDATIVE AND 
HYDROLYTIC STABILITY OF POSS-PCLU 
SCAFFOLDS 
6.1 SYNOPSIS 
Biodegradable PU scaffolds are a popular choice for tissue engineering and 
regenerative applications, particularly in mechanically challenging settings (e.g. the skin). 
Previous investigations mainly focussed on the integration of more or less hydrolysable 
components to modulate degradation rates. In this chapter, however, the objective was 
to synthesize a family of novel biodegradable PUs with varying amounts of hard segments 
in order to investigate the influence of hard segment chemistry on the degradation rate 
and profile. Specifically, we synthesized a PU based on a poly(ε-caprolactone 
urea)urethane backbone integrating polyhedral oligomeric silsesquioxane (POSS-PCLU) 
nanoparticles using dry polycaprolactone diol as the soft segment and different 
concentrations (24 %, 28 % and 33 % (w/v)) of dicyclohexylmethane diisocyanate as the 
hard segment with ethylenediamine as a chain extender. PUs lacking POSS nanoparticles 
served to prove the important function of POSS in maintaining the viscoelasticity of the 
PUs before, during and after degradation. Polymer tensile strength and Young’s moduli 
increase with increasing hard segment content whilst breaking strain was not 
significantly affected. Both in vitro and in vivo degradation studies revealed hard 
segment-dependent modulation of the materials’ viscoelastic properties which was 
attributable to (i) degradation-induced changes in the PU crystallinities and (ii) the 
presence or absence of POSS. The data obtained in this study highlight the influence of 
216 
 
hard segment content and POSS nanoparticles on PU properties. This provide 
opportunities for a higher degree of control over degradation rates and mechanical 
properties which is important for scaffolds intended for tissue engineering and 
regenerative purposes. 
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6.2 INTRODUCTION 
Segmented PUs are amongst the most favoured synthetic polymers used in the 
manufacture of biomedical devices due to their superior biomechanical properties and a 
unique combination of toughness, durability, flexibility and biocompatibility. Generally, 
PUs are synthesized by reacting soft segments of polyesters/polycarbonate with hard 
segment of diisocyanates. Since their discovery by Otto Bayer in 1937, the PU family has 
become the most versatile of any family of plastic materials gaining considerable 
popularity in the biomedical field as pacemaker leads, catheters, vascular grafts and 
prosthetic heart valves (Chawla et al. 1988; Izci et al. 2009; Rahmani et al. 2012; Desai et 
al. 2012). Whilst non-resorbable scaffolds are adequately suited for certain applications, 
their lack of degradation limits their use to the adult population and potentially 
necessitates revision surgeries to replace or remove such scaffolds. Bioresorbable 
scaffolds, on the other hand, must maintain temporary structural integrity within 
relatively harsh wound environments and degrade in a controllable fashion surrounded 
by enzymes and free radicals, pH as well as temperature fluctuations. Numerous 
investigations have studied the biodegradation behaviour of segmented PUs by 
integrating more or less hydrolysable components such as PEG, PLA, and PGA (G. Li et al. 
2012; Rafiemanzelat et al. 2013; Z. Li et al. 2012). However, degradation-induced loss of 
mechanical properties and rapid acidification of the degradation media limit their clinical 
application. Additionally, commonly used biodegradable PUs are based on aromatic 
diisocyanates which break down into  toxic by-products originating from the hard 
segments (Tang et al. 2003; Szycher, M.; Poirier, V.L.; Dempsey 1983b; Gogolewski 1988; 
Marchant, R.E.; Zhao, Q.; Anderson, J.M.; Hiltner 1987; Pinchuk 1994). Hard segments 
based on aliphatic 4,4’-methylenebis (cyclohexylisocyanate) (H12MDI), however, are 
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considered a safer alternative and we have thus developed a segmented nanocomposite 
PU based on degradable poly(ε-caprolactone)diol and H12MDI.  
Biodegradation is influenced by both the chemical and physical properties of the PU; 
surface properties (e.g. surface area and wettability), first order structures (chemical 
structure, molecular weight and molecular weight distribution) as well as higher order 
structures (glass transition temperature, melting temperature, degree of crystallinity and 
elastic modulus) of polymers play fundamental roles in the biodegradation process 
(Tokiwa et al. 2009). It is well known that higher molecular weight PCL (Mn > 4000) is 
more slowly degraded by Rhizopus delemar lipase than that with low Mn (Tokiwa, Y; 
Suzuki 1978). Similarly, polymer morphology, and by extension, their crystallinity affects 
degradation. Crystalline domains consist of tightly packed molecules which are more 
resistant than amorphous regions where hydrolytic or enzymatic attack mainly occurs. 
Within the amorphous region, molecules are loosely packed making them more 
susceptible to degradation. Thus, degradation rate is inversely proportional to the 
crystallinity of the polymer (Iwata and Doi, 1998). Here, we have synthesized POSS-PCLU 
polymers of incrementally increasing hard segment content to evaluate whether or not 
the diisocyanate content may be a suitable parameter in the fine-tuning of polymer 
degradation. Polymers lacking POSS nanoparticles were also synthesized in an effort to 
determine the influence of POSS inclusion on degradation as previous studies have 
attributed an increased resistance to degradative breakdown of PUs when supplemented 
with POSS (Gu et al., 2011). Degradation media spanning oxidative, hydrolytic and 
enzymatic conditions were selected in order to mimic as closely as possible the realistic 
environments encountered upon material implantation into the body. Under certain 
circumstances, in vitro degradation studies may even be considered superior to in vivo 
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implantation studies as each individual degradative condition and their effects exerted 
onto the polymer may be studied separately. 
6.2.1 Oxidative degradation 
Implantable devices may encounter oxidative conditions as particularly leukocytes 
and macrophages involved in the early foreign body reaction are able to produce reactive 
oxygen species such as superoxides (O2-), hydrogen peroxide (H2O2), nitric oxide (NO) 
and hypochloric acid (HOCl) (Labow, Tang, et al. 2002; Williams, D. F.; Zhong 1994). 
Particularly, aliphatic polyesters as used in the present study have been found to be 
susceptible to degradation via the nucleophilic attack of O2- and subsequent cleavage of 
ester bonds (Lee & Chu 2000). This mechanism is believed to be a key component of the 
stress cracking phenomenon frequently observed in long-term implantable PU devices 
(Sutherland et al. 1993). 
6.2.2 Hydrolytic degradation 
Water molecules can attack and break hydrolytically labile chemical bonds, 
breaking polymers into oligomers and finally monomers. Upon implantation, water can 
attack bonds located either on the surface or within the polymeric matrix via water 
uptake. Since hydrolysis can be catalysed by acids or enzymes (Williams, D. F.; Zhong 
1994), implantation of polyesters such as PLA or PGA which have acidic degradation 
products, results in accelerated breakdown due to a process called autocatalysis. A 
further important factor influencing the mode and rate of degradation is the polymer’s 
surface wettability with hydrophilic materials degrading more readily than hydrophobic 
ones. In terms of PUs, hard segment content as well as distribution within the amorphous 
region are postulated to significantly influence hydrolytic degradation as hydrolysable 
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bonds may be masked by compact hard segment micro-domains which can form by 
hydrogen bonding between individual hard segments. 
6.2.3 Enzymatic degradation 
Enzymes are cell-derived proteins capable of accelerating hydrolytic degradation 
processes. Naturally occurring and principally important in the breakdown of substrates 
for facilitated nutrient uptake, enzymes have also been demonstrated to accelerate 
biomaterial degradation (Santerre et al. 1994). The content and distribution of hard 
segments within the polymeric surface was shown to influence the manner in which 
enzymes adsorb and express their activity on the material’s surface so that increasing 
hard segment contents correlated with reduced degradation (Tang et al., 2001, Santerre 
and Labow, 1997). 
6.3 MATERIALS AND METHODS 
6.3.1 Polymer Synthesis 
Please refer to section 4.3.1.1. 
6.3.2 Scaffold Fabrication 
Please refer to section 4.3.1.2.  
6.3.3 In Vitro Degradation  
Accelerated degradation experiments were carried out according to ISO 10993:12 
specification under hydrolytic, enzymatic and oxidative conditions at 37 °C. Cast 
specimen of the different polymers were immersed in 5 mL of (i) sterile PBS, (ii) lipase 
(10 U/mL), (iii) collagenase (10 U/mL), (iv), cholesterol esterase (1 U/mL), or (v) 20 % 
H2O2 in 0.1 M cobalt chloride (CoCl2). Degradation media were changed every week to 
replenish enzymatic/oxidative activities and supernatants containing the degradation 
products were collected for subsequent toxicological analysis. At selected time points, 
221 
 
specimen were washed thrice with sterile distilled water and the air-dried overnight 
before being subjected to analyses. 
6.3.4 Evaluation of In Vitro Degraded Films 
6.3.4.1 1H Nuclear Magnetic Resonance (NMR) Spectroscopy 
Please refer to section 4.3.4.2.1. 
6.3.4.2 Gel Permeation Chromatography (GPC) 
Please refer to section 4.3.4.2.3. 
6.3.4.3 Differential Scanning Calorimetry (DSC) 
Please refer to section 4.3.4.3.1. 
6.3.4.4 X-Ray Diffraction (XRD) Crystallography 
Please refer to section 4.3.4.3.2.  
6.3.4.5 Attenuated Total Reflectance (ATR)-Fourier Transform Infrared (FTIR) 
Spectroscopy 
Please refer to section 4.3.4.2.2. 
6.3.4.6 Scanning Electron Microscopy (SEM) Evaluation of Surface Changes  
Differences in scaffold surface microscopic appearances were evaluated using SEM 
digital photography at magnifications of x 100, x 500 and x 1000. Degraded scaffolds were 
washed with PBS and air-dried for a minimum of 3 days. No dehydrating alcohol series 
was used for this purpose since exposure to ethanol significantly changes surface 
structures as demonstrated in chapter 5. Then, samples were mounted on aluminium 
stubs and sputter-coated with gold using an SC500 (EMScope) for electrical conductance. 
Photographs were taken using a Philips 501 scanning electron microscope.  
6.3.4.7 Static Contact Angel Measurement to Determine Surface Wettability 
Please refer to section 4.3.4.1.3. 
6.3.4.8 Tensiometry 
Please refer to section 4.3.4.3.3. 
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6.3.5 Cell Viability 
6.3.5.1 Preparation of Medium Containing Degradation Products 
Throughout the polymer degradation study, the degradation medium was renewed 
once a week to replenish enzymatic or peroxide activity. The old medium was collected 
and stored in -80 °C until further use. Prior to starting extract cytotoxicity studies, the 
media containing polymer leachables were filter sterilized and mixed with fresh medium 
at a range of concentrations (0 – control, 10, 50, and 70 % v/v).      
6.3.5.2 In Vitro Cytocompatibility of Leachables 
The cytocompatibility of any products released by the degradation of POSS-PCLU 
with varying percentage hard segments and PCLU-24 was assessed according to ISO 
standard 10993-5 using HDFa. Cells were seeded onto tissue culture plastic of 24-well 
plates at low densities of 2 x 104 cells/cm2 in complete culture medium. After 24 h, cells 
were microscopically assessed and subconfluency was verified. Medium was removed 
and replaced with fresh medium containing PU leachables at different concentrations. 10 % 
dimethylsulfoxide (DMSO) served as the positive control (Bae et al. 2012; Hua, K.; 
Carlsson, D.O.; Alander, E.; Lindström, T.; Stromme, M.; Mihranyan, A.; Ferraz 2014) and 
cells grown in complete medium with no added leachables were the negative control. 
Cytotoxicity was defined as cell viability below 70 % of the negative control as defined by 
the ISO standard 10993-5. 
At 6 h, 24 h, 72 h and 7 days, cell viability and proliferative capacity were assessed 
using AlamarBlue® cell proliferation assay. 
6.3.6 Animals 
26 male healthy Sprague-Dawley rats weighing 270-300 g were acclimatized for 1 
week prior to any experimental procedure. All animals were housed in special facilities 
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with controlled temperatures (24 ±1 °C) and a 12 h light/dark cycle. Animals had liberal 
access to water and a standard rat diet.  
6.3.6.1 Scaffold Implantation into Animals 
Eight week old rats were anaesthetised with isofluorane and a dorsal midline 
incision was created. Two porous scaffolds were implanted subcutaneously on either side 
of the midline. Round scaffolds (1 mm thickness, 16 mm diameter) were obtained using 
a cutting press, sterilized in 70 % ethanol and then washed 3 times with sterile PBS before 
implantation. One central suture restricted disc migration and folding in on itself. 
6.3.6.2 In Vivo Blood Flow and Oxygenation of Scaffolds 
At 4, 8, and 12 weeks, animals were anaesthetized using isofluorane and scaffolds 
were exposed. Real-time blood flow and scaffold oxygenation were measured using 
MoorFLPI Laser Doppler imager (Moor Instruments, Devon, UK) and VisisensTM oxygen 
sensor (PreSens, Regensburg, Germany), respectively.  
6.3.6.3 Scaffolds and Organ Harvest and Preparation for Histology 
After assessment of scaffold blood flow and oxygenation, animals were sacrificed 
humanely and both scaffolds and end organs (liver, spleen, brain, lung, and kidney) were 
harvested and placed in 4 % paraformaldehyde. Fixed samples were processed 
conventionally to produce 4 mm thin paraffin sections and stained with haematoxylin 
and eosin (H&E) or MSB (Martius, Scarlet and Blue) stain. Sections were analysed by a 
consultant histopathologist blinded to the study objectives.  
6.3.6.4 Immunostaining of Explanted Scaffolds 
Vascular infiltration of scaffolds was determined using goat polyclonal anti-rat 
CD31 (Santa Cruz) which identifies endothelial cells. Formalin fixed samples were cut at 
5mm, dewaxed, rehydrated and antigen retrieval performed for CD31 by microwaving in 
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500 mL Tris and EDTA for 3 min. Sections were then incubated in 5 % H2O2 in methanol 
to block endogenous peroxidase and incubated with the primary antibodies with normal 
rabbit or horse serum for 1 h at room temperature at the following dilutions of 1:300. The 
sections were then washed in phosphate buffered saline and incubated with biotinylated 
secondary stage antibody (rabbit anti goat for CD31) for 30 min and the reaction product 
was visualised by DAB. Sections were counterstained using Harris haematoxylin. 
6.3.7 Statistics 
Please refer to section 4.3.6. 
6.4 RESULTS AND DISCUSSION 
6.4.1 Synthesis and Molecular Characterization of Degraded POSS-PCLU Films 
The PCLU or POSS-PCLU PUs were synthesized from polycaprolactone diol with 
different dicyclohexylmethane diisocyanate contents, i.e. 24 %, 28 % and 33 %, using an 
ethylenediamine chain extender. The synthesis pathway is described in Figures 4.2 and 
4.3 and the composition is defined in Table 4.1. The chemical structures of POSS-PCLU 
PUs were verified by 1H NMR spectroscopy (Fig. 4.4). The range of hard segment content 
was as stated since below 10 %, hard segments have been demonstrated to offer only 
insufficient crosslinking capacity resulting in poor mechanical performance (Li, F.K.; 
Zhang, X.; Hou, J.N.; Xu, M.; Lu, X.L.; Ma, D.Z.; Kim 1997). Too high a hard segment content, 
on the other hand significantly interferes with hydrolytic or oxidative degradation due to 
stearic hindrance of chain scission sites by H-bonds. The synthesized PUs exhibited 
similar FTIR features but subtle NMR differences at 1.6 ppm. Such similarities are to be 
expected considering that PCLU is the major component. However, the small 
spectroscopic variations are congruent with the use of different concentrations of hard 
segment. Similarly, no significant differences were observed using DSC. Both soft and 
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hard segment Tg of all non-degraded polymers were in the range of -52.9 °C to -55.5 °C 
and +40.8 °C to +53.3 °C, respectively.  
The number average molecular weight (Mn) and molecular weight distributions 
(polydispersity index, PDI) of all polymers were analysed using GPC. Table 6.1 
summarizes the number average molecular weights and PDI of all variations of the PU 
degraded in each buffer for the maximum period of 6 months.  
 
Table 6.1. Composition, percentage crystallinity, number average molecular weight (Mn) 
and polydispersity indices (PDI) of control non-degraded PU films and films degraded in 
various buffers for a period of 6 months. 
Materials Degradation buffer χ (%) a Mn (x 104 g/mol) b Mw/Mn b 
PCLU-24 Control - 11.5 1.7 
 PBS - 11.9 1.5 
 Lipase 17.2 1.0 2.0 
 Collagenase 0.4 10.4 1.7 
 Cholesterol esterase 2.1 7.6 1.8 
 Hydrogen peroxide + CoCl2 37.3 0.6 1.9 
POSS-PCLU-24 Control - 11.9 1.4 
 PBS - 10.4 1.5 
 Lipase 19.4 1.0 1.9 
 Collagenase 0.4 9.2 1.6 
 Cholesterol esterase 1.3 7.6 1.7 
 Hydrogen peroxide + CoCl2 35.8 0.5 1.8 
POSS-PCLU-28 Control - - - 
 PBS - - - 
 Lipase 9.3 0.8 1.9 
 Collagenase 9.0 13.4 2.1 
 Cholesterol esterase - - - 
 Hydrogen peroxide + CoCl2 6.6 0.7 2.0 
POSS-PCLU-33 Control - - - 
 PBS - - - 
 Lipase 3.4 - - 
 Collagenase - - - 
 Cholesterol esterase - - - 
 Hydrogen peroxide + CoCl2 11.8 0.7 1.9 
Key: POSS, polyhedral oligomeric silsesquioxane; PCLU, poly(ε-caprolactone urea)urethane; a χ was determined by DSC. 
b Mn and Mw/Mn were determined by GPC. - = Values unavailable as samples did not dissolve in DMAc which suggests 
insignificant degrees of degradation. 
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The symmetrical bell shape and narrow distribution of the control non-degraded 
PUs demonstrate successful and complete polymerization. The molecular weights of 
these controls ranged from 11.5 x 104 to 11.9 x 104 g/mol with their corresponding 
molecular weight distributions between 1.4 and 1.7. (Table 5.1). The Mn was seen to 
decrease with increasing hard segment content due to a corresponding decrease in the 
proportion of PCL which is the highest Mn component in the PUs. In addition, POSS-
containing PUs show a higher Mn than PCLU-24 without POSS nanoparticles due to the 
additional molecules (POSS Mw ~ 1 kDa). Contrary to expectations, no significant trend 
could be observed between POSS inclusion and Mn post-degradation indicating too small 
a fraction of POSS inclusion (2 %). 
Exposure to lipase and hydrogen peroxide buffers resulted in the most significant 
mass losses, highest PDI and relatively higher crystallinities, consistent with previous 
reports (Shoae-Hassani et al., 2013a, Shoae-Hassani et al., 2013b, Guasti et al., 2013). 
Increasing the hard segment content predictably resulted in better resistance to 
degradation as demonstrated by incrementally decreasing crystallinities coupled to 
higher molecular weights (Table 5.1). POSS nanoparticle addition, however, did not seem 
to induce any changes in degradation behaviour as postulated by Mather group (Gu et al., 
2011). This discrepancy is likely due to the significantly smaller percentage fraction of 
POSS integrated into our polymeric systems (2 % versus 20 %). The normalized number 
average molecular weights (Mn) for PCLU-24, POSS-PCLU-24, POSS-PCLU-28 and POSS-
PCLU-33 exhibited a clear reduction during degradation (Fig. 6.1). At the final time point 
of this study (6 months in buffer solutions), PUs exposed to lipase and hydrogen peroxide 
buffer demonstrated the most significant reductions in Mn of > 90 %. This is consistent 
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with a combination of general bulk degradation coupled to some enzymatic surface 
erosion (Uhrich et al., 1999). 
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Figure 6.1. Mass loss over time after degradation in PBS, lipase, collagenase, cholesterol esterase 
and hydrogen peroxide buffers. (A) PCLU-24 and (B) POSS-PCLU-24. Degraded samples of POSS-
PCLU-28 and POSS-PCLU-33 could not be sufficiently dissolved in solvent and data is therefore 
missing. 
 
Exposure to PBS for 6 months resulted in only minor degradation (< 15 %) 
suggesting limited hydrolytic scission of water-labile ester linkages. Extensive hydrogen-
bonding between hard segment micro-domains has previously been suggested to mask 
cleavage sites, thus retarding degradation (Santerre and Labow, 1997). Similarly, bathing 
in collagenase buffer for 6 months resulted in less severe degradation compared to 
exposure to lipase and hydrogen peroxide buffers. A maximum loss in Mn of < 25 % was 
evident for collagenase-degraded PUs. Again, correlations between hard segment content 
and mass loss were evident. This oft-suggested theory of hard segment content-
dependent protective micro-domain formation is also reflected in our ATR-FTIR and DSC 
results (see below).   
(A) (B) 
228 
 
Material surface chemistries of non-degraded PCLU-24 and POSS-PCLU-24, POSS-
PCLU-28 and POSS-PCLU-33 were analysed using attenuated total reflectance (ATR)-
Fourier transform infrared (FTIR) spectroscopy and the spectra were overlaid for 
comparison (Fig. 6.2).  
 
 
 
 
      
Figure 6.2. Overlaid attenuated total reflectance (ATR)-Fourier transform infrared (FTIR) spectra 
of films after 6 months in (A) PBS, (B) lipase buffer, (C) collagenase buffer, (D) cholesterol esterase 
buffer and (E) hydrogen peroxide + CoCl2 buffer.  
 
(A) PBS (B) Lipase 
(C) Collagenase (D) Cholesterol esterase 
(E) Hydrogen peroxide 
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All control polymers exhibit common peaks at 2929 cm-1 and 2861 cm-1 which 
correspond to the alkyl groups of the hard segment, H12MDI. The peaks at 1726 cm-1 and 
1159 cm-1 represent the carbonyl (C=O) region of non-hydrogen-bonded urethane and 
the ester (O-C-O) absorbance of the soft segment, respectively. The heights of the latter 
two peaks are negatively correlated with increasing hard segment content. In the case of 
the C=O bond of the non-hydrogen-bonded urethane bonds, the lower height with higher 
percentage hard segment is due to the fact that in high hard segment polymers, most 
urethane bonds are hydrogen-bonded, leaving a smaller fraction of urethane bonds non-
bonded.  
With increasing hard segment content, the spectral peaks corresponding to 
hydrogen-bonded urethane (1633 cm-1) and urea (1551 cm-1) bonds increase in height 
providing a qualitative measure of bond content. Both PCLU-24 and POSS-PCLU-24 
containing the lowest amount of hard segment demonstrate relatively smaller peaks 
compared to the polymers of higher hard segment content. Similarly, polymers 
containing POSS nanoparticles exhibit a high peak at around 1094 cm-1 whilst PCLU-24 
does not.  
6.4.2 Thermal Properties of Degraded POSS-PCLU 
Segmented PUs display several thermal transitions, corresponding to the 
microstructure of the soft and hard domains. The thermal properties of cast control and 
degraded POSS-PCLU films with different percentage hard segments are summarized in 
Table 6.2.  
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Table 6.2. Thermal properties of (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-PCLU-28 and 
(D) POSS-PCLU-33 PUs. 
 
Materials Degradation buffer Tg (°C) a Tm  (°C) a 
Soft segment Hard segment 
PCLU-24 Control -54.8 51.1 - - 
PBS -55.4 41.7 - - 
Lipase -50.4 14.8 38.8 47.7 
Collagenase -55.1 - 43.7 - 
Cholesterol esterase -55.9 0.0 41.4 - 
Hydrogen peroxide + CoCl2 -23.5 - 46.4 - 
 
 
 
Materials Degradation buffer Tg (°C) a Tm  (°C) a 
Soft segment Hard segment 
POSS-PCLU-24 Control -52.9 40.8 - - 
PBS -56.7 39.4 - - 
Lipase -49.4 14.4 39.5 51.8 
Collagenase -54.9 - 41.8 - 
Cholesterol esterase -56.8 - 41.4 - 
Hydrogen peroxide + CoCl2 -24.3 - 45.8 52.7 
 
 
 
Materials Degradation buffer Tg (°C) a Tm  (°C) a 
Soft segment Hard segment 
POSS-PCLU-28 Control -55.4 52.5 - - 
PBS -56.3 52.5 - - 
Lipase -51.7 12.8 37.8 48.7 
Collagenase -52.6 - 39.4 50.2 
Cholesterol esterase -56.5 53.8 - - 
Hydrogen peroxide + CoCl2 -46.8 - 37.7 49.3 
 
 
  
Materials Degradation buffer Tg (°C) a  Tm  (°C) a 
Soft segment Hard segment 
POSS-PCLU-33 Control -55.5 54.1 - - 
PBS -56.2 52.1 - - 
(D) 
(C) 
(B) 
(A) 
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Lipase -54.4 11.5 39.5 49.4 
Collagenase -56.3 - - - 
Cholesterol esterase -56.4 - - - 
Hydrogen peroxide + CoCl2 -44.8 - 40.2 51.9 
Key: POSS, polyhedral oligomeric silsesquioxane; PCLU, poly(ε-caprolactone urea)urethane 
a Tg, Tm, ΔHm and χ were determined by DSC 
 
In general, soft segment glass transition temperatures, Tg, of POSS-PCLU and PCLU 
were independent of the hard segment content (ranging from 24 % - 33 %) indicating 
limited hard segment mixing within the soft domain. Similar results were found with PU 
systems based on poly(ethylene oxide), poly(tetramethylene oxide) and poly(propylene 
oxide) with comparable hard segment contents (Sung, C.S.P.; Hu, C.B.; Wu 1980; O’Sickey, 
M.J.; Lawrey, B.D.; Wilkes 2002; Korley et al. 2006). Tg of the PCLU soft segments ranged 
from approximately -60.0 °C for the control, non-degraded sample to -25 °C after 
oxidative degradation. The Tg shift to higher temperatures induced by the different 
degradation media indicates a degree of phase mixing between the soft and hard segment 
of the PU and crystallization of amorphous areas (Skarja & Woodhouse 1998). Oxidative 
conditions were seen to induce the most drastic increase in Tg, particularly in samples of 
relatively lower hard segment content, suggesting strong interactions between soft and 
hard segments secondary to degradation. Previous studies have confirmed the formation 
of hard segment micro-domain structures in segmented PUs which can protect or mask 
potential cleavage sites within their hard segments (i.e. urea and urethane bonds) via 
formation of an extensive network of hydrogen bonds (H-bonds) (Santerre & Labow 1997; 
Shibayama, M; Kawauchi, T.; Kotani, T.; Nomura, S.; Matsuda 1986). Thus, with increasing 
hard segment content, the extent of urethane H-bonding also increases, resulting in 
delayed degradation. This protective phenomenon was, indeed, present in the samples 
232 
 
with relatively higher hard segment content which resisted a significant increase in Tg 
post-degradation. 
None of the control polymers exhibited hard segment crystallization and hard 
segment Tg ranging from approximately 40 °C to 55 °C which is just below that observed 
by Skarja et al. (Skarja & Woodhouse 1998). This means that the hard segments of all 
control polymers are amorphous at room or body temperature (Skarja & Woodhouse 
1998) which may be due to a lack of efficient chain packing necessary for hard segment 
crystallization (Okkema & Cooper 1991) secondary to the mobile aliphatic diisocyanate 
(Szycher, M.; Poirier, V.L.; Dempsey 1983a) and the presence of bulky side-chains on the 
chain extender (ethylene diamine). 
Endothermic melting peaks were observed in samples exposed to lipase, 
collagenase, cholesterol esterase and hydrogen peroxide between 35 °C and 50 °C which 
were attributed to the melting of the crystalline portions of the soft segment (Shibayama 
et al. 1991). Double endotherms could be observed in all films exposed to lipase and 
hydrogen peroxide (Fig. 6.3) whilst no endothermic peaks were seen in control and PBS 
exposed samples, indicative of a mostly amorphous starting polymer and negligible 
degradation in PBS-exposed samples. Collagenase exposure induced the formation of a 
double melting peak only in POSS-PCLU-28 after 6 months and a small single endothermic 
peak in POSS-PCLU-24 after the same exposure period. Cholesterol esterase exposure did 
not induce melting peaks in any of the samples except PCLU-24 where a single small 
endothermic valley can be observed after 6 months of exposure. Double endothermic 
peaks may indicate the presence of either two distinct types of crystals or the 
recrystallization of a metastable crystal into a more stable form with increasing 
temperatures within polymorphic structures. 
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Figure 6.3. Differential scanning calorimetry graphs of (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-
PCLU-28 and (D) POSS-PCLU-33 films; (a) non-degraded control film, (b) in PBS, (c) in lipase 
buffer, (d) in collagenase buffer, (e) in cholesterol esterase buffer and (f) in hydrogen peroxide + 
CoCl2 buffer. Incubation period for all was 6 months. 
 
The latter underlies the principles of Ostwald’s rule of stages which states that when 
a material crystallises, it will move to equilibrium from an initial high-energy state (e.g. 
glass) via a cascade of stages requiring minimal changes in free energy. This implies that 
the sample will crystallise in sequence beginning with the least stable polymorph and 
progressing through any further metastable polymorph to the stable crystalline form 
(Ostwald 1897). 
(A) (B) 
(C) (D) 
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The melting temperature and percentage crystallinity are affected by the soft 
segment content and its molecular weight (Tokiwa et al. 2009). After oxidative and 
enzymatic degradation with hydrogen peroxide and lipase, respectively, the degree of 
crystallinity was positively correlated with the relative amounts of soft segments in the 
study samples, such that percentage crystallinity followed: PCLU-24 > POSS-PCLU-24 > 
POSS-PCLU-28 > POSS-PCLU-33. The higher the hard segment content within the samples, 
the lower the relative soft, crystallizable portion which is reflected in the DSC 
thermograms. Additionally, increases in soft segment Tg were correlated with higher 
percentage crystallinity induced by degradation (Fig. 6.4) and increased crystallinity 
resulted in a reduction in Tg step height secondary to a reduction in the amorphous 
content (Fig. 6.5).  
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Figure 6.4. Soft segment glass transition temperatures (Tg(s)) as a function of percentage 
crystallinity of control and degraded (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-PCLU-28 and (D) 
POSS-PCLU-33 polymers. 
(A) (B) 
(C) 
(D) 
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 This is likely due to increased phase mixing secondary to shorter chain length and 
thus reduced molecular weight of the soft segment. For reference, the crystal melting 
temperature for pure PCL is 57 °C (Engelberg & Kohn 1991) which was higher than those 
observed in the degraded samples, suggestive of phase mixing. 
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Figure 6.5. The normalized step height of the specific heat at Tg as a function of crystallinity. 
 
A small exothermic transition was detected towards the lower temperature side of 
the main endothermic peaks in all those samples exhibiting melting peaks and was 
attributed to the crystallization transition (Tc).  
XRD studies on films exposed to oxidative medium for the total period of 6 months 
revealed PCL peaks at 2θ = 21.3° and 23.7° for all PUs, in accordance with previous 
studies (Chan-Chan et al., 2010a). Similarly, exposure to lipase and collagenase buffers 
resulted in these PCL peaks, albeit at lower intensities (Fig. 6.6).  
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Figure 6.6. XRD patterns of degraded (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-PCLU-28 and (D) 
POSS-PCLU-33. Degradation time was 6 months. 
 
This so-called peak splitting is suggestive of the presence of different crystalline 
domains within some degraded films (Lee and Chu, 2008). This hypothesis is 
corroborated by the presence of double endothermic melting peaks on DSC traces of 
those samples which display peak splitting on XRD. 
Diffractograms of films degraded in hydrogen peroxide revealed further peaks at 2θ 
= 8° and 29.6° as well as broad shoulders at 15.7° and 19.2°. Neither cholesterol esterase 
buffer nor PBS incubation revealed peaks, suggestive of a lesser degree of degradation 
and relative conservation of the amorphous PU structure. Comparisons between different 
time points indicate a time-dependent formation of crystal structures which can also be 
observed in the DSC traces. These results suggest a condition- and time-dependent 
breakdown of the mostly amorphous PU into semicrystalline structures secondary to 
degradation-induced changes.  
(A) (B) 
(C) (D) 
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6.4.3 Degradation-Induced Changes in Mechanical Properties 
Mechanical properties of all PUs were affected by incubation in all buffers. The 
representative stress-strain curves for all materials before and after incubation in normal 
saline, enzymatic or oxidative buffers are shown in Figure 6.7. Overlaid on those graphs 
are the Young’s moduli, a measure for material stiffness. Specific degradation points (1, 4 
and 6 months) were chosen for mechanical evaluation but even after 4 weeks, PCLU-24 
incubated in lipase or hydrogen peroxide buffer disintegrated, making tensile testing 
impossible. In general, both tensile strength and Young’s modulus increased with 
increasing hard segment content for control non-degraded films which is likely due to 
increased crystalline to amorphous content ratio within the PUs leading to better phase 
separation as well as urethane bond interactions (Tatai et al., 2007).  
 
 
 
 
(A) 
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(B) 
(C) 
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Figure 6.7. Stress-strain curves overlaid against Young's moduli for (A) PCLU-24, (B) POSS-PCLU-
24, (C) POSS-PCLU-28 and (D) POSS-PCLU-33. Degradation time was 6 months. 
 
Degradation of PU films resulted in significant changes in mechanical properties, 
contrary to previously published reports (Gu et al., 2011). Differences in outcomes may 
be attributable to major differences in incubation periods with short time spans (days 
rather than months) failing to induce changes and thus potentially misrepresenting long-
term properties of investigated materials. In general, films incubated in any degradation 
buffer exhibited higher values for stress and strain at break, indicative of increased phase 
separation induced by degradation. 
In the current study, films incubated in collagenase buffer for 6 months exhibited 
the largest increase in both Young’s modulus and tensile strength whilst retaining 
dependence on the hard segment content as observed for non-degraded control films 
(films exposed to lipase buffer or hydrogen peroxide became too brittle to handle after 6 
(D) 
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months and thus were not included for mechanical analysis). This suggests a degradation-
induced influence on these mechanical parameters. However, films not containing any 
POSS nanoparticles (PCLU-24) demonstrated the highest increase in Young’s modulus 
compared to their compositional equivalent containing POSS (POSS-PCLU-24). This 
suggests a major role for POSS in protecting PUs from degradation induced loss in 
material elasticity. We can hypothesize that POSS nanoparticles potentially act as cross-
linking agents as suggested by Mather’s group (Wu et al., 2009). Cholesterol esterase 
buffer did not significantly impact upon the Young’s modulus after 6 months’ of 
incubation, however, a negative trend in modulus after PBS exposure could be observed 
for all PU films. This is likely due to a lack in phase mixing which is usually expected 
during degradation. Thus, significant phase separation results in dispersion of the 
crystalline hard segment within the amorphous region of the PU as supported by the lack 
of crystallinity data obtained using DSC spectral results. Small Young’s moduli are 
generally believed to suffer from high strain accumulation resulting in poor durability, 
thus compromising a material’s in vivo stability (Bernacca et al., 2002).  
6.4.4 Contact Angle Measurements  
Polymer hydrophilicity is an important parameter in their hydrolytic degradation. 
Hydrolysis requires the reaction between water and labile ester bonds and the reaction 
velocity depends on the abundance of both water and ester bonds. Thus, hydrophilic 
polymers capable of attracting water molecules generally degrade more rapidly than 
hydrophobic polymers presuming the ester bond concentration remains relatively stable 
(Göpferich 1996). Control non-degraded POSS-PCLU polymers did not exhibit significant 
differences in contact angle with a mean hydrophobic θ of 105°. PUs lacking POSS 
nanoparticles predictably were more hydrophilic as POSS is known to increase 
hydrophobicity when incorporated into polymeric systems (Schutzius et al., 2012).   
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Upon degradation, contact angles were shown to gradually decrease, in line with 
expectations (Fig. 6.8). As degradation progresses, the PCL component is preferentially 
broken down due to hydrolytically labile ester bonds. A reduced amorphous soft segment 
component thus favours relatively increased phase mixing which results in the polar hard 
segments aggregating at the material surface. This, in turn, reduces contact angle. It can 
further be observed that with higher starting hard segment content, degradation-induced 
increases in material hydrophilicity are more pronounced due to the relatively more 
polar segments within the degraded material. 
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Figure 6.8. Water contact angles of (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-PCLU-28 and (D) 
POSS-PCLU-33 at 4 weeks (TP1), 12 weeks (TP2) and 24 weeks (TP3). No contact angles could be 
obtained for the following due to disintegration: PCLU-24 in lipase buffer TP3, PCLU-24 in 
hydrogen peroxide + CoCl2 buffer TP1, TP2 and TP3, POSS-PCLU-24 in hydrogen peroxide + CoCl2 
(C) 
(B) 
(D) 
(A) 
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buffer TP1, TP2 and TP3, POSS-PCLU-28 in hydrogen peroxide + CoCl2 buffer TP2 and TP3, POSS-
PCLU-33 in hydrogen peroxide + CoCl2 buffer TP3. 
 
6.4.5 Surface Changes Induced by Degradation 
From a macroscopic point of view, degraded polymer films exhibited significant 
differences depending on the incubation buffer (Fig. 6.9).  
 
 
Figure 6.9. Macroscopic image of polymer films after 6 months in degradative media. 
 
Similarly, the microscopic surface morphology of enzymatically degraded PUs 
demonstrated differences when investigated by SEM analysis and compared with non-
degraded control PUs (Fig. 6.10). All films except PCLU-24 revealed spherical micro-
particulates on their surfaces which we hypothesize can be assigned to micro-aggregates 
of POSS nanoparticles as they cannot be seen in films lacking POSS (Gao et al., 2004). 
Compared to control films, all degradation buffers induced surface changes in the tested 
PUs. All films incubated in lipase buffer displayed uniform roughened and porous 
surfaces, indicating a surface-erosion mechanisms which is typical of enzymatic attack 
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(Christenson et al., 2006). Gradual degradation from non-porous into porous films 
enables these PU scaffolds to be used as delivery vehicles for a multitude of molecules 
such as drugs or genes (Peng et al., 2013). Films exposed to cholesterol esterase and 
hydrogen peroxide buffer, on the other hand, revealed significant stress-cracking 
associated with degradation. This is of clinical significance as inflammatory cells 
including monocyte-macrophages release both cholesterol esterases and oxidants 
capable of degrading PUs (Tang et al., 2001, Li et al., 1997). Overall, most degradative 
changes could be observed in films exposed to lipase and hydrogen peroxide buffers 
which is in agreement with results obtained by GPC and mechanical characterization. 
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Figure 6.10. Scanning electron microscopy images of: (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-
PCLU-28 and (D) POSS-PCLU-33: (i) control, (ii) in PBS for 6 months, (iii) in lipase buffer for 6 
months, (iv) in collagenase buffer for 6 months, (v) in cholesterol esterase buffer for 6 months and 
(vi) in hydrogen peroxide + CoCl2 buffer for 6 months. 
 
6.4.6 Cytocompatibility of Degradation Products 
Figure 6.11 shows the cell culture media supplemented with increasing 
concentrations of leachable solution.  
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Figure 6.11. Media containing filter-sterilized leachables from degraded polymers at 10 % v/v, 
50 % v/v and 70 % v/v. 
 
In general, a time- and concentration-dependent decrease in cellular viability was 
observed when HDFa were incubated with degradation extracts of any PU (Fig. 6.12 to 
6.16). In addition, toxicities seemed to be related to the hard segment content in the PUs. 
Higher hard segment PUs translated into lower cell viability. The results of this toxicity 
study were unexpected as theoretically, no component of the POSS-PCLU nanocomposite 
polymer is toxic individually (Rizvi et al., 2012). Similarly, H12MDI as opposed to MDI hard 
segment was utilized due to its superior biocompatibility (Hafeman et al., 2011). Most 
interestingly, previous studies using similar PU compositions to the one currently under 
investigation reported cytocompatibility and non-toxicity (Ahmed et al., 2013). Also, in 
vivo subcutaneous implantation studies of PCLU and POSS-PCLU variations revealed no 
significant inflammatory response (see below). We hypothesize that acidic degradation 
products were responsible for cell death rather than true cytotoxicity of the metabolites 
(Taylor et al., 1994). Taken together, these cytocompatibility results, whilst indicative of 
Lipase PBS Collagenase Hydrogen peroxide 
+ CoCl2 
Cholesterol 
esterase 
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potential toxicity, may not be extrapolated directly into an in vivo setting as the body’s 
circulatory potential is expected to flush away materials which may cause harm at high 
concentrations. Here, we used volume percent concentrations of degradation extracts to 
simulate highest concentrations of leachables closest to the implanted PU scaffold with 
gradually decreasing concentrations further away. One limitation of this study appears to 
be the incrementally decreasing percentage of growth medium which may be an 
explanation as to the concentration-dependent decrease in cell viability. More realistic 
means of analysis, therefore, include in vivo exposure studies over a sufficient time period. 
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Figure 6.12. AlamarBlue® cell viability assay over a period of seven days. HDFa were cultured in 
media containing extracts of polymers degraded in phosphate buffered saline for 6 months. 
Increasing concentrations of extracts represent the in vivo scenario where highest extract 
concentrations can be found in close proximity to the polymer scaffold. 
 
 
 
 
 
(A) PCLU-24 (B) POSS-PCLU-24 
(C) POSS-PCLU-28 (D) POSS-PCLU-33 
* * 
* * 
* * 
* 
* 
* * 
* 
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Figure 6.13. AlamarBlue® cell viability assay over a period of seven days. HDFa were cultured in 
media containing extracts of polymers degraded in lipase buffer for 6 months. Increasing 
concentrations of extracts represent the in vivo scenario where highest extract concentrations can 
be found in close proximity to the polymer scaffold. 
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Figure 6.14. AlamarBlue® cell viability assay over a period of seven days. HDFa were cultured in 
media containing extracts of polymers degraded in collagenase buffer for 6 months. Increasing 
concentrations of extracts represent the in vivo scenario where highest extract concentrations can 
be found in close proximity to the polymer scaffold. 
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Figure 6.15. AlamarBlue® cell viability assay over a period of seven days. HDFa were cultured in 
media containing extracts of polymers degraded in cholesterol esterase buffer for 6 months. 
Increasing concentrations of extracts represent the in vivo scenario where highest extract 
concentrations can be found in close proximity to the polymer scaffold. 
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Figure 6.16. AlamarBlue® cell viability assay over a period of seven days. HDFa were cultured in 
media containing extracts of polymers degraded in hydrogen peroxide + CoCl2 buffer for 6 months. 
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Increasing concentrations of extracts represent the in vivo scenario where highest extract 
concentrations can be found in close proximity to the polymer scaffold. 
 
6.4.7 In Vivo Blood Flow and Oxygenation 
Subcutaneous integration and the extent of vascularization were assessed visually, 
using a laser Doppler imager and an oxygen sensor (Fig. 6.17). Animals were 
anaesthetized and scaffolds were exposed. Visual comparison between scaffolds of 
different hard segment and different lengths of implantation revealed obvious 
dimensional differences. POSS-PCLU-33 scaffolds implanted for the shortest period (4 
weeks) appeared to retain most of their size compared to PCLU-24 scaffolds implanted 
for 12 weeks which were smallest. 
 
 
Figure 6.17. Macroscopic view of subcutaneously implanted scaffolds at (A) 4 weeks and (B) 12 
weeks. (C) Laser Doppler calibration using full fat milk and (D) analysis of vascularized scaffolds 
(A) (B) 
(C) (D) 
(E) (F) (G) 
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prior to explantation. (E-G) Monitoring of oxygen transfer from scaffolds through an oxygen sensor 
film as a measure of scaffold vascularization. 
 
All scaffolds, however, appeared to be firmly integrated with the subcutaneous 
tissue and encapsulated in a highly vascularized fibrous sheath. Qualitative 
measurements of the extent of superficial scaffold vascularization were obtained using 
laser Doppler imaging and oxygen sensing, the premise being that vascularized scaffolds 
would be able to carry oxygen to the scaffold surface which could be detected by a sensor 
foil placed onto the scaffold. The intensity of the change in colour of the sensor foil 
determined the extent of vascularization. Whilst relatively non-specific as a stand-alone 
analytic tool, combined with histological and immunohistochemical analyses, the ability 
and extent of vascularization may be confidently determined. 
6.4.8 Histological and Immunohistochemical Analysis of Explanted Samples 
At 12 weeks post-implantation, gross evaluation of explanted scaffolds and 
surrounding tissues revealed no signs of infection (Fig. 6.18).  
 
 
Figure 6.18. Histological haematoxylin & eosin stain of (A) non-implanted control scaffold and (B) 
implanted scaffold. Magnification x 200. 
 
As expected, scaffold degradation visibly increased in the following order: POSS-
PCLU-33, POSS-PCLU-28, POSS-PCLU-24 and PCLU-24 (Fig. 6.19). Arguably, PCLU-24 was 
(A) (B) 
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more degraded compared to its POSS-containing counterpart, supporting the hypothesis 
of POSS-induced slowing of degradation. Some polymers folded up on themselves despite 
the central suture. This, however, did not result in brittle fracture, underlining the elastic 
nature of these scaffolds.  
 
 
Figure 6.19. Histological comparison of the extent of connective tissue regeneration and in vivo 
degradation of scaffold groups. (A) PCLU-24, (B) POSS-PCLU-24, (C) POSS-PCLU-28 and (D) POSS-
PCLU-33. Magnification x 200. 
 
 Histological examination of the polymer sections (H&E) demonstrated that each PU 
group supported cellular infiltration and connective tissue ingrowth which traversed 
from the periphery of the polymer scaffold through to the opposite side. Cells initially 
populated the pores of the scaffolds before breaking through the polymeric structures to 
infiltrate the scaffold proper. Matrix deposition was accompanied by blood vessel 
formation as can be seen in Figures 6.20 and 6.21 (arrows). 
(A) (B) 
(C) (D) 
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Figure 6.20. Haematoxylin & eosin stained images of PCLU-24 after 4 weeks (A) and 8 weeks (C) 
and corresponding MSB stained images (B and D). The arrows indicate noticeable integration of 
the tissue infiltrate with the scaffold (C) and marked collagen deposition (D). Magnification x 100. 
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Figure 6.21. MSB stained POSS-PCLU-24 (A) and POSS-PCLU-33 (B) at 4 weeks demonstrating 
increased degradation of scaffolds of lower hard segment. (C) Vascular infiltration visible at 4 
weeks post-implantation. Magnification x 100 (A and B) and x 400 (C). 
 At 4 weeks post-implantation, 50 % of the PCLU-24 graft was populated with cells 
and a moderate amount of vasculature and collagen formation. At 12 weeks post-
implantation, collagen deposition was more abundant. Similar trends were observed for 
POSS-PCLU-24 scaffolds. However, more abundant collagen deposition and vascular 
infiltration was noticed at the 12 week time point. Scaffolds of higher hard segment 
content initially revealed significantly less cellular infiltration compared to softer 
scaffolds but demonstrated cellular proliferation rates similar to those observed in the 
softer scaffolds, indicating slower degradation of the PU scaffolds and thus slower tissue 
infiltration. After eight weeks, some degradation was noticeable in both PCLU-24 and 
POSS-PCLU-24 which presumably accelerated tissue infiltration.  
 Histological sections of end organs revealed no signs of inflammation when exposed 
to degradation products of any of the scaffolds (Fig. 6.22), suggesting excellent 
biocompatibility of both PCLU and POSS-PCLU scaffolds. 
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Figure 6.22. Representative haematoxylin & eosin stains of in vivo response to PCLU and POSS-
PCLU scaffolds. (A) Heart, (C) lung, (E) liver, (G) spleen and (I) kidney tissues with the 
corresponding sham-treated tissues (B, D, F, H and J). Magnification x 100. 
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6.5 CONCLUSION 
We synthesized a novel nanocomposite PU based on a poly(ε-caprolactone 
urea)urethane backbone integrating POSS nanoparticles. Differences in hard segment 
content and presence or absence of POSS particles were analysed with respect to their 
influence on in vitro and in vivo degradative behaviour. Degradation was strongly 
dependent upon hard segment micro-domain formation with PUs containing the highest 
number of hydrolytically labile urea and urethane bonds exhibiting the least degradation. 
Additionally, the mode of degradation was strongly influenced by POSS nanoparticle 
inclusion due to its ability to influence degradation.  
Rather than degrading into a stiff and brittle film which may compromise 
functionality of the implanted device, POSS nanoparticles were able to tailor material 
degradation whilst retaining vital elasticity. This is of great importance for tissue 
engineering applications involving tissues such as the skin or vasculatures. 
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7 PHOTO-POLYMERIZABLE GELATIN AS SKIN 
TISSUE ENGINEERING SCAFFOLDS: 
MECHANICAL, DEGRADATION AND 
BIOLOGICAL CONSIDERATIONS 3 
7.1 SYNOPSIS 
Biomimetic composite hydrogels based on natural polymers have generated 
significant interest in the field of tissue engineering and regenerative medicine. Gelatin 
which is the hydrolysed derivative of collagen retains the bio-functionality of its parent 
polymer and is biodegradable under physiological conditions. Additionally, collagen is 
the most abundant protein in extracellular matrix (ECM) of most tissues. Whilst gelatin 
hydrogels have been investigated for various tissue engineering applications, their 
suitability as a skin regeneration scaffold has not been researched so far. In this chapter, 
hydrogels based on methacrylated gelatin (GelMA) were generated. Their physical and 
biological properties were tunable by using different concentrations of gelatin with or 
without the addition of polyethylene glycol-diacrylate (PEG-DA) which has previously 
been shown to enhance mechanical properties. Physical properties including swelling 
ratio, degradation and mechanical properties were investigated. Moreover, in vitro 
cellular responses of an immortalized human keratinocyte cell line (HaCaT) and their 
potential for creating an epidermal layer were investigated. It was found that higher 
concentrations of GelMA and PEG-DA correlated with increased compressive moduli and 
decreased swelling as well as degradation rates. HaCaT culture at the air-liquid interface 
                                                             
3 In collaboration with the Khademhosseini laboratories at Harvard-MIT, Boston, USA. 
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resulted in the reconstruction of a stratified epidermis resembling that of normal human 
skin.  
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7.2 INTRODUCTION 
Skin is the largest organ of the human body and is composed of three layers 
including epidermis, dermis and hypodermis (Metcalfe and Ferguson, 2007). These three 
layers play an important role in protecting the body from any mechanical damage and 
against pathogens and microorganisms (Groeber et al., 2011). Loss of integrity of large 
portions of skin due to injury or illness may result in significant disability or even death. 
Healing of cutaneous wounds involves the regeneration of surface epidermis and repair 
of connective tissues by events that are largely independent of one another. If the wound 
is a shallow one, epidermal regeneration precedes repair in the dermis, but if the injury 
extends to the full thickness of the skin, epidermal regeneration and growth of 
granulation tissue takes place concurrently. In the past 30 years, great efforts have 
therefore been made to create substitutes that mimic human skin.  Ideally, tissue-
engineered skin needs to (i) provide a barrier layer of renewable keratinocytes which (ii) 
provides an elastic structural support for skin and (iii) is securely attached to the 
underlying dermis (MacNeil, 2007). Currently, however, no commercially available 
tissue-engineered skin replacement material possesses all of the above-mentioned 
properties (Shevchenko et al., 2010a). 
Current strategies to develop an ideal keratinocytes layer involves the use of 
suitable biocompatible and biodegradable scaffolds, such as collagen, hyaluronic acid and 
other biopolymers capable of supporting keratinocyte growth (Liu et al., 2010).  Amongst 
these, collagen is one of the most popular materials for production of tissue engineered 
human skin equivalents (e.g. Integra® dermal regeneration template, Apligraf®) as it is 
the major component of skin and constitutes the major part of the ECM (Harley and 
Yannas, 2007). Advantages of collagen are, however, offset by possible toxicities caused 
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by residual catalysts, initiators and unreacted or partially reacted chemical cross-linking 
agents that are generally employed to improve stability and mechanical properties (Yeh 
et al., 2011). One collagen derivative, namely gelatin (hydrolysed collagen), has a 
relatively lower antigenicity compared to collagen whilst maintaining the properties of 
biocompatibility and biodegradability and has thus become a popular alternative. In 
addition, gelatin is significantly less expensive than collagen (Yeh et al., 2011). 
Methacrylated gelatin (GelMA) maintains its unique properties, but additionally allows 
the material to be solidified from liquid to solid permanently upon light exposure 
whereas solidified gelatin may return to liquid state upon warming, limiting their 
usefulness in the body to temporary structures. We hypothesized that as a light 
polymerizable hydrogel based on collagen motifs, GelMA could successfully be 
micropatterned into a variety of shapes and configurations for tissue engineering and 
microfluidic applications, while retaining its high encapsulated cell viability and cell-
responsive elements (i.e. binding and degradation). In this chapter, gelatin methacrylate 
was used as scaffold material to achieve an ideal keratinocyte layer for further 
development of a multi-layered epidermis. 
Previously, it was reported that  keratinocytes increased adhesion density on stiffer 
hydrogel surfaces (Xu et al., 2012). Additionally, it was found that keratinocyte spreading 
and differentiation was associated with stiffness of polyacrylamide (PAAm) hydrogel 
(Trappmann et al., 2012). Currently, there are few studies researching the effects of 
stiffness on keratinocyte culture to produce a viable epidermis comprised of a stratified 
layer of keratinocytes. The aim of the present study is to understand the effect of material 
properties (i.e., stiffness, degradation and biological properties) on the reconstruction of 
an artificial epidermis to control proliferation, differentiation and stratification of human 
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keratinocytes. Firstly, hydrogels consisting of GelMA of incrementally increasing stiffness 
were fabricated. Then, HaCaT cells were seeded onto these hydrogels to develop a 
confluent cell monolayer which was then lifted to the air-liquid interface (ALI) to 
reconstruct a multilayer of keratinocytes (stratified epidermis). The effect of hydrogel 
properties on cell morphology, attachment, proliferation and stratification was 
quantified and eventually the optimum formulation was selected for the development of 
an artificial epidermis (Fig. 7.1).  
 
 
Figure 7.1. Schematic illustration of the synthesis steps involved in creating an artificial epidermis 
on gelatin methacrylate (GelMA) hydrogels. 
 
7.3 MATERIALS AND METHODS 
7.3.1 Materials 
Porcine skin gelatin, methacrylic anhydride were purchased from Sigma-aldrich, St. 
Louis, MO; Dulbecco's phosphate buffered saline (DPBS), fetal bovine serum (FBS), 
live/dead® assay, rhodamine-phalloidin, 4',6-diamidino-2-phenylindole (DAPI), Quant-
iT™ PicoGreen® dsDNA reagent kits were from Invitrogen, San Diego, CA; proteinase k 
were from HyClone, Logan, UT; 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-
propanone (Irgacure 2959) from CIBA Chemicals, Basel, Switzerland; polyethylene 
glycol-diacrylate (PEG-DA; Mw 4000) was purchased from Sigma-Aldrich Chemical Co. (St. 
Louis, MO, US).  
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7.3.2 Synthesis of Gelatin Methacrylate (GelMA) 
GelMA was synthesized as described previously (Van Den Bulcke et al., 2000). 
Briefly, 10 g of type A porcine skin gelatin was mixed at 10 % (w/v) into DPBS at 60 °C 
and stirred until fully dissolved. 8 mL of methacrylic anhydride was added until the target 
volume was reached at a rate of 0.5 mL/min to the gelatin solution under stirred 
conditions at 50 °C and allowed to react for 3 h. Following a 5 x dilution with additional 
warm (40 °C) DPBS to stop the reaction, the mixture was dialyzed against distilled water 
using 12–14 kDa cut-off dialysis tubing for 1 week at 40 °C to remove salts and unreacted 
methacrylic anhydride. The solution was lyophilized for 1 week to generate white porous 
foam and stored at −80 °C until further use. The degree of methacrylation was quantified 
using 1H NMR spectroscopy. The spectra were collected at room temperature in 
deuterium oxide at a frequency of 600 MHz using a Varian INOVA NMR spectrometer with 
a single axis gradient inverse probe. 
7.3.3 Preparation of GelMA Hydrogels with Varying Degrees of Methacrylation 
Incrementally increased amounts of freeze-dried GelMA macromer was mixed into 
DPBS containing 0.5 % (w/v) 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-
propanone (used as photo-initiator) at 80 °C to make final concentration of GelMA at 5, 
7.5, 10, 12.5, 15, 17.5 and 20 % (w/v). The prepolymer solution was then pipetted into a 
polydimethylsiloxane (PDMS) mold, covered with 3 - (Trimethoxysilyl) propyl 
methacrylate (TMSPMA) treated glass slide and exposed to 6.9 mW/cm2 UV light (360 - 
480 nm). For mechanical, swelling ratio and degradation study, samples of 6 mm 
diameter and 3 mm thickness were fabricated upon 180 s UV exposures whereas for 
biological studies, samples of 8 mm diameter and 200 µm thickness were produced upon 
30 s UV exposure. For all test, 4 replicates were used unless otherwise stated. 
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7.3.3.1 Introduction of PEG+ 
To a subset of GelMA prepolymer solutions of 5, 10, 15 and 20 % (w/v), PEG-DA 
(Mw 4000) at concentrations of 1 % (v/v) of the initial GelMA concentrations (i.e. 0.5, 1, 
1.5 and 2 % (v/v)) was added and processed into hydrogels as described in section 7.3.3. 
7.3.4 Characterization of GelMA Hydrogels 
7.3.4.1 Mechanical Testing 
Cross-linked samples were detached from the glass slide and incubated in DPBS at 
37 °C for 24 h. The samples were blotted dry and compressed at a rate of 1 mm/min using 
an Instron 5542 mechanical tester. The compressive modulus was determined as the 
slope of the linear region of stress-strain curve corresponding with 0–10 % strain.  
7.3.4.2 Water Content Analysis 
Detached samples were incubated in DPBS at room temperature for 24 h, removed 
from DPBS, lightly blotted dry and weighted (WS). Samples were then lyophilized and 
weighed to determine the dry weight (WD). The water content of the swollen gel (SR) was 
calculated according to the following equation: 
𝑆𝑅 =  
𝑊𝑆 − 𝑊𝐷
𝑊𝑆
− 100 % 
 
7.3.4.3 Determination of diffusibility of hydrogel formulations 
All diffusibility studies were performed at 37 °C. Samples of 5 % (v/v) or 20 % (v/v) were 
placed in 1.5 mL Eppendorf tubes with 500 µL of FITC-labelled BSA in DPBS. At 0, 1, 2, 4, 
6, 8 and 24 h, samples were collected and fluorescence was visualised under a fluorescent 
microscope at x 4 magnification. 
 270 
 
7.3.4.4 Degradation Study 
Samples were placed in 1.5 mL Eppendorf tubes with 500 µL of DPBS with 2 U/mL 
of collagenase type II at 37 °C.  At time points 0, 2, 10, 24, 48, 72 and 96 h, the collagenase 
solution was removed and the samples were washed twice with sterile deionized water, 
freeze-dried and weighed. The percentage degradation (DP) of the gels was determined 
using the following equation: 
DP = 
W0-Wt
W0
 x 100 % 
where W0 is the initial sample dry weight and Wt is the dry weight after time t. 
7.3.5 Culture of Human Keratinocytes (HaCaT) 
HaCaTs were incubated at 37 °C in DMEM supplemented with 10 % FBS and 1 % 
penicillin/streptomycin.  The cells were maintained in tissue culture polystyrene (TCP) 
and passaged 1:6 when the cells reached 70 % confluence.   
7.3.5.1 Culture of HaCaT Monolayer 
7.3.5.1.1 Cell Adhesion 
HaCaT cell suspension was seeded on surfaces of samples of different GelMA 
concentration at a seeding density of 2 x 106 cells/cm2. Rhodamine-labelled 
phalloidin/DAPI for F-actin/cell nuclei staining was used according to the manufacturer’s 
instructions to examine cell adhesion on samples following 1, 4, 24 h, 4, and 7 days of 
culture in medium. Briefly, following 3 washing steps with PBS, samples were fixed in 4 % 
paraformaldehyde (PFA) for 30 min, permeabilized using 0.1 % Triton X-100 for 20 min, 
then blocked in 1 % BSA for 45 min. Rhodamine-labelled phalloidin solution (dilution 
1:40) was then added and incubated with the cells at 37 °C for 45 min. The samples (at 7 
days) were doubly stained with E-Cadherin antibodies (a cell adhesion molecule and 
epithelial cell marker) diluted 1:200 in PBS containing 1 % BSA for 45 min at room 
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temperature. Samples were subsequently incubated with FITC-labelled goat-anti-mouse 
secondary antibody (dilution 1:800) for 45 min in dark conditions. Last, DAPI solution 
(dilution 1:1000) was added to the cells and incubated at 37 °C for 5 min. The cells were 
then imaged and the cell number and cell area were measured using NIH ImageJ software. 
7.3.5.1.2 Cell Proliferation  
Cell proliferation was evaluated using PicoGreen® DNA quantification assay. At each 
time point (0, 1, 4 and 7 days), the samples were lysed for 2 h with 500 µL of 50 µg/mL 
proteinase K at 37 °C, and pelleted by centrifugation at 18000 x g at 4 °C for 10 min. 
Samples were then incubated with PicoGreen® working solution, dilution 1:200, for 5 min 
at room temperature, protected from light. Fluorescence of the whole sample mixture 
was measured in 96-well plates (Thermo Fisher Scientific, Waltham, MA), at excitation 
and emission wavelengths of 485 and 520 nm, respectively, using a microplate reader 
(Fluostar, Ortenberg, Germany). 
7.3.5.1.3 Epidermal Differentiation of HaCaT Monolayers 
Differentiation of HaCaT monolayers was monitored using Involucrin, a 
differentiation marker of HaCaT. After cells were cultured in submerged conditions for 1, 
4 and 7 days,  the samples were fixed in -20 °C methanol for 10 min, permeabilized in 0.5 % 
Triton for 5 min, then blocked twice using a mixture of 5 % BSA and 10 % goat serum for 
30 min each. Cells were subsequently incubated with the primary antibodies to 
Involucrin at 1:1000 for 45 min at room temperature and then with Alexa Fluor 488-
conjugated secondary antibody ( goat-anti-mouse antibody, dilution 1:800) for 45 min in 
dark conditions at room temperature. Cell nuclei were then counter-stained with DAPI 
for 5 min. All samples were imaged immediately without mounting.  
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7.3.5.2 Reconstruction of Human Epidermis 
After one week of culture under submerged condition, cells were conditioned in 
serum-free medium for 2 h before being lifted to the ALI. Cells remained at the ALI for 2 
weeks with regular changes of differentiation medium (3:1 DMEM:F12, 1 % Pen/Strep, 
5 % FBS). In order to view the stratified multilayer of the resultant epidermis, samples 
were fixed in 4 % PFA, embedded in parafﬁn and cut at 5 µm using a Reichert-Jung 2035 
microtome. Sections were picked up on 2 % 3-aminopropyltriethoxysilane (APES) in 
acetone coated slides and stained with hematoxylin and eosin (H&E). After 
deparaffinization and rehydration, the sections were boiled in 10 mM citrate buffer. 
Endogenous peroxidase activity was quenched with 3 % hydrogen peroxide in methanol. 
The sections were then incubated following the protocol described by the manufacturer. 
Slides were incubated with blocking buffer followed by the application of the primary 
antibody Ki-67 at 1:100 and Involucrin at 1: 100 overnight at 37 °C. Sections were then 
labelled with secondary antibodies (Alexa Fluor 488-conjugated secondary antibody 
(goat-anti-mouse antibody, dilution 1:500) and Alexa Fluor 594-conjugated secondary 
antibody (goat-anti-rabbit antibody, dilution 1:800), respectiveley). Visualization of 
samples was performed using a Nikon Eclipse Ti-S fluorescence microscope. 
7.3.6 Statistics 
Please refer to section 4.3.6. 
7.4 RESULTS AND DISCUSSION   
7.4.1 Effects of Methacrylation Degree, PEG and Surface Modifications on GelMA 
Hydrogel Properties 
7.4.1.1 Tunable Compressive Moduli and Degradation Rates 
Mechanical properties of hydrogels are well documented to influence cellular 
behaviour, function and differentiation (Engler et al., 2006, Engler et al., 2007). To 
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compare mechanical properties of photocrosslinked hydrogels of different GelMA 
concentrations, constant strain-rate compression tests were performed over time on 
samples incubated in DPBS. In general, statistical analysis illustrated a significant effect 
of increasing GelMA concentrations on the compressive modulus of hydrogels indicating 
a tunability of their compressive moduli (p < 0.05; Fig. 7.2). Addition of PEG-DA, however, 
did not significantly increase the compressive modulus compared to corresponding 
control formulations without PEG-DA, contradicting previous reports (Hutson et al., 
2011), except for hydrogels of 20 % (w/v) GelMA where addition of PEG-DA resulted in 
a synergistic effect on the compressive modulus, enhancing the modulus more than an 
increase in GelMA concentration alone. We hypothesize that at 20 % GelMA concentration, 
covalent crosslinking reduced gelatin dissolution enough allowing for increased gelatin 
resident time within the matrix, thus increasing the duration of its biofunctionality. 
Increasing the GelMA concentration from 5 % to 20 % increased the compressive 
modulus by > 50-fold whilst increasing the equivalent hydrogel to 20 % + PEG-DA 
increased compressive moduli by > 80-fold. These data reveal a tunable increase in the 
compressive modulus of composite hydrogels. 
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Figure 7.2. Compressive moduli of hydrogels of different GelMA concentrations with or without 
PEG-DA supplementation. (A) Results for hydrogels after synthesis and (B) after dehydration and 
subsequent rehydration. Results are given as mean ± one SD. * = p < 0.05. 
(A) 
(B) 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
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Table 7.1 summarizes the different GelMA formulations with and without the 
addition of PEG-DA and the resultant mechanical properties and degradation behaviours.  
 
Table 7.1. Differences in mechanical properties, water content and degradation rate with 
incrementally increasing GelMA content. 
Formulations Compressive Modulus 
(kPa) 
Water Content  
(%) 
Degradation after 96 
h (%) 
GelMA 5 % 2.5 ± 0.4 94.2 ± 0.8 100 ± 0.0 
GelMA 7.5 % 14.1 ± 3.1 92.9 ± 1.4 100 ± 0.0 
GelMA 10 % 26.0 ± 1.2 87.8 ± 0.4 39.5 ± 3.2 
GelMA 12.5 % 43.2 ± 4.1 86.3 ± 0.2 30.0 ± 3.5 
GelMA 15 % 88.8 ± 21.6 85.0 ± 0.4 21.2 ± 4.3 
GelMA 17.5 % 97 ± 24.5 84.1 ± 0.4 17.5 ± 3.1 
GelMA 20 % 107.6 ± 18.0* 82.5 ± 0.3 13.5 ± 3.9 
GelMA 5 % + 0.5 % PEG 2.3 ± 0.7 93.7 ± 0.1 58 ± 5.6* 
GelMA 10 % + 1 % PEG 27.2 ± 4.8 88.0 ± 0.5 32.1 ± 3.1 
GelMA 15 % + 1.5 %PEG 103.8 ± 2.2 84.6 ± 0.4 10.8 ± 2.1* 
GelMA 20 % + 2 % PEG 162.8 ± 36.5* 82.0 ± 0.7 4.5 ± 1.1* 
*statistically significant difference compared with control formulations without PEG. 
 
From a macroscopic perspective, varying degrees of methacrylation do not result in 
obvious differences in GelMA hydrogel appearance (Fig. 7.3).  
 
 
Figure 7.3. Macroscopic view of GelMA hydrogels of increasing methacrylation degree. (A) 5 % 
GelMA, (B) 10 % GelMA, (C) 15 % GelMA and (D) 20 % GelMA.  
(A) (B) 
(C) (D) 
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However, upon handling the hydrogels, those of lowest GelMA percentage (5 % 
(w/v)) unsurprisingly appeared more watery due to a lesser degree of cross-linking and 
subsequent inability to store water.  
The water content and swelling characteristics of hydrogels are critical in tissue 
engineering applications, as they can greatly affect the pore size, mechanical properties 
and diffusivity of oxygen, drugs, nutrients and other water-soluble metabolites 
(Bayramoglu et al., 2014, Peppas et al., 2006). This was of particular importance 
considering subsequent elevation of GelMA hydrogels to the air-liquid interface (ALI) for 
keratinocyte stratification and epidermal reconstitution. As such, the effects of 
incrementally increasing GelMA concentrations as well as PEG-DA on the swelling 
profiles of composite hydrogels was evaluated. Figure 7.4 (II) and (III) show the water 
content and degree of swelling as a function of GelMA concentration. Statistical analysis 
revealed a significant effect of GelMA concentrations in driving the swelling properties of 
the hydrogels (p < 0.05). The general trend for the tested formulations is a decreased 
water content and swelling degree with increasing GelMA concentrations as a higher 
GelMA concentration resulted in a higher amount of cross-links which altered the bulk 
properties of the resulting hydrogels by increasing the cross-linking density. This, in turn, 
reduced the space between gel networks and resulted in a decreased swelling ratio 
secondary to the development of higher elastic constraints when the gels were swelled 
in water. For the hydrogels containing the smallest GelMA concentration, the swelling 
percentage is about 170 % at swelling equilibrium. For the gels containing the highest 
amount of GelMA, the swelling percentage is about 15 % at equilibrium. Water content 
for all GelMA formulations was > 80 % supporting results obtained by swelling tests. 
 
(A) GelMA 5 %, 0 h  (B) GelMA 5 %, 24 h 
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Figure 7.4. (I) Diffusion study on 5 % and 20 % GelMA using Fluorescein isothiocyanate (FITC)-
labelled bovine serum albumin (BSA). (A) GelMA 5 % at 0 h, (B) GelMA 5 % at 24 h, (C) GelMA 20 % 
at 0 h and (D) GelMA 20 % at 24 h. Magnification x 4. Scale 100 µM. (II) Water content analysis as 
a function of GelMA concentration. (III) Hydrogel swelling capacity as a function of GelMA 
concentration. Results are given as mean ± one SD. * = p < 0.05. 
 
However, PEG-DA supplementation did not results in statistically significant 
differences in swelling ratio or water content. Due to collagen being a hydrophilic 
structure, large intake of water by the cross-linked gel network was observed. 
Similar to native gelatin, GelMA maintains its susceptibility to enzymatic 
degradation. PEG hydrogels, on the other hand, cannot be degraded enzymatically 
(Benton et al., 2009). Previous studies investigating the degradation profiles of GelMA 
with or without PEG-DA used 2.5 U/mL of type II collagenase (Benton et al., 2009, Hutson 
(C) GelMA 20 %, 0 h (D) GelMA 20 %, 24 h  
(I)  
(II)  
* 
* 
* 
* 
* 
* (III)  
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et al., 2011). Here, we implemented a similar method to analyse degradation patterns of 
composite hydrogels. The remaining mass of photocrosslinked hydrogels over time was 
determined as a measure of degradation. Statistical analysis of the obtained results 
revealed a significant effect of incrementally increasing GelMA concentrations on the rate 
of degradation (p < 0.05). 
Similarly, a significant effect of PEG-DA concentration on degradation rates was 
observed with PEG-DA synergistically acting with GelMA to reduce degradation rates. 
Over a period of 96 h, hydrogels with the lowest GelMA concentration (5 % (w/v)) 
completely degraded while incrementally increased methacrylation degrees 
corresponded to slower degradation rates (Fig. 7.5 (A)).  
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Figure 7.5. Remaining mass as a function of time for (A) GelMA hydrogels of different 
methacrylation degrees and (B) GelMA PEG-DA composite hydrogels. Results are given as mean ± 
one SD.  
 
GelMA hydrogels containing PEG-DA demonstrated even higher resistance to 
degradation compared to the same percentage GelMA without PEG-DA, indicating a 
bimodal tunability of degradation rates. After 96 h of degradation, hydrogels of 10 % 
GelMA concentration retained 60.5 % of their mass whilst hydrogels of 10 % GelMA + 
(A) 
(B) 
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PEG-DA retained 67.9 % of their mass which is a 7.4 % increased mass compared to 
GelMA alone. The difference in mass between 15 % GelMA and 15 % GelMA + PEG-DA 
after 96 h of degradation was even higher at 12.3 %. These data illustrate that PEG-GelMA 
composite hydrogels display tunable degradation rates which can be altered by changing 
the concentrations of either GelMA, PEG-DA or both. 
7.4.1.2 Cellular Response to Surface Mechanical Properties 
The ECM provides mechanical, biochemical and biophysical cues able to influence 
surrounding cellular behaviour. These are largely due to the ECM composition (i.e. 
glycoproteins, matrix proteins, proteoglycans and glycosaminoglycans (Badylak, 2005)) 
which provides a 3D micro-environment for cell growth (Cukierman et al., 2001). In 
addition to such molecular signals, certain anchorage-dependent cells further sense and 
can respond to changes in a biomaterial’s modulus of elasticity, or stiffness (Discher et al., 
2005) by altering cellular behaviours including cell proliferation, locomotion, adhesion, 
spreading, morphology, striation and differentiation in the case of stem cells (Discher et 
al., 2009, Engler et al., 2004, Flanagan et al., 2002, Khatiwala et al., 2006, Pelham and 
Wang, 1997, Reinhart-King et al., 2005, Wang et al., 2000). For example, NIH 3T3 murine 
fibroblasts have been demonstrated to undergo more apoptosis and reduced 
proliferation on relatively soft as opposed to stiff substrates (Wang et al., 2000). On the 
other hand, when grown on stiff polyacrylamide (PAA) hydrogels, NIH 3T3 cellular 
spreading was seen to increase. Similarly, keratinocytes cultured on gelatin hydrogels of 
different gelatin concentrations reinforced with different concentrations of PEG-DA 
demonstrated increased adhesion density and more intercellular connections on stiffer 
hydrogel surfaces (Xu et al., 2012). Higher gelatin concentrations which corresponded to 
increased stiffness provided more cell-binding motifs such as Arg-Gly-Asp (RGD) for cell 
adhesion. PEG, on the other hand, lacks these cell binding sequences but allows for the 
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fine-tuning of the hydrogel’s mechanical and degradation properties. First, in order to 
investigate the effects of different GelMA concentrations on cellular adhesion and 
proliferation, HaCaT cells were seeded onto GelMA hydrogels, cultured for 7 days and 
stained with FITC-labelled phalloidin and DAPI to visualise F-actin fibres and the cell 
nucleus, respectively (Fig. 7.6).  
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Figure 7.6. (I) Cell proliferation on GelMA hydrogels of (A) 5 %, (B) 10 % and (C) 20 % GelMA 
concentration. Cells were stained for FITC-labelled Phalloidin (i) and nuclei were counterstained 
with DAPI (ii). Images were merged in (iii). (II) Cell counts per mm2 as a function of GelMA 
concentration. (III) Influence of GelMA concentration and resultant compressive moduli on cell 
proliferation over a period of 7 days. Results are given as mean ± one SD. * = p < 0.05. 
(A) i (A) ii (A) iii 
(B) i (B) ii (B) iii 
(C) i (C) ii (C) iii 
(I)  
(II)  * 
* 
* 
* 
* 
(III)  
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Statistical analysis revealed a significant effect of GelMA concentration on cell 
proliferation (p < 0.05). The data demonstrated that an increased concentration in GelMA 
increased cellular attachment, suggesting that stiffer hydrogels supported more 
attachment.  
Significantly more cells attached and subsequently proliferated on hydrogels of at 
least 7.5 % GelMA percentage as opposed to 5 % GelMA hydrogels (p < 0.05). In addition, 
there was no statistically significant increase in cell numbers on hydrogels of > 10 % 
GelMA concentration, suggesting that hydrogels containing 10 % GelMA are the most 
suitable formulation for cell adhesion and proliferation.  
Therefore, for subsequent cell studies, 10 % (w/v) GelMA hydrogels were used. In 
order to investigate the effects of PEG-DA on cellular adherence and proliferation on the 
GelMA hydrogel, composite GelMA-PEG gels were synthesized and HaCaTs cultured for a 
period of 7 days. Cells were stained for cytokeratin and E-Cadherin. No differences in 
either proliferation or extent of differentiation were observed between cells grown on 
10 % GelMA, 10 % GelMA + 1 % PEG or tissue culture plastic (Fig. 7.7), the latter being 
surface-modified for ideal cell attachment and growth.  
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Figure 7.7. Fluorescent images of HaCaTs grown on GelMA hydrogels of different compositions or 
surface coatings. (A) 10 % GelMA, (B) 10 % GelMA + PEG and (C) tissue culture plastic. Cells were 
stained for (I) cytokeratin (i) or (II) E-Cadherin (i) and nuclei were counterstained with DAPI (ii). 
Stained images were overlaid with differential interference contrast (DIC) images (iii) to give 
merged images (iv). Magnification x 20. Scale 100 µM. 
 
These data indicate optimal cytocompatibility of GelMA hydrogels. However, whilst 
GelMA displays many desirable attributes as a hydrogel for tissue engineering, 
supplementation with PEG-DA has been demonstrated to enable tuning of swelling as 
well as degradation rates without compromising cytocompatibility.  
7.4.2 Reconstructed Human Epidermis 
Previously, studies about the development of artificial epidermis relied on the 
observations that keratinocytes can be grown in vitro to produce thin epithelial sheet 
graft (Rheinwald and Green, 1975). However, the need for a fibroblast feeder layer as well 
as low plating efficiency shifted efforts into developing alternative culture techniques 
involving the use of biocompatible and biodegradable scaffolds such as collagen or 
hyaluronic acid which are capable of favouring keratinocyte growth (Liu et al., 2010, 
Machens et al., 2000). Such composite dermal-epidermal skin substitutes, however, may 
only survive provided the epidermal layer is firmly attached to the dermal substrate 
(Cooper et al., 1990). We thus sought to use a hydrogel which favoured skin cell adhesion 
and proliferation, facilitated ECM deposition and were biocompatible. Our results 
(A) i 
(C) i 
(B) i 
(C) ii 
(B) ii 
(C) iii 
(B) iii 
(A) iv 
(C) iv 
(B) iv 
(II)  
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 283 
 
demonstrated the 10 % (w/v) GelMA hydrogel fulfilled all those three requirements. H&E 
stained images demonstrated the development of a multi-layered and stratified 
epidermis after 4 weeks of culture at the air-liquid interface (ALI) not dissimilar to human 
skin (Fig. 7.8 (A) and (C)). Next, epidermal layers grown on GelMA hydrogels and human 
skin were stained for Ki67, a proliferation marker which is usually confined to the 
proliferative compartment of the basal keratinocyte layer (McCormick et al., 1993) and 
Involucrin, an early marker of terminal differentiation normally detected in the upper 
stratum corneum and stratum granulosum. 
 
 
Figure 7.8. (A) Haematoxylin and eosin (H&E) histological section of human skin and (B) 
fluorescent image human skin stained for Ki61 and involucrin. (C and D) Corresponding images of 
HaCaTs cultured on GelMA hydrogels at the air-liquid interface for 4 weeks. Magnification x 4. 
Scale 100 µM. 
 
Immunohistochemical examination revealed Involucrin positive cells in the entire 
stratum granulosum of human skin but only few within the reconstructed epidermis after 
4 weeks of ALI. Ki67 positive cells were seen to be confined within the basal layer in 
(A) (B) 
(C) (D) 
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human skin but scattered throughout all epidermal layers when cultured on GelMA (Fig. 
7.8 (B) and (C)). These results indicate that whilst the constructed composite skin 
substitute can form a multi-layered epidermis with histological similarities to that of 
normal skin, the organisation of the distinct layers found within healthy skin was 
somewhat distorted. It is possible that both the use of the immortalized HaCaT cell line 
as well as a lack of a dermis proper resulted in a lack of vital paracrine signalling factors 
for structural organization of the epidermis. It has previously been demonstrated that 
HaCaT cells grown on collagen gels containing human dermal fibroblasts produced a 
well-structured and differentiated squamous epithelium with a nearly complete 
basement membrane after 3 weeks of organotypic co-culture (Schoop et al., 1999).  
7.5 CONCLUSION 
This chapter highlights the ability to influence mechanical, degradation and cell 
behaviour on GelMA hydrogels by tuning the concentrations of GelMA, PEG-DA or both.  
We created an artificial skin comprising of a stratified layer of keratinocytes and a dermal 
matrix consisting of GelMA hydrogel. The obtained data suggest that GelMA-PEG-DA 
composite hydrogels may be customised to meet necessary requirements for skin tissue 
engineering.  
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8 OVERALL CONCLUSIONS AND FUTURE 
OUTLOOK 
8.1 LIMITATIONS OF SYNTHETIC POLYURETHANES AND COLLAGEN-BASED 
HYDROGELS AND A PROPOSAL FOR A FUTURE BIO-SYNTHETIC COMPOSITE 
MATERIAL 
8.1.1 Advantages and Disadvantages of Polyurethanes as Tissue Engineering Platforms 
The majority of PUs used in the manufacture of degradable tissue engineering 
platforms belongs to the polyester family. Scaffolds based on biodegradable PGA, PLA, 
their copolymers and PCL have been extensively researched for their use as tissue 
regeneration platforms, not only due to their degradability, but primarily due to their 
controllable manufacture and facile modifiability which enables exact tailoring of the 
polymeric structure to suit individual applications (Shirakata et al., 2014, Jiang et al., 
2014, Tsao et al., 2014). The major clinical uses for such degradable systems include 
resorbable sutures, drug delivery systems and orthopaedic fixation devices (Behravesh 
et al., 1999, Middleton and Tipton, 2000). More recently, the field of tissue engineering 
and regenerative medicine has increased their focus on biodegradable scaffolds to 
regenerate not only tissues but whole organs using synthetic polyester urethanes due to 
the ability to fabricate these materials into various shapes with desired surface and pore 
morphologies conducive to tissue in-growth and vascularization. Additionally, synthetic 
polymers can be specifically designed to display chemical functional groups to further 
induce tissue regeneration. The ability to modulate mechanical parameters of synthetic 
polyester-based PU scaffolds is a further advantage which should not be underestimated 
since the viscoelastic character as well as the material stiffness have far-reaching 
implications with respect to cellular behaviour as demonstrated in chapter 7. Lastly, 
synthetic PUs are cost-effective compared to biological polymers as the starting materials 
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are cheap and material synthesis usually produces a high yield with reproducible 
structures. 
A material intended for the purpose of implantation not only has to be versatile to 
suit numerous applications but must also satisfy biocompatibility requirements; it must 
degrade into non-toxic metabolites whilst supporting appropriate cell growth and 
proliferation. Many synthetic polyester PUs, however, demonstrate room for 
improvement since frequently, their degradation products acidify the surrounding 
tissues resulting in cell damage or death. Further, their inherently hydrophobic character 
is unfavourable to cell attachment. Thus it appears that many of the currently available 
degradable synthetic PU polymers do not fulfil all of the requirements and significant 
chemical changes to their structure may be required if they are to be formulated for tissue 
regenerative applications.  
8.1.2 Advantages and Disadvantages of Collagen/Gelatin Hydrogels as Tissue 
Engineering Platforms 
Collagen, being the most abundant protein in the human body and the main 
structural protein in connective tissues, appears to be the evident first choice for tissue 
engineering applications, in particular for skin regenerative purposes. Collagen is 
inherently biocompatible as it naturally displays cell-binding motifs and has a hydrophilic 
cell-attracting nature. Gelatin, being the hydrolysed derivative of collagen, retains its 
biological properties and hydrogels made from gelatin, in particular, demonstrate 
beneficial properties as (i) hydrogels are mostly comprised of water and thus display 
excellent transport properties allowing for facile diffusion of nutrients and waste 
products, and (ii) gelatin has been found to improve wound healing as indicated by 
significantly earlier re-epithelialization and dermal maturation of the defective area 
(Huang et al., 2009).  
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Such benefits, however, are offset to a degree by their generally poor mechanical 
properties and premature degradation rates which, whilst tunable to a degree, display 
finite levels of control, unlike synthetic polymers. Further disadvantages of naturally-
derived polymers include their potential immunogenicity and ability to transmit 
pathogens when originating from animal sources, the batch variability and poor 
processability and the relatively low cost-efficiency. Poor mechanical strength may 
ultimately lead to difficulty handling such hydrogels which poses problems during 
surgical implantation of such scaffolds. The ability to tune both mechanical and 
degradation profiles by varying the cross-linking density, whilst initially appearing to 
solve the mechanical issues, almost proves to be a curse in disguise as incomplete cross-
linking and subsequent cross-linker toxicities are known to have detrimental effects on 
cells.  
Scaffolds made from synthetic and natural polymers, i.e. composite scaffolds, have 
therefore emerged as the proclaimed answer to the individual components’ drawbacks. 
The aim to exploit the undisputed benefits of both synthetic and natural polymers whilst 
addressing their respective disadvantages has concerned scientists for decades. Thus for 
future studies, a combinatorial approach to obtain a synergistically acting ‘super-
platform’ is suggested for functional tissue regeneration. 
8.2 CONCLUSIONS 
The investigations carried out in this thesis resulted in several major conclusions. 
1) Loss of skin tissue remains a major problem with infection-related morbidity and 
mortality being a leading cause of death. Additionally, the frequently suboptimal 
cosmetic outcomes for most skin-loss victims should not be underestimated as it may 
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have a considerable psychosocial impact upon the affected individuals. Currently 
available treatment strategies are lacking both in availability (i.e. limited numbers of 
organ donors) and total safety – the latter pertaining to skin substitutes derived from 
both cadaveric human donors as well as dermal substitutes derived from animal 
origins (e.g. Integra® dermal regeneration template) which bear the risks of 
pathogen transmission. Thus, an alternative treatment strategy needs to be sought 
and the emergence of tissue engineering is believed to have the potential to achieve 
just that. Conceptually, tissue engineering aims to create a biocompatible platform 
able to provide a 3D scaffolding for the wound bed which cells can recognise and 
integrate into in order to regenerate lost tissues. Ideally, the scaffold should be 
resorbable in time to create space for the newly developing structures whilst 
providing an optimum level of mechanical support for the surrounding tissues and 
cells.  However, the ideal biomaterial has yet to be developed. 
2) As such, in this thesis, a suitable scaffolding material was sought. The ideal tissue 
engineering scaffold should possess the following characteristics; (i) 
biocompatibility, (ii) biodegradability into non-toxic metabolites, (iii) non-
immunogenicity and (iv) suitability in terms of cell attachment and proliferation. 
Here, we developed a novel biodegradable nanocomposite PU based on a poly(ε-
caprolactone urea)urethane backbone integrated with POSS nanoparticles (POSS-
PCLU). The non-degradable family member POSS-PCU (a poly(carbonate 
urea)urethane) has already demonstrated clinical feasibility with several first-in-
man compassionate cases. PUs are desirable candidate materials for tissue 
engineering scaffolds due to their tunable mechanical properties and degradation 
profiles as well as their straight-forward synthesis. Advantages of incorporating 
POSS nanoparticles include its non-immunogenicity and an increase in surface nano-
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structuring which is hypothesized to enhance cell recognition and subsequent 
adherence. 
3) The main focus of this thesis was to characterize this novel nanocomposite polymer 
and attempt to demonstrate tunable degradation rates in addition to in vitro 
cytocompatibility. With this in mind, PUs of varying hard segment content were 
developed and characterised. 1H NMR and ATR-FTIR spectral analysis confirmed the 
formation of PUs with varying hard segment contents. Molecular weight analysis 
revealed no significant differences in Mn between the formulations. DSC and XRD 
studies confirmed the mostly amorphous nature of PCLU and POSS-PCLU. Compared 
to bulk properties, surface analyses of PCLU differed significantly from POSS-PCLU, 
most notably with the appearance of microscopic surface particulates which are 
hypothesized to be POSS aggregates which extrude out onto the polymer surface 
upon scaffold fabrication. Differences between PCLU and POSS-PCLU surfaces were 
further confirmed by contact angle measurements which demonstrated that addition 
of POSS leads to an increased angle. 
4) Prior to commencing in vitro cytocompatibility studies, however, the degradable 
polymer scaffolds needed to be sterilized. Conventional steam sterilization 
(autoclaving) or any other means of sterilization applying either heat or water 
molecules are suboptimal due to their potential to degrade the samples leading to 
changes in mechanical and degradation properties. Alternative methods such as 
exposure to ethylene oxide gas was also considered unsafe due to the presence of 
residual toxic fumes within the scaffolds. Several different sterilization as well as 
disinfectant methods were trialled. However, it appeared that microbial eradication 
using laboratory-available techniques inevitably resulted in changes to the surface 
structures as seen on SEM and AFM images. Interestingly, scaffolds treated with a 70 % 
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ethanol solution appeared to not only clean the scaffolds sufficiently but also 
enhanced cell adherence and proliferation. Upon further investigation of the 
literature, ethanol treatment had been suggested to be used as a post-production 
processing tool in order to enhance cytocompatibility. 
5) Despite reasonable cytocompatibility, POSS-PCLU scaffolds remain suboptimal due 
to their inherent hydrophobicity. In an attempt to develop a scaffold with favourable 
cytocompatibility whilst retaining the viscoelastic properties of POSS-PCLU, a 
composite scaffold based on synthetic POSS-PCLU and a naturally-derived polymer 
was conceptualized. In collaboration with the Khademhosseini laboratories at 
Harvard-MIT, a biological hydrogel consisting of methacrylated gelatin (GelMA) was 
synthesized and its in vitro compatibility with an immortalized human keratinocyte 
cell line (HaCaT) was assessed.  As expected, hydrophilic GelMA hydrogels were 
superior in terms of cytocompatibility compared to POSS-PCLU scaffolds. The results 
demonstrated that GelMA hydrogels were tunable, to a degree, with respect to their 
mechanical properties and degradation profiles – both factors are important for 
keratinocyte growth. HaCaTs cultured on GelMA hydrogels of different 
methacrylation degrees revealed better spreading on stiffer gels. Eventually, an in 
vitro reconstructed stratified epidermal layer was created on GelMA hydrogels which 
demonstrated similarities to natural human skin. Regrettably, however, it was not 
possible to combine GelMA with POSS-PCLU due to issues surrounding intellectual 
property rights. 
6) Subsequently, focus was placed back onto the evaluation of POSS-PCLU. In vitro 
degradation studies involved the exposure of the different PU formulations to 
hydrolytic, oxidative and enzymatic conditions to simulate the in vivo scenario. Hard 
segment content was demonstrated to influence degradation significantly, thus 
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confirming our hypothesis of rate tunability. Furthermore, the integration of POSS 
nanoparticles was shown to affect the mode of degradation, allowing for a bulk loss 
whilst retaining its viscoelasticity as opposed to developing a brittle nature as was 
seen with the same PU lacking POSS. This was thought to be due to the protective 
function exerted by POSS nanoparticles on the soft segments of the PU which are 
responsible for the material’s elasticity. 
7) Subcutaneous implantation studies demonstrated that POSS nanoparticle 
incorporation into the scaffold conferred a degree of immune tolerance to the 
composite system. Additionally, POSS-PCLU demonstrated the ability to become fully 
integrated into the host system as shown by extensive vascularization and connective 
tissue deposition into the scaffold. Simultaneous scaffold degradation could be 
observed, suggesting that POSS-PCLU may fulfil the important criterium of timely 
degradation. 
8.3 CLOSING REMARKS AND FUTURE OUTLOOK 
Despite inexhaustible efforts having contributed significantly to the status quo of 
the field of tissue engineering and regenerative medicine, the ultimate panacea in terms 
of biomaterial scaffold is yet to be developed. Obstacles including the incomplete 
elucidation of the extensive biomolecular cascades leading to complete tissue 
regeneration and the current inability to fully mimic human disease or injury states in 
vitro or in vivo remain to be overcome. Little by little, each tiny piece of new information 
will contribute to the colossal puzzle that is nature. 
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Appendix 
9 SURFACE AND MECHANICAL ANALYSIS OF 
EXPLANTED POLY IMPLANT PROSTHÈSE 
SILICONE BREAST IMPLANTS 4 
9.1 SYNOPSIS 
The recent events surrounding Poly Implant Prosthèse (PIP) breast implants have 
renewed the debate about the safety profile of silicone implants. The intentional use of 
industrial-grade instead of certified medical-grade silicone is thought to be responsible 
for reportedly higher frequencies of implant rupture in vivo. The differences in 
mechanical and viscoelastic properties between PIP and medical-grade silicone implant 
shells were investigated. Surface characterization of shells and gels was carried out to 
determine structural changes occurring after implantation. Breast implants were 
obtained from women at the Royal Free Hospital (London, UK). PIP implants were 
compared with medical-grade control silicone implants. Tensile strength, tear resistance 
and elongation at break were assessed using a tensile tester. Surfaces were analysed 
using attenuated total reflectance–Fourier transform infrared (ATR-FTIR) spectroscopy. 
Spearman correlation analyses and Kruskal–Wallis one-way statistical tests were 
performed for mechanical data. There were 18 PIP and 4 medical-grade silicone implants. 
PIP silicone shells had significantly weaker mechanical strength than control shells (p < 
0.009). There were negative correlations between mechanical properties of PIP shells 
and implantation times, indicative of deterioration of PIP shells over time in vivo (r2 = –
0.75; p = 0.009 for tensile strength; r2 = –0.76; p = 0.001 for maximal strain). Comparison 
                                                             
4 The following chapter has been adapted from Yildirimer et al. Br J Surg 2013;100(6):761-767. 
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of ATR-FTIR spectra of PIP and control silicones demonstrated changes in material 
characteristics during the period of implantation suggestive of time-dependent bond 
breakage and degradation of the material. This study demonstrated an increased 
weakness of PIP shells with time and therefore supports the argument for prophylactic 
removal of PIP breast implants. 
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9.2 INTRODUCTION 
Breast augmentation using implantable silicone devices remains among the most 
commonly performed procedures in aesthetic and reconstructive surgery, with more 
than 8000 patients undergoing breast enhancement annually in the UK alone (choices, 
2012). Despite the routine use of silicone breast implants, complications such as capsular 
contraction and implant rupture are common, necessitating the removal and replacement 
of such devices after several years. According to a recent report issued by the US Food 
and Drug Administration, the reoperation rate after receiving breast implants for 
cosmetic augmentation was between 20-40 %, whereas the rate for patients having 
reconstruction was as high as 70 %, at 8–10 years after implantation (FDA, 2011). The 
recent Poly Implant Prosthèse (PIP; La Seynesur-Mer, France) breast implant scandal has 
revived realistic worries about the mechanical stability of implanted silicones. PIP breast 
implants, manufactured by the eponymous French company, were distributed globally 
beginning in 2001 until their recent ban in 2010. The intentional use of breast fillers 
manufactured with industrial silicone intended for use as mattress fillers, rather than 
acceptable medical-grade materials, has led to the withdrawal of PIP implants for breast 
augmentation. This decision was enforced by the Medicines and Healthcare products 
Regulatory Agency on 31 March 2010. Other European countries swiftly followed suit. 
Over 300 000 PIP breast implants have been distributed worldwide, with approximately 
47 000 women affected in the UK alone (NHS, 2012). With reportedly higher and more 
variable rupture and leakage rates compared with approved medical-grade silicone 
implants (AFSSAPS, 2011), PIP breast fillers have instilled significant concern in both 
patients and surgeons. This study was designed to compare the mechanical properties of 
medical-grade silicone shells used to manufacture standard breast implants and shells of 
PIP silicone implants, and to evaluate the impact of the local environment after 
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implantation on the mechanical, morphological and chemical properties of PIP silicone 
shells and gels. 
9.3 MATERIALS AND METHODS 
PIP silicone gel-filled breast implants were obtained from the Department of Plastic 
and Reconstructive Surgery, Royal Free Hampstead NHS Trust Hospital (London, UK) 
throughout January to March 2012. These prostheses had been implanted in women 
between February 2001 and May 2011. Retrieved implants were disinfected manually 
using alcohol wipes, labelled and stored until further analysis. Explanted prostheses was 
assessed by visual inspection and implants were subsequently separated into two groups 
(intact or ruptured) depending on shell integrity. In preparation for testing, the gel was 
removed from the shell, and the shell was once again disinfected as described above. 
Medical-grade silicone implants (NatrelleTM, Allergan, Marlow, UK; Mentor MemoryGel®, 
Johnson & Johnson Medical Limited, Wokingham, UK; Impleo, Nagor, Glasgow, UK) 
explanted from other women were used as controls. 
9.3.1 Mechanical and Viscoelastic Properties of Implanted Silicone Shells 
Please refer to section 4.3.4.3.3. 
9.3.2 Surface Characterization of Silicone Shells and Gels 
Please refer to section 4.3.4.2.2. 
9.3.3 Statistical Analysis 
Two-tailed Spearman rank correlation analyses were performed for tensile strength, 
strain at break and tear resistance. Kruskal-Wallis test was used for group comparison, 
followed by Mann-Whitney U test if significant. p < 0.050 was considered statistically 
significant. Graph-Pad Prism® version 5 (GraphPad, La Jolla, California, USA) was used for 
statistical analysis. 
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9.4 RESULTS AND DISCUSSION  
The recent PIP scandal has led to renewed debates about the safety of implantable 
silicone devices for the augmentation of breast tissues. In February 2012, the Scientific 
Committee on Emerging and Newly Identified Health Risks (SCENIHR) published a report 
focusing on the physical, chemical and toxicological profiles of both the filler and shell of 
PIP implants (SCENIHR, 2012). The intentional use of lower quality industrial-grade 
silicone underlies the demonstrable mechanical fragility of the PIP shells and accelerated 
biodegradability of gels. This has been confirmed by the final report of the expert group 
commissioned by the medical director of the National Health Service in the UK (Keogh, 
2012). A study conducted by the Australian Government Therapeutic Goods 
Administration, analysing low molecular weight (LMW) impurities of PIP and medical-
grade silicone gels, found higher levels of LMW cyclic silicones 
(octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylmyclo-
hexasiloxane) in PIP implants (2012). Although these impurities have not been 
associated with health risks, they are thought to accelerate outer shell weakening, 
allowing silicone to leach across the shell into the surrounding tissues (SCENIHR, 2012). 
Despite negative in vitro genotoxicity results (AFSSAPS, 2011), in vivo irritancy tests 
provided evidence for local development of sores, lymphadenopathy and breast pain, 
which were deemed to be related to the amount of extruded silicone gel and the duration 
of exposure.  
In the present study, 18 PIP breast implants were explanted from ten women, 
following implantation for a median of 126 (range 46-150) months. 4 control medical-
grade silicone implants were explanted during the same time interval (Table 9.1).  
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Table 9.1. Patient age, duration of implantation and reasons for removal of implants. 
Patient age (years) Period of implantation 
 
Duration of implantation 
(months) 
Reason for explantation 
Intact PIP shell    
40 05/2008 – 03/2012 46 Prophylactic removal following 
beast discomfort 
40 05/2008 – 03/2012 46 Prophylactic removal following 
beast discomfort 
66 04/2005 – 03/2012  83  
55 06/2004 – 02/2012 102 Left implant ruptured (not 
obtained) 
42 02/2003 – 03/2012  109  
71 05/2003 – 03/2012 118 Capsular contracture 
71 05/2003 – 03/2012 118 Capsular contracture 
50 06/2001 – 02/2012 126  
50 06/2001 – 02/2012 126 Sharp pain around implant 
35 08/2001 – 03/2012 128 Contralateral implant rupture 
44 02/2001 – 02/2012 132 Prophylactic removal 
following nipple discharge 
47 02/2001 – 02/2012 132 Prophylactic implant removal 
47 02/2001 – 02/2012 132  
35  06/1999 – 02/2012 150 Bilateral tenderness around 
implants 
35 06/1999 – 02/2012 150 Bilateral tenderness around 
implants 
Ruptured PIP shell    
42 02/2003 – 03/2012 109  
35 08/2001 – 03/2012 128 Implant rupture + white 
exudates 
44 02/2001 – 02/2012 132 Prophylactic implant removal 
following nipple discharge 
Medical-grade 
silicon (control) 
shell 
   
67 11/2005 – 12/2012 85 Capsular contracture & 
displacement  
47 12/2011 – 12/2012 12 Implant exchange post-
reconstruction 
43 04/2009 – 12/2012 32 Implant exchange for 
cosmetic reasons 
43 04/2009 – 12/2012 32 Implant exchange for 
cosmetic reasons 
 
Reasons for breast augmentation in the study population included primary 
reconstruction after mastectomy, cosmetic enhancement, and implant revision or 
exchange procedures. Reasons for implant removal ranged from prophylactic 
explantation, discomfort or tenderness around implants and nipple discharge to clinically 
determined implant rupture. Visual inspection of the implanted silicone shells and 
comparison of gels from ruptured versus intact implants demonstrated significant 
yellowing of exposed gels (Fig. 9.1).  
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Figure 9.1. (A) Ruptured Poly Implant Prosthèse (PIP) breast implant (arrow) revealing yellow 
discoloration of the industrial-grade silicone gel within. (B) Direct comparison between silicone 
gels removed from ruptured (yellow) and intact (white) implants. (C) Yellowing and calcifications 
can be seen on the surface of an explanted, non-ruptured PIP implants. 
 
Further, gels revealed variable consistency, ranging from highly cohesive to soft, 
non-adhesive and brittle. Gel cohesiveness increases as the number of cross-links 
increases, resulting in implants with superior shape retention. Gels removed from 
ruptured PIP implants were more likely to be non-adhesive and prone to breakdown on 
manual handling compared with gels taken from intact PIP and control implants. The 
probable reason for this is that in vivo exposure of the silicone gel leads to degradation 
and cross-link scission. 
9.4.1 Mechanical Testing of Silicone Shells 
Correlation analyses demonstrated that tensile strength, maximal strain at rupture 
and tear strength were negatively correlated with shell implantation times (Fig. 9.2 (A-
C)). There were statistically significant differences in tensile strength, maximal strain 
(elongation at break) and tear strength between intact and ruptured PIP compared with 
control shells (p = 0.009 and p < 0.001, respectively) (Fig. 9.2 (D-F)). 
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Figure 9.2. (A-C) Spearman rank correlation between duration of implantation and mechanical 
parameters of Poly Implant Prosthèse (PIP) silicone shells: (A) tensile strength (r2 = - 0.75; p = 
0.009), (B) elongation at break (r2 = - 0.76; p = 0.01), and (C) tear strength (r2 = - 0.49; p = 0.047). 
(D-F) Box plots comparing tensile strength (D), elongation at break (E), and tear strength (F) 
between medical-grade silicone control implants and intact and ruptured PIP shells. 6 pieces per 
implant shell were analysed. Values are presented as median (horizontal line within box), 5-95th 
percentile (box) and range (error bars). * p < 0.05 (Mann-Whitney U test).  
* * 
* 
* 
* * 
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9.4.2 Surface Characterization of Silicone Shells and Gels 
ATR-FTIR spectroscopy was performed on silicone gels and shells of PIP implants 
that had ruptured in vivo and medical-grade silicone control implants that had not 
ruptured (Fig. 9.3). All spectra showed significant peaks at 786.8 cm–1, which 
corresponded to Si–C bond vibrations. The peak at 1009.6 cm–1 is generated by the 
stretching vibrations of Si–O–Si bonds, corresponding to the polymer backbone (Kaali et 
al., 2010). Bending vibrations at 1257.4 cm–1 correspond to Si–CH3 bonds. Compared with 
the unexposed control, the peak intensities of the PIP gel at 786.8 and 1009.6 cm–1 were 
decreased significantly, whereas a new broad peak was detected between 3200 and 3600 
cm–1 (Fig. 9.3 (B)). This broad peak corresponds to vibrations of the Si–OH bonds. 
Additionally, a new ‘protein-like’ (Kaali et al., 2010) peak between 1525 and 1760 cm−1 
was observed in gels from explanted prostheses. Silicones are generally considered to be 
resistant to degradation but exposure to a strongly acidic environment results in 
hydrolytic degradation of cross-links and chain scission of the polymeric backbone (Tan 
et al., 2007). Such changes were observed in the present investigation, resulting in the 
conversion of the Si–O–Si bond to a Si–OH bond, corresponding to the appearance of a 
peak between 3200 and 3600 cm–1 on FTIR spectra of PIP gels. Kaali and colleagues (Kaali 
et al., 2010) demonstrated an association between bacterial biofilm formation on silicone 
surfaces and material degradation, leading to changes in mechanical stability and surface 
characteristics. Micro-organismal penetration of silicone implants exposes the gel to 
bacteria-derived toxins capable of gel breakdown. Peri-implant inflammation, as part of 
the foreign body response, and bacterial contamination during the implantation 
procedure further accelerate silicone degradation. 
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Figure 9.3. Overlaid attenuated total reflectance-Fourier transform infrared spectra of silicone 
gels and shells (6 per implant) from explanted Poly Implant Prosthèse (PIP) implants (A), (C) and 
comparison with medical-grade silicone control implants (B), (D). The peak at 786.8 cm-1 reflects 
Si-C bonds (800-760 cm-1), the peak at 1009.6 cm-1 represents siloxane (Si-O-Si) bonds (1100-
1000 cm-1) and the peak at 1257.4 cm-1 corresponds to Si-CH3 bonds (1280-1250 cm-1) within 
the silicone compound. The spectra obtained from the PIP implant gels and shells have different 
peak intensities, most prominently shown within the marked areas, indicative of differing numbers 
(C) 
(D) 
1257.4 cm-1 
1009.6 cm-1 
786.8 cm-1 
1257.4 cm-1 
1009.6 cm-1 
786.8 cm-1 
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of bonds within the material. This suggests material degradation, which cannot be seen in the 
spectrum of the control shells. 
 
The appearance of a ‘protein-like’ peak on infrared spectra of PIP gels that had 
ruptured in vivo (between 1525 and 1760 cm–1) corresponds to the presence of a biofilm 
and bacterial cell wall material (Donlan et al., 2004, Bosch et al., 2008, Bosch et al., 2006). 
This finding is consistent with environmentally induced breakdown of gels. Scala and 
Hickman (Scala and Hickman, 1958) demonstrated a temporal association between 
exposure to bodily fluids with or without inflammatory surroundings and silicone 
degradation. Breast implants filled with medical-grade silicone have reported rupture 
rates of 2.1 % for primary augmentation and 1.5 % for primary reconstruction 
(Hammond et al., 2012).  
3 of a total of 18 PIP implants were ruptured at explantation. Although this reflects 
the current opinion of PIP implant stability, the relatively small number of specimens 
analysed must be taken into account to avoid rash overestimation. However, this study 
corroborated correlations between the duration of implantation and PIP implant 
degeneration. Accelerated PIP implant degeneration was also reflected in the reasons for 
PIP removal, which included discomfort, nipple discharge and clinically diagnosed 
implant rupture. Control implants, however, were removed primarily for cosmetic 
reasons at relatively earlier time points compared with PIPs. This may skew results in 
favour of controls. Nevertheless, the present data demonstrated mechanical weakening 
of PIP shells compared with medical-grade shells and variability within the PIP cohort. 
Although differences between intact and ruptured PIP implants were not significant 
statistically, this trend should not be underestimated; a larger implant cohort may have 
resulted in a statistically significant difference, as demonstrated by Necchi and colleagues 
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(Necchi et al., 2011). Clinical observations have previously suggested the presence of two 
distinct subpopulations of PIP implants: those manufactured from suboptimal industrial 
silicone that are more susceptible to rupture and those containing ‘normal’ appearing 
silicones. The Agence Nationale de Sécurité du Médicament et des Produits de Santé has 
previously confirmed the heterogeneous nature of PIP implant quality (AFSSAPS, 2011). 
Although the SCENIHR has emphasized that silicone breast implants can fail regardless 
of manufacturer, several case reports have demonstrated the unreliability and 
unpredictability of PIP implants, resulting in symptomatic implant rupture and silicone 
leakage (Berry, 2007, O'Neill et al., 2008, Adams et al., 2007). This analysis of the material 
properties of substandard industrial silicones used in the manufacture of PIP silicone 
breast implants has demonstrated statistically significant negative correlations between 
PIP shell strength and implantation times. 
9.5 CONCLUSION 
The present investigation demonstrated significant correlations between duration 
of implantation and structural deterioration. Combined with the propensity of PIP 
implants to rupture prematurely, implant carriers are exposed to unknown substances 
with potentially serious long-term effects. Although a final decision for or against 
prophylactic removal of such implants must take into account the clinical picture, the data 
presented in this study strongly suggest that there is a direct relationship between 
duration of implantation of PIP breast implants and a weakening of shell mechanical 
strength, which is an independent risk factor for implant rupture and subsequent 
complications. This study therefore supports the argument for prophylactic removal of 
PIP silicone breast implants. 
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